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Muscle fatigue is defined as the reduced capacity to produce torque or power in 
response to contractile activity.  Previous work has observed greater fatigue in older than 
young adults in response to high-velocity contractions, but similar fatigue with age in 
response to moderate-velocity contractions.  The mechanisms for these age-related 
differences is not clear.  One potential explanation is a greater accumulation of putative 
agents of fatigue (e.g., Pi, H2PO4-, and H+) in older than young muscle during high- but 
not moderate-velocity contractions.  Older muscle may accumulate these metabolites to 
greater extent because of deficits in muscle metabolic economy (ME).  This dissertation 
sought to address these knowledge gaps using 31P-MRS to evaluate the role of 
bioenergetics in two studies: 1) age-related differences in knee extensor muscle fatigue in 
response to two distinct bouts of contractions chosen to permit high- (MVDC20%; 20% 
MVIC) and moderate-velocity (MVDC120; 120°.s-1) contractions, and 2) in vivo muscle 
ME during three 24-s bouts of maximal isometric, isokinetic or isotonic contractions 
(MVIC, MVDCIsoK, MVDCIsoT).  We observed similar fatigue in young and older adults 
vii 
 
in response to the MVDC20% protocol. Surprisingly, this was coincident with lower pH 
and greater [H2PO4-] in young than older muscle.  In response to the MVDC120 protocol, 
fatigue, [Pi], and [H2PO4-] were greater, and pH lower, in young than older muscle.  
During both protocols, oxidative ATP production increased from baseline to the end of 
the fatiguing contractions in older, but not young, muscle.  Collectively, these results 
indicate relatively greater oxidative ATP production in older than young quadriceps 
during in vivo contractions at two different loads (20% MVIC (MVDC20%) versus ~50% 
(young) and 35% MVIC (older) at the start of the MVDC120 task).  Further, these results 
suggest the contractile machinery is more sensitive to changes in pH in older than young 
muscle in vivo.  In Study 2, we observed similar in vivo muscle ME during the MVIC, but 
lower ME in older than young muscle during the MVDCIsoK and MVDCIsoT tasks.  These 
results show an age-related deficit in ME that is evident only during dynamic 




Chapters 1 through 3 include the dissertation proposal as submitted to the 
Graduate School in December 2017.  During pilot testing, some of the methods used were 
modified.  These changes are outlined in the addendum to Chapter 3.  Chapters 4 and 5 
correspond to Study 1 and 2, respectively, and Chapter 6 provides an overall summary of 
this work.  
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Age-Related Changes in Muscle Structure & Function 
Maximal force and power production are lower in older (≥65 years) compared 
with young (≤40 years) adults (23,24,45,48-50,132,190,234).  Myriad factors may 
contribute to these age-related decrements in force and power, including a loss of muscle 
mass (24,115,141), slower maximal contraction velocity (48,50,132,232), and slowed 
crossbridge kinetics (164).  The loss of maximal contraction velocity may be due to 
selective atrophy of type II muscle fibers (142,143,175), caused by a loss of high-
threshold motor neurons (62,63,119,158,230).  However, the loss of high-threshold motor 
neurons that occurs during the denervation-reinnervation process is most notable beyond 
approximately 75 years of age (87,193).  Slowed crossbridge kinetics, on the other hand, 
are apparent in 65-75 year olds (164), and provide an additional molecular explanation 
for the loss of the skeletal muscle power before the age of 75.  This age-related loss of 
muscular strength and power has significant consequences for older adults by increasing 
their likelihood of falling, and placing them at risk for injuries and a loss of independence 
(169,196). 
The reductions in torque production and contractile velocity with age are evident 
in the downward shift in the torque-velocity curve, as illustrated in Figure 1.1 
(24,132,228,232).  Indeed, these deficits in older muscle combine to shift the power-load 
or power-velocity curve down- and left-ward (132,157,184,228).  Cross-sectional studies 
suggest that the loss in muscular power with age occurs prior to the reduction in maximal 
force production (157,159).  Additionally, specific power (peak power per unit cross-
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sectional area) declines at a faster rate than specific strength (maximal torque per unit 
cross-sectional area) with age, suggesting the primary culprit for the age-related decline 
in power may be slowed contractile velocity, independent of the age-related decline in 









Figure 1.1. The effect of age on the torque-velocity curve in human knee extensors. Adapted 
from Callahan et al. (24). 
The fall in maximal force and power production with age may be explained, at 
least in part, by changes in the muscle’s architecture (pennation angle and fascicle 
length).  Because pennation angle reflects the number of sarcomeres in parallel, a larger 
pennation angle enables greater maximal force production (146).  On the other hand, 
muscles with longer fascicles are capable of producing more force at a given contraction 
velocity due to an increased number of sarcomeres in series (146).  The greater force 
produced by long fascicles at high velocities is likely due to the reduced sarcomeric 
shortening required for a given whole-fiber shortening (19).  The pennation angle and 
fascicle length of the vastus lateralis have been shown to decrease with age by 3-6° (~15-
30%) and 5-12 mm (~6-11%), respectively (124,191).  Because pennation angle and 
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fascicle length are determined by their geometric arrangement within a muscle, as 
illustrated in Figure 1.2, these architectural parameters are intrinsically affected by the 
muscle thickness or cross-sectional area (19).  As such, the changes in muscle 





Figure 1.2. An overview of muscle architecture. Adapted from Blazevich. (19). 
In order to generate movement, the force produced by muscular contraction is 
transmitted to the skeleton via connective tissues such as tendons and aponeuroses.  
These load-bearing connective tissues also act as biological springs, capable of storing 
and releasing elastic energy (14,95).  During cyclical contractions, such as those 
occurring during walking, force contributions from passive-elastic energy help minimize 
the energy cost of movements (208).   
Muscle-tendon unit stiffness has been measured using several different methods, 
including a quick release technique (61,177,178) and ultrasound imaging combined with 
dynamometry measures of force (84,219).  The quick release technique models stiffness 
as the frequency response of a perturbed system.  With this technique, some studies have 
shown an increase in stiffness with age (177,178), while others demonstrate no age-
related differences (61).  Because the proposed study will measure muscle-tendon unit 
stiffness using the ultrasound and dynamometry technique, this literature review only 
focuses on that technique. 
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To assess muscle-tendon unit stiffness with ultrasound and dynamometry, the 
elongation of the aponeurosis is tracked, using ultrasonography, while simultaneous 
measures of force are obtained during a ramped isometric contraction (i.e., a contraction 
that increases in intensity over a period of time).  The change in length and force can be 
plotted, and the slope of this relationship used as an index of muscle-tendon unit stiffness.  
Using this approach, several studies have demonstrated a decrease in muscle-tendon unit 
stiffness with age (125,150,219).  However, other studies have shown no effect of age on 
muscle-tendon unit stiffness (84,217). 
Theoretically a stiffer muscle-tendon unit is capable of storing and releasing more 
elastic energy.  As such, force and power production might be lower in older compared 
with young adults, especially during rapid muscular contractions, because of age-related 
differences in muscle-tendon unit stiffness.  Additionally, if the muscle-tendon unit is 
more compliant in older compared with young adults, the metabolic economy may be 
lower with age.  If true, muscle-tendon unit stiffness may provide a structural rationale 
for age-related differences in metabolic economy. 
Age-Related Differences in Muscle Fatigue 
Muscle fatigue is defined as the reduced ability of a muscle to produce torque or 
power in response to a period of contractile activity (112). Because activities of daily 
living, such as climbing stairs or walking, require repeated dynamic contractions (184), 
the ability to resist muscle fatigue may be especially important for older adults to 
maintain their quality of life (227).  Numerous studies have reported less fatigue in older 
(≥65 years) compared with young muscle (≤40 years) in response to isometric 
contractions (28,35,60,114,130).  Conversely, when completing dynamic contractions, 
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especially at high velocities (e.g., 270°.s-1 in the knee extensors), older muscle fatigues to 
a greater extent than young muscle (9,24,48,49,159).  This crossover from less to greater 








Figure 1.3. Illustration of the fatigue paradox in aging knee extensors. Fatigue was quantified 
under different conditions and defined by the decline in torque or power, as follows: isometric 
(torque), moderate velocity dynamic contractions (power), or high velocity dynamic contractions 
(power). MVIC, maximal voluntary isometric contraction; MVDC, maximal voluntary dynamic 
contraction; int, intermediate velocity; hi, high velocity. *indicates group differences in fatigue 
(p<0.05). Adapted from Callahan & Kent-Braun (24). 
When contractions are performed at slow or moderate velocities (e.g., ≤120°.s-1 in 
the knee extensors), similar fatigue is observed in young and older muscle 
(23,24,49,147).  Callahan & Kent-Braun reported strong associations between torque-
velocity characteristics at baseline and knee extensor fatigue in both young (r = -0.63) 
and older (r = -0.72) women (24).  However, no associations were observed between their 
measure of the torque-velocity curve (V50; the velocity associated with 50% maximal 
isometric torque) and fatigue induced by isometric or high velocity contractions (24).  
Because contractile velocity is an important factor in power loss at baseline 
(49,157,159,184), maximal contraction velocity might be a better predictor of fatigue 
during high-velocity contractions than V50.  Despite repeated observations of these age-
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related differences in muscle fatigue, the mechanisms for greater fatigue in older 
compared with young muscle in response to high-velocity contractions remain poorly 
understood. 
Figure 1.4. The pathway of force production. An illustration of the events leading to force 
production in the myocyte, beginning with: 1) cortical excitation, 2) motor unit activation, 3) 
release of acetylcholine, depolarization of the sarcolemma, and subsequent calcium release from 
the sarcoplasmic reticulum, and 4) the crossbridge cycle, which is 5) powered by energy (ATP).  
Adapted from Kent-Braun et al. (112). 
Because of the multi-faceted nature of force and power production, identifying the 
exact cause(s) of muscle fatigue is challenging.  Indeed, fatigue can originate at myriad 
sites along the pathway of force production (Figure 1.4).  The initial signals to produce 
force are generated in the motor cortex of the brain in the form of nerve action potentials 
(Figure 1.4, point 1).  These nerve action potentials propagate along the corticospinal 
tract to alpha motor neurons in the spinal cord.  Each axon of a motor neuron innervates 
numerous skeletal muscle fibers (Figure 1.4, point 2).  Collectively, a motor unit consists 
7 
 
of a motor neuron and all of the skeletal muscle fibers innervated by that motor neuron.  
Once the nerve action potential reaches the neuromuscular junction, acetylcholine is 
released into the synaptic cleft, the sarcolemma is depolarized which generates a muscle 
action potential that travels through the T-tubular system, and calcium (Ca2+) is released 
from the sarcoplasmic reticulum (SR) into the cytosol (Figure 1.4, point 3).  Once in the 
cytosol, Ca2+ binds with troponin-C to uncover myosin binding sites on actin.  Myosin 
will continue to bind with, displace, and detach from actin in accordance with the 
crossbridge cycle of muscular contraction (Figure 1.4, point 4).  The process in which the 
electrical signal (i.e., muscle action potential) is transformed into a mechanical movement 
(i.e., displacement of actin and generation of force) is known as excitation-contraction 
coupling (ECC) (65). 
Mechanisms of Muscle Fatigue 
Although the causes of muscle fatigue can be numerous (Figure 1.4), broadly 
speaking fatigue can occur as a result of changes in neural activation (central fatigue; 
numbers 1 and 2 in Figure 1.4) and changes within the muscle’s local environment 
(peripheral fatigue; numbers 3, 4, and 5 in Figure 1.4).  The use of electrical stimulation 
permits the evaluation of central activation by comparing the torque produced during a 
maximal voluntary contraction (MVC) with that obtained during a superimposed tetanic 
stimulus (116).  Likewise, fatigue-induced changes in the ratio of peak torques obtained 
during a MVC and an electrically-stimulated tetanic train can be used to indicate failure 
of central activation (18,116).  Most studies suggest that central activation failure does 
not contribute to age-related differences in muscle fatigue in response to isometric or 
dynamic contractions (23,131); although this finding is not always supported (216).  To 
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date, only one study has examined age-related differences in central activation in 
response to high-velocity contractions (49).  Because the electromyographic (EMG) 
signal was unaltered in young and older men in response to high-velocity dynamic 
contractions of the knee extensors, Dalton et al. concluded that failure of neuromuscular 
activation was not an important factor in the age-related differences in muscle fatigue 
(49). 
Peripheral causes of muscle fatigue include failure of ECC and metabolic 
inhibition of the crossbridge cycle (112).  Failure of ECC can be detected in vivo as a 
decrease in the ratio of peak torques elicited by low- and high-frequency electrical 
stimulations (67).  Blunted torque production in response to a low-frequency stimulus is 
thought to be due to impaired Ca2+ release (30).  Indeed, ECC failure generally occurs in 
response to prolonged muscular activity (7); although intermittent submaximal isometric 
contractions have also been shown to elicit low-frequency fatigue in young and older 
men (4). 
In unfatigued muscle, the time required for force to fall by 50% from its peak 
(T1/2) following an electrically-stimulated contraction is generally longer in older than 
young adults (24,35,114,131), potentially as a result of greater type I fiber numbers or 
area in older muscle (143).  In young and older muscle, the T1/2 typically becomes 
prolonged in response to fatiguing muscular activity (114,131), presumably due to 
slowed Ca2+ release from troponin or uptake by the sarcoplasmic reticulum (1).  During 
fatiguing isometric contractions, reported changes in T1/2 are varied, with some authors 
reporting a greater increase in T1/2 only in young muscle (131) and others reporting 
similar slowing of T1/2 in young and older muscle (114).  In contrast, Dalton et al. 
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reported a greater slowing of muscular relaxation in older compared with young muscle 
in response to moderate- and high-, but not slow-velocity contractions (49). 
The lesser fatigue of older compared with young muscle in response to isometric 
contractions is thought to arise from the greater proportion of ATP produced via 
oxidative phosphorylation (ATPOX) in older compared with young muscle (128).  
Because of this greater reliance on oxidative phosphorylation, concentrations of the 
metabolic by-products of non-oxidative ATP production (e.g., proton, H+; inorganic 
phosphate, Pi; and diprotonated phosphate, H2PO4-) known to inhibit crossbridge kinetics 
(57,59,176) were lower in older compared with young muscle (114,128).  The authors of 
one of these studies suggest the decreased reliance on ATP production from the creatine 
kinase reaction (ATPCK) and glycolysis (ATPGLY) with age is greater than would be 
predicted by the modest decrease in type II fiber area (128).  The accumulation of H+ 
slows ADP release from the actin-myosin complex and thus reduces contractile velocity 
(57,58,123).  The accumulation of Pi and H2PO4- causes myosin to dissociate from actin 
after its powerstroke, reducing total force production, because ADP is still attached to the 
dissociated myosin molecule (56,59).  Additionally, elevated [H+] and [Pi] decrease the 
muscle’s sensitivity to Ca2+ (59,181), directly interfering with crossbridge formation. 
Overall, the literature indicates that the capacity for producing ATP via oxidative 
phosphorylation declines with age in the knee extensor muscles (73).  Coupled with the 
higher ATP demand of dynamic compared with isometric contractions (205), the deficit 
in oxidative capacity may require older muscle to rely more on phosphocreatine (PCr) 
breakdown and non-oxidative glycolysis for ATP production than young muscle.  If true, 
H+, Pi, and H2PO4- would accumulate more in older compared with young muscle, 
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providing a metabolic basis for the crossover to greater fatigue in older muscle during 
high-velocity dynamic contractions.  Further, because ATP consumption increases with 
contractions of short duration (13,89) as the production of force is more costly than the 
maintenance of force (202), the energetic demands of moderate-velocity contractions 
may be sufficiently low to prevent older muscle from relying on PCr breakdown and 
glycolysis to a greater extent than young muscle.  These hypotheses remain to be tested. 
There are 3 main sites of ATP consumption within skeletal muscle; i) myosin 
ATPase, ii) SERCA pump (Ca2+ ATPase), and iii) Na2+/K+ ATPase.  The latter 2 are 
commonly referred to as pumps because they work against the concentration gradient of 
the ions they are moving.  The Na2+/K+ pump is located on the sarcolemma and is 
responsible for the ATP-consuming process of pumping both sodium and potassium 
against their concentration gradients in order to restore the resting membrane potential 
following activation (37).  The Ca2+ ATPase, located on the SR, pumps Ca2+ from the 
cytosol back into the SR after activation; a necessary process for force relaxation.  
Approximately 30-50% of the total ATP cost of contraction is associated with the 
Na2+/K+ and Ca2+ ATPases, the majority of which is attributed to SERCA pump activity 
(8).  The remaining 50-70% of ATP consumption is used by myosin ATPase in the 
crossbridge cycle (8). 
Use of phosphorus magnetic resonance spectroscopy (31P-MRS) allows non-
invasive measurement of ATP production rates during muscle contractions in vivo (20).  
Because [ATP] is maintained until extreme levels of fatigue (226), the rate of ATP 
production is equal to its rate of consumption (128,226).  In studies comparing age-
related differences in ATP consumption rates, accounting for the decline in muscle mass 
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with age by examining the metabolic economy of muscle (ME; mass-normalized torque 
produced per unit ATP consumed) is required.  During an MVIC sustained for 120s, 
Boska et al. observed no change in ME, suggesting that ME does not change with muscle 
fatigue (20).   
Only a few studies have examined age-related differences in ME 
(31,130,137,139).  Some authors have reported higher (130) or similar (31) ME in older 
compared with young muscle during maximal isometric contractions.  Conversely, Layec 
et al. have observed lower ME in older than young muscle during dynamic contractions 
(137,139).  However, these studies varied in methodology and the muscle studied, which 
further confuses the issue at this time.  Thus, whether age-related changes in ME are 
velocity-dependent and can provide a metabolic rationale for the crossover in muscle 
fatigue is currently unclear. 
Summary and Statement of the Problem 
Old age is associated with a reduction in maximal force, power, and contraction 
velocity in the unfatigued state.  These age-related deficits in muscle function are likely 
due to reductions in muscle mass, slowed crossbridge kinetics, shifts in muscle fiber type, 
muscle-tendon unit stiffness, and pennation angle and fascicle length (i.e., muscle 
architecture) in older compared with young adults.  The extent to which the differences in 
muscle architecture contribute to age-related differences in fatigue is unclear at this time. 
Older muscle fatigues less than young muscle in response to isometric 
contractions (33).  This age-related difference in muscle fatigue can be explained by a 
greater proportion of ATPOX in older compared with young muscle during isometric 
contractions (31,114,128,130).  Paradoxically, older muscle fatigues to a greater extent 
12 
 
than young muscle in response to high-velocity contractions (24,49), and age-related 
differences in muscle fatigue are abolished when contractions are performed at moderate 
velocities (23,24,49).  The mechanism(s) of this “fatigue paradox” in which older muscle 
transitions from less to greater fatigue than young are not known.    
 Age-related differences in fatigue induced by maximal isometric and moderate-
velocity dynamic contractions are generally not associated with deficits in central 
activation (23,49,131), failure of ECC (4), or slowing of contractile properties (114,131).  
However, fatigue elicited by contractions performed at higher velocities may result in 
age-related deficits in these measures.  Likewise, this greater fatigue in older muscle 
might be related to a lower baseline maximal contraction velocity in older muscle 
(48,50,132,232), as a result of changes in fiber type composition (142,143,175) and 
slowed crossbridge kinetics with age (164).  Any deficit in baseline maximal contraction 
velocity would cause older muscle to operate at a higher relative velocity during these 
dynamic protocols. 
The capacity for ATP production via oxidative phosphorylation is impaired in the 
knee extensors of older compared with young adults (73).  This deficit could result in 
older muscle relying on the glycolytic pathway to a greater extent than young muscle 
when the energetic demands are sufficiently high, such as during high-velocity dynamic 
contractions.  Additionally, ME might be lower in older knee extensor muscles compared 
with young, which could exacerbate fatigue if the energetic demand outweighs its supply.  
An age-related decline in muscle-tendon unit stiffness may worsen ME with age during 
high-velocity contractions, because less energy is returned from elastic structures to the 
muscle to amplify power production.  Although logical, a metabolic basis for the greater 
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fatigue in older muscle in response to high-velocity contractions has not been evaluated.  
This dissertation has the potential to elucidate the causes of exacerbated muscle fatigue in 
response to high-velocity contractions in older compared with young adults. 
 
Age-Related Differences in Knee Extensor Muscle Fatigue: The Role of 
Bioenergetics and Muscle-Tendon Unit Stiffness 
 The primary aim of this study is to determine the extent to which differences in 
intracellular energy metabolism explain the age-related differences in muscle fatigue due 
to moderate- (e.g., 120°.s-1) and high-velocity (e.g., 240°.s-1) maximal voluntary 
contractions.  The secondary aim of this study is to investigate the role of contraction 
velocity on potential age-related differences in ATP demand during isometric, moderate- 
and high-velocity contractions of the unfatigued muscles.   
Figure 1.5. Overview of the measures to be collected at each visit. 
Groups of young (21-40 years; n=20, 10 men) and older (65-80 years; n=20, 10 
men) sedentary-to-recreationally active adults will be matched for habitual physical 
activity, using accelerometry (23,24,131).  This study will require 3 visits, 1 to the 
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Human Testing Center (HTC) and 2 to the Human Magnetic Resonance Center (hMRC) 
at the University of Massachusetts Amherst.  The total time commitment for this study is 
approximately 3-4 hours.  Visit 1 will involve measures of mobility, muscle-tendon unit 
stiffness, and familiarization with the fatigue protocols to be completed at Visits 2 and 3.  
Measures of muscle contractile and non-contractile volumes, intracellular bioenergetics, 
and fatigue (1st of 2 protocols) will be made at Visit 2.  Lastly, measures of oxidative 
capacity, intracellular bioenergetics, and fatigue (2nd of 2 protocols) will be made at Visit 
3.  An overview of the measures to be made at each visit is illustrated in Figure 1.5. 
The primary outcome variables for the study include oxidative capacity, [H+], 
[Pi], and [H2PO4-] during both fatigue trials, the ME of isometric and dynamic 
contractions at 120°.s-1 and 240°.s-1, and muscle-tendon unit stiffness.  Group descriptive 
characteristics will include age, height, body mass, blood pressure, timed up-and-go 
(TUG), and an advanced version of the short physical performance battery (SPPB-A).  
The conceptual framework for this study is shown in Figure 1.6. 
Figure 1.6. Conceptual framework for this dissertation. Muscle fatigue is caused by the 
concentrations of H+, Pi, and H2PO4-, which increase when ATP demand is greater than 
oxidative ATP production. The dashed lines represent the possible links between contraction 




Aim 1: To determine whether there is a bioenergetic basis for the paradoxical 
relationship between muscle fatigue and aging 
H 1a: Baseline oxidative capacity of the vastus lateralis will be higher in young 
than older adults. 
If supported, this would indicate a deficit in the ability of older compared with 
young muscle to produce ATP via oxidative phosphorylation.  
H 1b: Cytosolic [H+], [Pi] and [H2PO4-] will increase to a greater extent in older 
than young muscle during the high velocity (240°.s-1) fatigue trial. 
This result would provide novel evidence for the role of these metabolites in the 
age-related difference in high-velocity muscle fatigue.  
H 1c: Neither fatigue nor cytosolic [H+], [Pi] and [H2PO4-] will differ between 
age groups during the moderate velocity (120°.s-1) fatigue trial. 
If true, this would support the concept that the muscles of healthy older adults can 
meet the energy demands imposed by moderate contraction velocities, and thus 
fatigue does not exceed that of young adults. 
H 1d: The proportion of ATP derived from oxidative phosphorylation will be 
lower in older than young muscle during the high velocity (240°.s-1) fatigue trial, 
but not between groups during moderate velocity (120°.s-1) fatigue trial. 
If supported, this would indicate that the energy demands of high- but not 
moderate-velocity contractions forces older muscle to rely on non-oxidative ATP 




Aim 2: To determine the impact of contraction velocity on muscle metabolic economy in 
the unfatigued muscles of young and older adults 
H 2a: Metabolic economy (Nm.s.cm-3.mM ATP-1) will be higher in older 
compared with young muscle during a 24s isometric contraction. 
If true, this would support the notion that isometric contractions are less 
energetically costly in older compared with young muscle when not fatigued, and 
provide support for the metabolic cause of less fatigue in older compared with 
young muscle in response to isometric contractions. 
H 2b: Metabolic economy (Nm.s.cm-3.mM ATP-1) will not be different between 
age-groups during contractions at 120°.s-1. 
If supported, this would provide a mechanism to support the observation that 
young and older muscle fatigue to a similar extent in response to moderate-
velocity contractions. 
H 2c: Metabolic economy (Nm.s.cm-3.mM ATP-1) will be lower in older 
compared with young muscle during contractions at 240°.s-1. 
This result would indicate that older muscle is at an energetic disadvantage when 
performing high-velocity contractions, even when not fatigued, and provide 
additional support for a metabolic cause of the greater fatigue in older compared 
with young muscle in response to high-velocity contractions. 
 
Exploratory Aim 1: To examine age-related differences in muscle-tendon unit stiffness 
and how those differences may be related to muscle fatigue 
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EH 1a: Muscle-tendon unit stiffness of the vastus lateralis will be greater in 
young compared with older adults. 
If true, this may provide support for a structural mechanism to explain the age-
related differences in metabolic economy and muscle fatigue. 
EH 1b: Muscle-tendon unit stiffness will be positively associated with fatigue 
(defined as % initial power) induced by high-velocity contractions (240°.s-1). 
If these two variables are positively associated, it would suggest that muscle-
tendon unit plays an important role in the age-related differences in muscle 
fatigue, potentially by exacerbating poor metabolic economy in older muscles. 
 
 Successful completion of the proposed work will advance the field by providing 
novel insight into energetic flux, metabolite concentrations, and metabolic economy 
during moderate- and high-velocity muscle contractions in vivo.  Additionally, this work 
will evaluate age-related differences in MTU stiffness and examine the role of those 
differences in muscle fatigue.  To date, no studies have examined age-related differences 
in bioenergetic flux during contractions where velocity is controlled, the proposed study 
will yield new information regarding the potential causes of age-related differences in 
muscle fatigue.  Because activities of daily living, such as stair climbing and walking, 
require repeated dynamic contractions, the ability to resist muscle fatigue may be 
important for maintaining quality of life into old age.  As such, the new information 
gained by the proposed study may be helpful for identifying targets to extend the 
healthspan of older adults.  Overall the proposed study will improve our understanding of 





Age-Related Changes in the Neuromuscular System 
Sarcopenia refers to the progressive loss of skeletal muscle mass and function 
associated with age (71), and affects approximately 30% and 50% of individuals over 60 
and 80 years of age, respectively (10).  The effects of sarcopenia include a loss of 
mobility and quality of life as well as an increased risk of hospitalization (71,97).  Indeed, 
the estimated financial cost of these effects is significant, totaling 18.5 billion dollars in 
the United States in 2000 (98).  Therefore, there is compelling rationale to investigate 
age-related changes in neuromuscular system structure and function. 
Nervous System 
Beyond the age of 60 years there is a decline in the number of motor neurons in 
humans (158,230).  Because of this loss of motor neurons, muscle fibers undergo a 
denervation-reinnervation process whereby the motor neurons innervating type II muscle 
fibers may be lost and replaced with slower motor neurons (87).  This denervation-
reinnervation process can result in a selective atrophy of type II fibers and a greater 
proportion of type I muscle fibers in older compared with young adults (141-143,175).  
However, this fiber-type shift with aging is generally small in magnitude (<10%) and is 
not always observed (39,193).  In contrast with the reports of a fast-to-slow shift in 
muscle fiber composition, a longitudinal study observed an increase in the percentage of 




At the neural level, muscular force production is modulated by 2 factors: 
recruitment and rate coding.  Motor unit recruitment describes the number of activated 
motor units, which occurs in accordance with the size principle (i.e., smallest to largest) 
as the force produced increases (86,165).  Rate coding of motor units refers to the motor 
unit discharge rate (MUDR), with faster MUDRs resulting in greater force production 
(103,167). 
The inability to completely activate a muscle during maximal contractions is 
termed central activation failure, and can be caused by a failure to recruit all of the 
available motor units or a decline in the maximal MUDR (110).  Central activation can be 
assessed indirectly by combining maximal voluntary and electrically stimulated 
contractions.  One approach to assess central activation involves delivering a tetanic 
stimulus during an MVIC, with an increase in torque reflecting central activation failure 
(110).  An alternative method to quantify if central activation failure is present following 
a fatiguing bout of contractions is to compare the peak torques obtained during maximal 
voluntary and electrically stimulated contractions (18).  Using these techniques, similar 
central activation has been observed in the dorsiflexors (113,114,120,131) and knee 
extensors (23,24) of young and older adults.  In contrast with these studies, Stackhouse et 
al. reported failure to completely activate the knee extensors in ~50% of the older adults 
in their study (216).  Similarly, incomplete activation of the knee extensors was observed 
in very old (85-97 years) adults and was unaltered by 12 weeks of resistance exercise 
training (81). 
There is some evidence of lower MUDRs in older compared with young adults 
during maximal and submaximal contractions of several muscle groups, including the 
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first dorsal interosseous (104), dorsiflexors (42), and knee extensors (103).  However, a 
lack of age-related differences in MUDRs have also been reported during maximal and 
submaximal contractions of the knee extensors (199) and plantar flexors (47,118).  
Because maximal MUDRs increase with short-term training (32), these discrepant 
findings may be due to differences in participants’ physical activity status across studies.  
Despite lower MUDRs resulting in less force production (212,233), any decline in 
MUDRs with age may be offset by a leftward shift in the force-frequency relationship 








Figure 2.1. Age-related changes in the force-frequency relationship of the quadriceps. Data for 
young (filled circles) and older (open circles) are Mean±SE.  Adapted from Allman & Rice (3) 
Changes in muscular co-activation, defined as concomitant activation of agonist 
and antagonist muscles, with age are somewhat equivocal.  An increase in muscle co-
activation might mechanically oppose force production.  Greater co-activation in older 
compared with young shanks was shown in one (91) but not another study (183).  When 
performing isolated knee extension and flexion, greater co-activation was only present 
during contractions of the extensors (149).  However, increased co-activation of the 
quadriceps and hamstrings with age is not associated with contraction velocity (36). 
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Other changes occur within the nervous system with age, such as decreased 
conduction velocity of motor neurons due to a loss of myelinated neurons (160).  
Additionally, declines in cortical excitability and atrophy of the primary motor cortex 
have been shown in older compared with young adults (179,206). 
Muscle Size, Force, and Power 
Whole muscle cross-sectional area, quantified by magnetic resonance imaging 
(MRI), declines in multiple muscle groups with age.  Kent-Braun et al. reported a 12% 
decline in the contractile area of the tibialis anterior in old compared with young men and 
women (115).  Using a similar technique, McNeil et al. reported no significant 
differences in the size of dorsiflexor muscles in 25, 65, and 85 year old men (157).  
However, the cross-sectional area of the knee extensors has been consistently shown to 
decline by ~27% with age (24,90,231).  Callahan & Kent-Braun reported a decline in 
knee extensor size of ~28% in older compared with young women (24).  More recently, 
Hogrel et al. observed a greater decline in the size of the rectus femoris (35%) than the 
vastus intermedius (25%), vastus lateralis (28%), and vastus medialis (19%) in older 
compared with young adults (90).  However this observation is in contrast with that of 
Trappe et al. who reported similar atrophy across all knee extensor muscle in older 
compared with young adults (231).   
Differences in the age-related decline in muscle size between muscle groups 
might be related to altered patterns of use in old compared with young muscle (122).  In 
addition to the decline in muscle size with age, there is a concomitant increase in non-
contractile content of muscle in older compared with young adults (24,115). 
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Accompanying the decline in muscle size, maximal voluntary force production 
declines with age (79,172).  In a 10 year longitudinal study of 120 adults (age 46-78 
years), Hughes et al. reported 14 and 16% reductions in knee extensor and flexor 
strength, respectively (93).  To account for the decrease in muscle mass with age, many 
researchers report specific strength (force per unit muscle cross-sectional area).  Despite 
lower absolute strength in older compared with young men, Kent-Braun & Ng reported 
no age-related difference in specific strength of the dorsiflexors in males and females 
(113).  However, McNeil et al. demonstrated specific strength to be reduced in very old 
adults (~85 years) compared with young (~25 years) and older (~65 years) men (157).  
Callahan & Kent-Braun observed no differences in specific strength of the quadriceps in 
young and older women (ref).  However, Jubrias et al. reported the decline in quadriceps 
cross-sectional area with age only accounted for 50% of the age-related reduction in 
maximal force production (101). 
Muscular power is lower in multiple muscle groups of older compared with young 
adults (24,132,157,159,164).  Reid et al. reported a ~9% loss in knee extensor power, but 
no change in maximal isometric strength, over a 3 year period in healthy older adults 
(197).  Additionally, in a study of young (~26 years), old (~64 years), and very old (~84 
years) men, maximal isometric strength was preserved in old, but not very old muscle 
(159).  However, contractile velocity and power at 20% MVIC were lower in old and 
very old compared with young men.  In old age (>65 years), specific power (power per 
unit muscle cross-sectional area) declines at a faster rate than specific force (157).  
Maximal contraction velocity declines in multiple muscle groups with age (50,132,232).  
The deficits in maximal torque production and contractile velocity with age result in a 
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downward shift in the torque-velocity curve (24,132,228,232) as illustrated in Figure 1.1, 
and a down- and left-ward shift in the power-load or power-velocity curve 
(132,157,184,228,232). 
Muscle Architecture 
The elegant microscopic structure of skeletal muscle fibers is well established.  
However, less is known about skeletal muscle architecture, which refers to the orientation 
of muscle fiber bundles (fascicles) relative to the axis of force generation, the length of 
those fascicles, and the thickness of the muscle (146).  The architecture of a muscle can 
be characterized in vivo, using ultrasonography, by two variables: pennation angle (i.e., 
the fascicle angle relative to the axis of force generation) and fascicle length (173).  In 
general, muscles with large pennation angles (e.g., vastus lateralis) have a greater number 
of sarcomeres in parallel and are capable of generating high forces (19).  On the other 
hand, muscles with longer fascicles (e.g., biceps femoris) have a greater number of 
sarcomeres in series and are suited to high shortening velocities (19).  Figure 2.2 
illustrates the theoretical difference between a long and short fascicle on the force-










Several studies have shown a decrease in pennation angle and fascicle length of 
the human vastus lateralis (125,191) and triceps surae (170,173,218) with age.  Power et 
al. reported pennation angle and fascicle length of the vastus lateralis to be ~25% and 
~12% smaller and shorter, respectively, in older compared with young men (191).  Kubo 
et al. observed an age-related decline in the fascicle length of the vastus lateralis in men 
but not women (124).  Thom et al. reported fascicle length of the medial gastrocnemius to 
account for ~58% of the difference in maximal contraction velocity in young and older 
men (228).  However, Fitzgerald et al. (unpublished observation) found that neither 
muscle thickness nor fascicle length of the vastus lateralis were associated with maximal 
voluntary isometric torque, maximal power at 240°.s-1, or maximal contraction velocity in 
young or older women (r2≤0.261, p≥0.241).  Moreover, these architectural variables were 
not associated with muscle fatigue in young or older women (r2≤0.147, p≥0.397). 
Muscle-Tendon Unit Stiffness 
The force produced by muscular contraction is transmitted to the skeleton via 
connective tissues, such as tendons and aponeuroses, to generate movement.  These 
connective tissues act as ‘biological springs’, which are capable of storing and releasing 
elastic energy (14,95).  During cyclical contractions, such as those occurring during 
walking, force contributions from these ‘biological springs’ help to minimize the energy 
cost of movements (208).   
Theoretically, a stiffer muscle-tendon unit is capable of storing and releasing 
more elastic energy.  As such, force and power production could be lower in older 
compared with young adults, especially during rapid muscular contractions, if there exists 
an age-related difference in muscle-tendon unit stiffness.  Additionally, if the muscle-
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tendon unit is more compliant in older compared with young adults, metabolic economy 
may be lower with age.  If true, muscle-tendon unit stiffness may provide a structural 
rationale for age-related differences in metabolic economy. 
Muscle-tendon unit stiffness has been measured using several different methods, 
including a quick release technique (61,177,178) and a technique which combines 
ultrasound imaging with dynamometry measures of force (84,219).  The quick release 
technique models stiffness as the frequency response of a perturbed system.  With this 
technique, some studies have shown an increase in stiffness with age (177,178), while 
others demonstrate no age-related differences (61).  Because the proposed study will 
measure muscle-tendon unit stiffness using the technique which combines ultrasound 
imaging and dynamometry measures of force, the remainder of this literature review only 
focuses on that technique. 
Figure 2.3. In vivo assessment of muscle-tendon unit stiffness. Panel A shows the torque tracing 
during a ramped maximal voluntary isometric contraction. Panel B shows the force-extension 
relationship of the human dorsiflexor muscle. Adapted from (84). 
To assess muscle-tendon unit stiffness with ultrasound imaging and 
dynamometry, the elongation of the aponeurosis is visualized using ultrasonography, and 
tracked using software, while simultaneous measures of force are obtained during a 
ramped isometric contraction (i.e., a contraction that increases in intensity over a period 
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of time).  The change in length and force can be plotted, and the polynomial slope of this 
relationship used as an index of muscle-tendon unit stiffness, as shown in Figure 2.3.   
Using this technique, Kubo et al. reported a significant age-related decrease in 
muscle-tendon unit stiffness of the vastus lateralis (a knee extensor muscle) in women 
(125).  Moreover, Kubo et al. observed no change in muscle-tendon unit stiffness in older 
and middle-aged women in response to 6 months of low-load resistance training (e.g., 
body weight squats).  An age-related decrease in muscle-tendon unit stiffness has also 
been reported in the plantar flexors (150,218).  Conversely, others have reported no effect 
of age on muscle-tendon unit stiffness in the plantar flexors (217) or dorsiflexors (84).  
Mademli et al. demonstrated that muscle fatigue induced by isokinetic contractions of the 
plantar flexors at 60°.s-1 until volitional fatigue elicited no change in muscle-tendon unit 
stiffness in older men (151).  This finding suggests that the mechanical properties of the 
muscle-tendon unit are unaffected by muscle fatigue. 
Contractile Properties 
The T1/2 (time required for force to fall by 50% from its peak following an 
electrically-stimulated contraction) tends to be longer in older than young muscle 
(24,35,50,94,114,131,189).  This slowing of force relaxation has been observed in 
multiple muscle groups including the dorsiflexors (35,114,131,189), knee extensors 
(24,94), and plantar flexors (50).  McNeil et al. reported that T1/2 of the dorsiflexors was 
only longer in very old (~84 years) and not old (~65 years) compared with young (~26 




Theoretically, slowed muscular relaxation following an electrically imposed 
stimulus could be caused by reduced Ca2+ uptake into the SR or a slower rate of Ca2+ 
dissociation from troponin (66).  Because Ca2+ uptake is powered by an ATPase, slowed 
muscle relaxation in older compared with young adults may be due to a reduction in the 
concentration of Ca2+-ATPase with age (66).  Hunter et al. investigated the cause of age-
related differences in T1/2 and reported slower relaxation times, decreased Ca2+ uptake 
and Ca2+-ATPase activity in older compared with young muscle (94).  However, after 12 
weeks of resistance training, Ca2+ uptake and Ca2+-ATPase activity increased in older 
muscle while relaxation time was unchanged (94).  Based on these findings, Ca2+ uptake 
by the SR is not the cause of slower muscular relaxation in older compared with young 
muscle.  Hunter et al. suggested that other factors affecting muscle relaxation, including 
Ca2+ uptake by cytosolic buffers, the rate of Ca2+ dissociation from troponin-C, 
crossbridge kinetics, and muscle-tendon unit stiffness must explain the age-related 
slowing of T1/2 (94). 
Muscle Fatigue and Aging 
During repeated contractile activity, the force- and power-generating capacity of 
muscle declines; a process known as muscle fatigue (72).  In response to isometric 
contractions, the literature supports relatively less fatigue in older compared with young 
muscle (23,24,28,35,60,114,130,131,201,204).  Callahan et al. observed a greater decline 
in knee extensor MVIC in young compared with older adults (43±3% and 29±3%, 
respectively) following 4min of intermittent isometric contractions (23).  Using the same 
protocol, Callahan & Kent-Braun reported a greater decrease in knee extensor MVIC in 
young (59.8±2.5% initial MVIC) compared with older (71.1±3.7% initial MVIC) women 
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(24).  These 2 studies highlight the reproducibility of the observation that older adults 
experience less fatigue than young adults in response to isometric contractions. 
Conversely, the literature supports greater muscle fatigue in older compared with 
young muscle in response to dynamic contractions, especially at high velocities (9,24,48-
50,159,184,189,234).  One of the first studies to highlight this was conducted by Petrella 
et al. who demonstrated greater fatigue, defined as the decline in peak velocity during 
isotonic contractions, in older compared with young adults in response to 10 maximal 
contractions of the knee extensors using a load equal to 40% MVIC (184).  Recently, 
Dalton et al. examined age-related differences in muscle fatigue in response to isokinetic 
or isotonic contractions performed at the velocity or load, associated with peak power, 
respectively (48).  In that study, fatigue was defined as the number of contractions 
performed until peak power declined to 40% of that achieved at baseline.  The authors 
reported no age-related differences in muscle fatigue in response to the isokinetic task, 
but greater muscle fatigue in older compared with young in response to the isotonic task, 
and suggested that age-related differences in muscle fatigue may be masked when the 
contraction velocity is constrained (48).  However, if the contraction velocity is 
sufficiently high (e.g., 270°.s-1), older muscle has been shown to experience greater 
fatigue compared with young muscle (24). 
Fatigue in response to slow- and moderate-velocity contractions is similar 
between age groups (23,24,49,147).  Dalton et al. investigated the effect of contraction 
velocity on age-related differences in muscle fatigue using 3 different knee extension 
protocols (slow, 60°.s-1; moderate, 180°.s-1; and fast, isotonic at 20% MVIC) in young 
and older men (49).  The authors reported a similar decline in power between groups in 
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response to slow (old: 53%, young 53%) and moderate (old: 45%, young 38%) velocities, 
but not in response to fast contraction protocol (old: 35%, young: 23%).  This study is 
particularly useful for highlighting the fatigue paradox because all 3 protocols were 
performed by the same participants.  Combined, these studies indicate that older muscle 
transitions from less fatigue in response to isometric contractions to greater fatigue in 
response to high-velocity contractions. 
Callahan & Kent-Braun reported strong associations between V50 (the velocity 
associated with 50% MVIC) at baseline and knee extensor fatigue, induced by 
intermittent contractions at V50, in both young (r = -0.63) and older (r = -0.72) women 
(24).  However, no associations were observed between V50 and fatigue induced by 
intermittent isometric or high-velocity (270°.s-1) contractions (24).  Because contractile 
velocity is an important factor in power loss at baseline (49,157,159,184), maximal 
contraction velocity might be a better predictor of fatigue during high-velocity 
contractions than V50.  Pilot data from our lab (young, n=6; older, n=4, women) indicates 
that maximal contraction velocity, measured as the peak velocity during an isokinetic 
contraction at 500°.s-1, explains 41% of the variance in muscle fatigue (defined as the % 
initial power) following high-velocity contractions of the knee extensors (Figure 2.4).  
Thus, inherently faster muscles appear to experience less fatigue in response to high-
velocity contractions. Although the observation of greater fatigue in older compared with 
young muscle has been observed repeatedly, the mechanisms to explain this crossover in 




Figure 2.4. Relationship between maximal contraction velocity of the knee extensors and muscle 
fatigue. Data are unpublished observations reported by Fitzgerald et al. 2019. 
Mechanisms of Muscle Fatigue 
Muscle fatigue can result from changes at any site along the pathway of force 
production (Figure 1.4).  Typically, the etiology of fatigue is classified as occurring due 
to central (central or peripheral nervous system) or peripheral (within the muscle) factors 
(112). 
Bigland-Ritchie demonstrated central activation failure in response to a sustained 
60s MVIC of the knee extensors in some, but not all, participants who varied in age from 
25-50 years (18).  In response to intermittent submaximal isometric contractions of the 
knee extensors, the decline in voluntary and electrically-stimulated contractions was 
shown to be markedly similar; suggesting that fatigue induced by this contraction mode 
may be entirely due to failure within the muscle itself (17).  Studies examining age-
related differences in central activation failure in response to isometric (4,23,35,114,131) 
and dynamic (23,131) contractions generally support these early observations.  However, 
a few studies have reported the presence of central activation failure in response to 
isometric contractions, although in these studies the magnitude of the decline in central 
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activation was similar in magnitude in young and older adults (46,204).  To our 
knowledge, only one study has shown greater central activation failure in older compared 
with young adults in response to isometric contractions (216).  Thus, central activation 
failure does not appear to explain the age-related differences in muscle fatigue in 
response to isometric contractions.  Recently, Fitzgerald et al. (unpublished observations) 
reported greater muscle fatigue in older compared with young women in response to 
4min of intermittent maximal voluntary dynamic contractions of the knee extensors at 
240°.s-1, with no evidence of central fatigue (ratio of MVIC:80Hz peak torque) in either 
group (p≥0.35). 
Maximal MUDRs have been shown to decline in response to sustained MVICs 
(15,16,34,46,201).  The literature generally supports a similar decline in MUDRs in 
response to isometric contractions with age (34,46,190).  Dalton et al. reported a ~44% 
decline in MUDR in young and older men in response to a sustained contraction at 75% 
MVIC (46). 
Peripherally, fatigue may be caused by changes within the myocellular 
environment.  Changes in ECC, from depolarization of the sarcolemma to Ca2+ binding to 
troponin-C may contribute to muscle fatigue.  In vivo, failure of ECC can be examined by 
comparing the change in a muscle’s force response to electrically-evoked contractions at 
low and high frequencies (67).  During fatigue, the force produced by a low-frequency 
stimulation may decrease (low frequency fatigue) while the force produced by a high-
frequency stimulation does not decrease as much because of force summation (Figure 
2.5).  The decrease in force elicited by a low-frequency stimulus is likely caused by 
impaired Ca2+ release from the SR (30,67,144).  By comparing the ratio of torque elicited 
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by low- and high-frequencies, several studies have shown that ECC is impaired with 
muscle fatigue (4,7,190,203).  However, the fatigue-induced decline in the ratio of low- 
to high-frequency force production appears to be similar in young and older adults in 
response to isometric contractions (4,35).  In response to 4min of intermittent maximal 
voluntary dynamic contractions of the knee extensors, Fitzgerald et al. (unpublished 
observations) found failure of ECC in both young and older women (p≤0.021), although 
the magnitude of ECC failure was similar in young and older women (p≥0.361).  These 
findings suggest that ECC failure cannot explain the age-related differences in muscle 
fatigue induced by high-velocity contractions. 
 
Figure 2.5. Force responses to electrically-stimulated contractions during fatigue. Adapted from 
Edwards et al. (67). 
Following repeated isometric (35) and dynamic (49) contractions, the T1/2 
increases in duration, likely due to a slowing of Ca2+ ATPase activity (144).  However, 
other factors which affect muscular relaxation may also cause this slowing, including 
reduced Ca2+ uptake by cytosolic buffers, impaired Ca2+ dissociation from troponin-C, 
slowed crossbridge kinetics, and decreased muscle-tendon unit stiffness. 
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While some studies report a greater decrease in the T1/2 in older compared with 
young muscle (49,121), this finding is not consistent across the literature (23,35).  Dalton 
et al. reported a longer T1/2 in older compared with young men in response to moderate- 
and high-velocity contractions (49).  The authors further reported no age-related 
differences in T1/2 in response to slow-velocity contractions of the knee extensors.  
Recently, Fitzgerald et al. (unpublished observations) observed slower force relaxation at 
baseline in older compared with young women (p=0.003).  In that study, participants 
completed 4min of intermittent, high-velocity contractions of the knee extensors, which 
elicited greater muscle fatigue in older compared with young women (p=0.005).  In 
response to fatigue, there was a similar slowing of T1/2 in young and older women 
(p=0.500).  Moreover, baseline T1/2 was associated with muscle fatigue in older 
(r2=0.589, p=0.04) but not young women (r2=0.105, p=0.479).  These findings suggest 
that slower baseline contractile characteristics with age explains a significant portion of 
the greater muscle fatigue in older compared with young women. 
In vivo experiments have shown the loss of force during isometric contractions is 
strongly associated with [H+], [Pi], and [H2PO4-] (54,238).  At the molecular level, 
elevated [H+], [Pi], and [H2PO4-] have been shown to impair force production and 
unloaded shortening velocity (58).  In vitro experiments in which [H+] is elevated to 
levels observed during fatigue in vivo have shown ADP-release from the actin-myosin 
complex is slowed under these conditions (57,58,123).  The slowing of ADP-release 
caused a reduction in contractile velocity in those experiments (57,58).  Similar studies 
have investigated the effects of high [Pi] and [H2PO4-] on crossbridge kinetics.  Elevated 
[Pi] and [H2PO4-] appear to cause myosin, with ADP still bound, to dissociate from the 
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actin filament after its powerstroke, which reduces force production (56,59).  However, 
when [H+] and [Pi] are both present in the in vitro milieu, the effect of [H+] on contractile 
velocity is attenuated (58).  An additional result of high [H+] and [Pi] is a decrease in 
muscles sensitivity to Ca2+ (59,181).  Any reduction in the Ca2+ sensitivity during fatigue 
exacerbates force loss because less Ca2+ is released from the SR in the fatigued state 
(140,144).  Together, the increase in [H+], [Pi], and [H2PO4-] with fatigue impair force 
and power production. 
The greater fatigue in young compared with older muscle in response to isometric 
contractions is associated with an accumulation of the metabolic by-products of non-
oxidative ATP production ([H+], [Pi], and [H2PO4-]) in young muscle (114,130).  Indeed, 
during a sustained 60s MVIC, ATPOX is relatively greater in older than young muscle, as 
shown in Figure 2.6 (128).  Lanza et al. used cuff-ischemia to test the hypothesis that 
glycolytic ATP production is impaired in older muscle and found that when oxygen 
supply is compromised, older muscle can upregulate its glycolytic ATP production to 
similar levels observed in young muscle (130). 
Figure 2.6. Relative contributions from each bioenergetic pathway to total ATP production.  
ATPgly, glycolytic ATP production; ATPOX, oxidative ATP production; ATPCK, ATP derived via 
the creatine kinase reaction. Adapted from Lanza et al. (128). 
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Muscle oxidative capacity can be defined in vivo as the maximal rate at which a 
muscle can consume oxygen under conditions in which delivery of oxygen and substrate 
are not limited (29).  This rate reflects the maximal rate of oxidative phosphorylation 
within the muscle under study.  Following a brief contraction in which intracellular pH is 
relatively unchanged, the kinetics of PCr recovery follow a mono-exponential curve 
which is strictly attributable to mitochondrial ATP production (6,162,194).  The rate 
constant of this curve (kPCr, s-1) can be determined, as illustrated in Figure 2.7, and used 
as an index of muscle oxidative capacity (117). This technique for measuring oxidative 
capacity is highly reliable and well correlated with in vitro respirometry measures of 
mitochondrial capacity (129) and oxidative enzyme activities (134,156).  Because muscle 
oxidative capacity is higher in active compared with sedentary older adults, matching 
groups for physical activity when examining age-related differences in muscle energetics 









Figure 2.7. Mono-exponential recovery of PCr reflects in vivo muscle oxidative capacity. 
Adapted from Kent & Fitzgerald (111). 
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Our recent systematic review and meta-analysis revealed older adults have 
impaired oxidative capacity of the knee extensors compared with young adults (73).  This 
finding is illustrated by the negative standardized effect in Figure 2.8.  Coupled with the 
higher ATP demand of dynamic compared with isometric contractions (205), this deficit 
in oxidative capacity may require older muscle to rely more on phosphocreatine (PCr) 
breakdown and non-oxidative glycolysis for ATP production than young muscle.  If true, 
[H+], [Pi], and [H2PO4-] would increase more in older compared with young muscle, 
providing a metabolic basis for the crossover to greater fatigue in older muscle during 
high-velocity dynamic contractions.  Additionally, an in vitro study, which used a 
fluorescence-linked assay, demonstrated rat diaphragm muscles shortening at peak power 
output consumed ~3x more ATP compared with that consumed during an isometric 
contraction (209).  Further, because ATP consumption increases with contractions of 
short duration (13,89), as the production of force is more costly than the maintenance of 
force (202), the energetic demands of moderate-velocity contractions may be sufficiently 
low to prevent older muscle from relying on PCr breakdown and glycolysis to a greater 











Figure 2.8. Age-related changes in muscle oxidative capacity. Data are Standardized Effects ± 
Standard Error. Positive standardized effects indicate greater muscle oxidative capacity in older 
compared with young adults. *indicates a significant of age (p<0.05).  Adapted from Fitzgerald et 
al. (73). 
There are 3 main sites of ATP consumption within skeletal muscle; i) myosin 
ATPase, ii) Ca2+ ATPase, and iii) Na2+/K+ ATPase.  The latter 2 are commonly referred 
to as pumps because they work against the concentration gradient of the ions they are 
moving.  The Na2+/K+ pump is located on the sarcolemma and is responsible for the 
ATP-consuming process of pumping both sodium and potassium against their 
concentration gradients in order to restore the resting membrane potential following 
activation (37).  The Ca2+ ATPase, located on the SR, pumps Ca2+ from the cytosol back 
into the SR after activation; a necessary process for force relaxation.  Approximately 30-
50% of the total ATP cost of contraction is associated with the Na2+/K+ and Ca2+ 
ATPases.  The majority of this energy cost is attributed to Ca2+ ATPase activity (8).  The 




Use of phosphorus magnetic resonance spectroscopy (31P-MRS) allows non-
invasive measurement of ATP production rates during muscle contractions in vivo (20).  
In 1986, Taylor et al. used 31P-MRS to examine the effect of low- and high-intensity 
contractions of the forearm on [ATP] (226).  The authors demonstrated that [ATP] is well 
maintained during low-intensity contractions (~30% MVIC, 1 contraction every 2s for 
5min), but decreased by ~45% during high-intensity contractions (100% MVIC, 1 
contraction every 2s until exhaustion) in some, but not all participants.  Thus, because 
[ATP] is maintained until extreme levels of fatigue (226), the rate of ATP production is 
equal to its rate of consumption (128,226).  In studies comparing age-related differences 
in ATP consumption rates, accounting for the decline in muscle mass with age by 
examining the metabolic economy of muscle (ME; mass-normalized torque produced per 
unit ATP consumed) is required.  The few studies conducted to date suggest ME is higher 
(130) or similar (31) in older compared with young muscle during maximal isometric 
contractions.  Christie et al. evaluated ME in the dorsiflexors of young, older, and older 
mobility-impaired adults and reported no age-related differences during a sustained 12s 
MVIC (31).  Layec et al. also reported no age-related difference in ME in the knee 
extensors of older compared with young adults during a sustained 24s MVIC (136).  
However, the authors of that study did report lower ME in older compared with young 
adults during intermittent contractions of the knee extensors.  The latter finding suggests 
there is an age-related increase in the cost of developing but not maintaining force. 
To date, 2 studies have examined age-related differences in ME during dynamic 
contractions (137,139).  Layec et al. determined the maximal power output during an 
incremental knee extension protocol and subsequently quantified ME over 5 min of knee 
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extensions at 40% of each participant’s maximal work rate (139).  The authors reported 
significantly higher ME in young compared with older muscle. 
The studies which have evaluated age-related differences in ME of human 
skeletal muscle have varied considerably in methodology and the muscle studied, which 
precludes a consensus being reached at this time.  If ME is lower in older knee extensor 
muscles compared with young during high-velocity contractions, fatigue may be 
exacerbated because the energetic demand outweighs its supply.  However, whether age-
related changes in ME are velocity-dependent and can provide a metabolic rationale for 
the crossover in muscle fatigue is currently unclear. 
Summary 
In summary, fatigue is greater in older compared with young muscle in response 
to high-velocity contractions.  However, the mechanisms to explain this age-related 
difference in muscle fatigue remain unclear at this time.  Preliminary findings from 
Fitzgerald et al. (unpublished observations) indicate neither central activation nor ECC 
failure can explain these age-related differences in muscle fatigue.  These preliminary 
results do, however, suggest that slowed contractile properties at baseline can explain a 
significant portion of the age-related differences in muscle fatigue in response to high-
velocity contractions.  However, it is unclear how these slowed contractile properties at 
baseline might affect bioenergetic flux during high-velocity contractions. 
Several knowledge gaps have been identified.  Firstly, the extent to which deficits 
in muscle oxidative capacity affect the contribution from the 3 bioenergetic pathways 
during moderate- and high-velocity dynamic contractions has not been addressed.  
Secondly, changes in ME may be age- and velocity-dependent and thus provide a 
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metabolic rationale for the age-related differences in muscle fatigue.  Lastly, age-related 
differences in muscle-tendon unit stiffness may provide a structural mechanism for the 
greater loss of muscular power in older compared with young adults in response to high-





Age-Related Differences in Muscle Fatigue: The Role of Bioenergetics 
Participants 
For this study, 20 young (25-40 years; 10 men) and 20 older (65-80 years; 10 
men) adults will be recruited.  Participants will be recruited from Amherst and the 
surrounding communities using flyers, word of mouth, and mailing lists.  Individuals who 
have participated in previous studies and indicated their desire to participate in future 
studies will be contacted via email or telephone to assess their interest in the study. 
Table 3.1 shows the sample size estimates, which were calculated to detect 
significant differences with 80% power, an alpha level of 0.05, and an equal number of 
participants in young and older groups (GPower v3.1; (70)).  Although the sample size 
estimates for detecting age-related differences in ME during isometric and dynamic 
contractions indicate total group sizes of 44 and 46 participants would be required, 
respectively, the decision to include 20 young and 20 older adults was made due to the 
financial constraints of testing additional participants.  Further, the scant data available on 
age-related differences in ME precludes a comprehensive estimate of the required sample 
size.  On the whole, the sample size estimates indicate that the recruitment of 40 
participants will provide adequate statistical power to detect differences in the main 
outcome variables (i.e., muscle fatigue, oxidative capacity, ME, and MTU stiffness). 
Upon completion of this study, participants will receive a $30 gift card to a local store in 




Table 3.1. Sample size estimates for outcome variables 
 Variable 
(units) 




Hi-Vel fatigue  
(% initial) 




(23) KE 0.43±0.12 0.44±0.11 3280 
H2.1a 
Oxidative capacity  
(Qmax, mM ATP.s-1) 
(100) VL 0.77±0.04 0.64±0.05 6 
H2.1a 
Oxidative capacity  
(KPCr, s) 
(133) VL 0.029±0.008 0.024±0.006 52 
H2.1a 
Oxidative capacity  
(Qmax, mM ATP.s-1) 








(137) PF 3.7±1.7 5.1±2.0 46 
H2.2b 
ME peak power 
(mM.min-1.W-1) 
(139) PF 2.4±1.9 7.2±4.1 14 
Aim 3 
MTU stiffness  
(kN/strain) (105) VL 57.9±10.6 46.1±15.5 34 
Values are Mean±SD. Hi-Vel, high-velocity; Mod-Vel, moderate-velocity; T1/2, time for PCr 
to recover to 50% of baseline [PCr]; Qmax, theoretical maximal rate of oxidative ATP 
synthesis; kPCr, rate constant for PCr recovery; mM, millimolar; min, minute; Nm, Newton 
meter; W, Watt; kN, kilo Newtons; strain, aponeurosis elongation; KE, knee extensors; VL, 
vastus lateralis; PF, plantar flexors. 
 
Except for the informed consent (Appendix A), telephone screening form 
(Appendix B), Magnetic Resonance (MR) safety form (Appendix C), all documents 
(paper and electronic) will be labeled with a participant code instead of the individual’s 
name.  All informed consent documents and the list identifying each participant’s code 
number will be kept separate from documents containing the participant code and stored 
in a locked cabinet.  All electronic data will be kept on a password-protected computer in 
a locked office, and this computer will be kept offline.  Those steps will be taken to 




 Young (25-40 years old) or older (65-80 years old) men or women 
 Relatively healthy (see exclusion criteria) 
Exclusion Criteria: 
 Diagnosis of cardiovascular, pulmonary, musculoskeletal, neurological, or 
metabolic disease 
 More than two 30 min bouts of moderate intensity exercise per week, as 
determined by self-report during the telephone screening 
 Use of medications that may affect physical function or fatigue (e.g., beta-
blockers, calcium channel blockers, sedatives, tranquilizers, etc.) 
 Current smoker or smoking cessation within the previous year 
 Clinically significant arthritis in the lower extremities 
 History of muscle cramps or pain 
 History of dyspnea, cramping, light-headedness, or other symptoms upon 
exertion 
 Pregnant 
 Metal implants or unable to undergo an MRI exam (e.g., claustrophobia) 
 
Young and older groups will be matched for habitual physical activity, which will 
be measured using a uniaxial accelerometer (ActiGraph GT3X, Pensacola, FL).  To help 
in the recruitment of sedentary-to-recreationally active individuals, participants will be 
asked about their current phyiscal activity habits during the initial phone screening.  
Those who report completing more than two 30 min bouts of exercise per week will be 
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excluded.  Similar physical activity criteria have been used in studies examining age-
related differences in muscle fatigue in our lab (23,24,131).  Visits 2 and 3 will be 
separated by at least 3 days to prevent any effect of fatigue at Visit 2 affecting the 
measures taken at Visit 3. 
Procedures 
This study will require 3 visits, all of which will take place at the University of 
Massachusetts Amherst.  Visit 1 will take place at the human testing center (HTC), which 
is located within the Institute for Applied Life Sciences.  Visits 2 and 3 will take place in 
the human magnetic resonance center (hMRC), which is also located within the Institute 
for Applied Life Sciences.  The total time commitment for the study is approximately 3 
hours.  Visit 1 will involve consenting, measures of mobility and muscle-tendon unit 
stiffness, and familiarization with the fatigue protocols to be completed at Visits 2 and 3.  
Measures of muscle contractile and non-contractile volumes, intracellular bioenergetics, 
and fatigue (1st of 2 protocols) will be made at Visit 2.  Lastly, measures of oxidative 
capacity, intracellular bioenergetics, and fatigue (2nd of 2 protocols) will be made at Visit 
3. 
At the beginning of Visit 1, the participant will read and sign an informed consent 
document, as approved by the Institutional Review Board at the University of 
Massachusetts Amherst, and in accordance with the Declaraction of Helsinki.  With the 
exception of this informed consent document and the MR safety form (Appendix C), all 
participant information will be de-identified.  All individuals in the older group will be 
asked to sign a letter requesting their physician’s clearance to participate in Visits 2 and 
3.  Once their physician has reviewed the study information and given their approval, the 
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older participant will be scheduled for their second and third visits.  If their physician 
does not approve the individual to participate in Visits 2 and 3, we will not schedule any 
further visits for that participant.  A conceptual framework for the study is shown in 
Figure 1.6. 
Paperwork and Anthropometrics 
Each participant will complete 3 documents, including the MR safety form 
(Appendix C), medical history form (Appendix D), and Physical Activity Readiness 
questionnaire (Appendix E).  After completing the paperwork, the participant’s height, 
body mass, and seated blood pressure will be measured using standardized procedures 
(23,24,131,132). 
Mobility Measures 
In order to facilitate comparisons with previous studies, two common metrics of 
mobility will be completed to help characterize the participant’s physical function.  First, 
the participant will complete the Timed-Up-and-Go (TUG) test, which is measured as the 
time a participant takes to stand up from a seated position, walk 3m, return to the chair 
and sit down (188).  This test will be completed twice with 1 min of rest between each 
trial, and the fastest of the 2 trials will be used to characterize the participant’s mobility.  
Participants will be instructed to complete the TUG at their usual walking speed (188).  
Next, the participant will complete the Advanced Short Physical Performance Battery 
(SPPB-A) which includes 3 parts that combine measures of chair rise time, balance time 
in 3 different positions, and gait speed over a 4m path (210).  The time required to 
completely stand up and sit back down 10 times in a standardized chair (seat height = 
45cm) will be recorded with a stopwatch.  For the chair rise task, the participant will be 
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instructed to fold their arms across their chest and complete the task as fast as possible.  
For the balance tasks, the participant will stand with their feet in 3 different positions 
(side-by-side, semi-tandem, and tandem) for as long as possible, up to a maximum of 30s.  
If the participant loses their balance and reaches out for the wall or the research assistant, 
the trial will be stopped and the time the participant was able to hold the balance position 
will be recorded.  Next, the participant will walk along a straight, 4m path at a casual 
speed as though they were walking along the street.  This test will be repeated twice with 
1 min between trials.  The time to walk 4m will be recorded using a stopwatch, and the 
fastest time will be used for analysis.  This walking test will then be completed, with the 
same instructions, while the participant tries to walk within a 20cm path.  Each measure 
of the SPPB-A will be scored, from 0-4, and summed to facilitate comparisons with other 
studies (210).  For both mobility tests, a research assistant will be present to provide 
support and guard against falls, as necessary.  The principal investigator will initiate each 
task verbally and record the duration of timed tasks using a stopwatch. 
Muscle-Tendon Unit Stiffness 
After completing the mobility tests, the participant’s thigh, shank, and total leg 
length will be obtained using a tape measure.  A small mark will be made with indelible 
ink at the midpoint between the lateral femoral condyle and greater trochanter of the 
femur.  Next, the participant will perform 5 min of unloaded cycling on a recumbent 
cycle ergometer (Schwinn, Nautilus, Inc., Vancouver, Washington), in order to “warm 
up.”  The participant’s dominant leg will then be determined by asking “which leg would 
you use to kick a ball?”  This leg will be used for all measures of muscle tendon-unit 
stiffness.  The participant will be seated on an Biodex 4 dynamometer (Biodex Medical 
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Systems, Shirley, NY) in an upright position with their hips at 90° and a starting knee 
angle of 100° extension (180° = full extension).  Next, the participant will complete 2 
maximal isometric voluntary contractions, with 1 min rest between each contraction to 
prevent muscle fatigue.  These isometric contractions will be completed at a knee angle 
of 100°, and each contraction will be held for ~3-4s.  If peak torque differs by greater 
than 10%, an additional maximal voluntary isometric contraction.  Once baseline 
isometric torque is determined, the participant’s vastus lateralis will be visualized using 
an ultrasound system (Affiniti 70, Philips Healthcare, Bothell, WA).  Specifically, B-
mode ultrasound will be obtained using a linear array transducer (Philips model: L12-5) 
and an insonation angle of 60° (191).  The transducer will be placed over the midpoint of 
the vastus lateralis, identified as 50% of the length between the greater trochanter and 
lateral epicondyle, and adjusted as necessary to obtain the best visualization of the muscle 
fascicles, and superficial and deep aponeuroses.  Next, participants will complete 5 
ramped isometric contractions (i.e., contractions which increase in intensity over time) 
while an ultrasound video of the participant’s vastus lateralis is obtained concurrently.  
Force feedback will be provided throughout these ramped contractions, and participants 
will be asked to match a visual target.  The duration of these ramped isometric 
contractions will be determined during pilot testing, but will be between 10 and 30s.  The 
displacement of the deep aponeurosis will be tracked using an automated, custom-written 
MatLab program, and plotted against the increase in torque from the ramped isometric 
contraction.  The slope of this relationship will be fit with a 2nd order polynomial to 
determine the muscle-tendon unit stiffness (84). 
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Familiarization: Fatigue Trials 
While still seated on the Biodex 4 dynamometer, the participant will complete 
two 40-s trials of dynamic contractions with their dominant leg to familiarize them with 
the fatigue trials to be performed at Visits 2 and 3.  Specifically, the participant will 
complete 40s of maximal voluntary dynamic contractions at 120°.s-1 and 240°.s-1, with 1 
contraction completed every 2s.  Each contraction will be cued by an audible beep, and 
all dynamic contractions will be completed over a 35° range of motion (105-140°) for 
each velocity tested.  For all contractions, the participant will be asked to fold their arms 
across their chest and “kick out their leg as hard and fast as possible.”  Visual feedback 
regarding torque will be provided using an LED box for all contractions. 
Habitual Physical Activity 
At the end of Visit 1, the participant will be given an accelerometer and activity 
log (Appendix F), and asked to wear the device for a 7 day period.  The participant will 
be instructed to wear the accelerometer at their right hip, and data will be recorded with a 
60s epoch.  A minimum of 10 hours of accelerometry data will be required per day to be 
included in the analysis, and data will be required for a minimum of 4 complete days (3 
weekdays and 1 weekend day).  These criteria have been demonstrated to provide good 
reliability for quantifying overall, light, and moderate-to-vigorous physical activity 
(153,154).  To assist with capturing activities not detectable by this accelerometer (e.g., 
swimming, cycling, etc.), the participants will also be given an activity log and asked to 
record their daily activities, sleep schedule, times the accelerometer was removed, and 
activities which they consider to be atypical for them.  ActiLife v6.13 software 
(ActiGraph, Pensacola, FL) will be used to calculate average daily activity counts as well 
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as minutes spent in moderate-to-vigorous physical activity, using established cutpoint 
thresholds for uniaxial ActiGraph accelerometers (74). 
Muscle Cross-Sectional Area 
Upon arriving for Visit 2, the participant will be asked to remove all jewelry and 
any other metallic objects on their person.  To ensure their safety, participants will also 
walk through an upright metal detector, and have a hand-held metal detector passed over 
their body.  Next, they will be positioned supine inside a MR scanner (Skyra 3T, Siemens 
Medical Systems, Erlangen, Germany) while T1-weighted images of the thigh of their 
dominant leg, determined at Visit 1, are obtained using an 18 channel phased-array coil.  
The acquisition parameters for these images will be: turbo spin echo sequence, echo time 
= 8.1ms, matrix = 192x192, field of view = 230x230mm, slice thickness = 6mm with no 
gaps.  An example of the T1-weighted images to be obtained is shown in Figure 3.1. 
A custom-written MatLab program (MathWorks, Natick, MA) will be used to 
quantify the fat-free muscle cross-sectional area (CSA, cm2) of the knee extensors, as 
previously done in our lab (24).  This MatLab program will parse intramuscular fat from 
muscle tissue, which is particularly useful in studies of aging because intramuscular fat 
content increases with age (24,90).  The program achieves this by analyzing the signal 
intensity of pixels within a region of interest, selected by the investigator, and producing 
a histogram of those signal intensities.  The histogram displays 3 peaks corresponding to 
the signal intensity from bone and connective tissue, muscle, and fat.  By selecting the 
outer boundaries of the peak from muscle, thresholds are assigned for the signal intensity 
from muscle.  Next, the muscle perimeter will be manually traced, avoiding any 
subcutaneous fat, and the MatLab program will compute the muscle CSA (cm2) and fat 
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CSA (% total) for each slice.  Muscle volume will be calculated as the sum of CSAs for 
the knee extensor muscles.  To eliminate the possibility of inter-investigator error, the 
same investigator will analyze all MR images.  
Intracellular Bioenergetics 
After the images have been obtained, participants will be removed from the MR 
scanner and a dual-tuned (proton and phophorus; 10 × 8cm) copper coil will be affixed 
over the vastus lateralis of their dominant leg using athletic wrap and tape.  The 
participant will then be re-positioned inside the scanner.  The knee and ankle of the leg 
will be strapped to a custom-made knee extension ergometer using Velcro straps (Figure 
3.2).  Additionally, an inelastic stap will be fastened over their hips to prevent unwanted 
movement.  This ergometer is capable of imposing and recording isometric, isokinetic 
and isotonic contractions of the knee extensor muscles (96). 
Gradient-echo scout images will be obtained to ensure the vastus lateralis of the 
participant’s dominant thigh is positioned within the isocenter of the magnet.  The 
homogeneity of the magnetic field will be optimized by localized shimming on the proton 
signal of tissue water.  The participant will then complete either a moderate- or high-
velocity fatigue protocol (see Fatigue Protocols), the order of which will be randomized 
across Visits 2 and 3.  Cytosolic pH and concentrations of phosphorus-containing 
compounds will be continuously and noninvasively obtained using 31P-MRS.  These 
measures will be acquired for 90s before, during, and 10 min after completion of the 
fatigue protocol at Visits 2 and 3.  The acquisition parameters for these spectra will be: 
hard pulse, 60° flip angle, 2000ms repetition time, 2048 complex points, 4000Hz spectral 
width, 465 total acquisitions. 
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The MRS free induction decays will be analyzed using jMRUI v6.0beta.  For Aim 
1, spectra will be averaged to achieve 90s and 20s resolution at rest and during the fatigue 
protocol, respectively.  For the recovery period, the time resolution will be 8s and 30s 
during the first and last 5 min, respectively.  This time resolution will yield better signal-
to-noise than if no averaging is performed, and will provide better time resolution than 
previous investigations examining age-related differences in muscle fatigue using 31P-
MRS (114). 
Once averaged, spectra will be zero-filled (2,048 points) and Fourier-transformed.  
A 1Hz Lorentzian filter will be applied and the spectra will be manually phased.  After 
setting the PCr peak to 0 parts per million, the spectra will be line-fit using the AMARES 
algorithm and the area under the peaks corresponding to phosphomonoesters, Pi, 
phosphodiesters, PCr, and gamma ATP quantified (Figure 3.3, panel A).  The 
concentrations of Pi and PCr will be calculated assuming that [Pi] + [PCr] = 42.5mM in 
resting muscle (161).  Intracellular pH will be calculated based on the chemical shift (σ) 
of Pi relative to PCr (168).  Because broadening and splitting of the Pi peak can occur 
due to distinct pH pools during contractions (180), 2 curves will be used to fit Pi and the 
weighted average of the 2 peaks will be used when Pi splitting is evident as described in 
[Eq. 3.8].  The concentration of H2PO4- will be calculated as (127): 
 
 









Once positioned inside the MR scanner at Visits 2 and 3, and with the dual-tuned 
coil affixed over the participant’s vastus lateralis, the participant will complete 2 MVICs 
with 1 min of rest between each, to determine peak torque at baseline.  If the 2 peak 
values differ by more than 10%, 1 additional MVIC will be performed.  Participants will 
then perform 2 sets of 3 MVDCs, with 1 min of rest between sets to prevent muscle 
fatigue, to determine peak power at baseline.  Because of the physical constraints of the 
MR scanner’s bore, the range of motion for all dynamic contractions will be limited to 
30° with a starting knee angle of ~110° (180° = full extension).  The velocity of these 
dynamic contractions will be matched to the velocity of the fatigue trial (i.e., 120°.s-1 or 
240°.s-1) the participant will perform at this visit. 
After baseline measures of maximal torque and power have been obtained, the 
participant will complete a fatigue trial consisting of 4 min of MVDCs at one of 2 
velocities.  The moderate-velocity fatigue protocol will consist of MVDCs at 120°.s-1.  
Because each contraction will last ~0.3s and participants will complete 1 contraction 
every 2s, the duty cycle will be ~13%.  The high-velocity fatigue protocol will consist of 
1 MVDC every 2s at 240°.s-1, providing a duty cycle of ~7.5%.   
Participants will be cued for each contraction with an auditory tone and verbal 
encouragement will be provided by a research assistant.  Visual feedback will also be 
provided using a large screen visible to the participant.  Measures of torque, velocity, and 
knee angle will be collected at 500Hz using a custom-written MatLab user interface for 
all isometric and dynamic contractions.  Peak torque during each dynamic contraction 
will be identified during the isovelocity phase.  The peak power produced during each 
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contraction will be calculated as the product of peak torque and the corresponding 
velocity observed at that time, as illustrated in Figure 3.4.  The peak power achieved 
during the 2 sets of 3 baseline MVDCs will be used to provide a visual target, which 
participants will be able to view real-time throughout the fatigue trial.  To determine the 
relative decline in peak power, fatigue during the moderate- and high-velocity protocols 
will be calculated as (24): 
 
 
average peak power over final 5 contractions
average peak power at baseline and during fatigue trial
 100 [Eq. 3.2] 
 
Muscle Oxidative Capacity 
Upon arrival at hMRC for Visit 3, the participant will be safety screened, 
positioned inside the MR scanner with the dual-tuned coil fastened over the vastus 
lateralis of their leg, and their knee and ankle strapped to the ergometer using the same 
procedures as at Visit 2.  Gradient scout images will be obtained to ensure the participant 
is correctly positioned inside the MR scanner and the magnetic field will be optimized 
using the same method as Visit 2.  The participant will then perform a sustained 24s 
MVIC of their knee extensors.  The duration of this contraction has been demonstrated to 
deplete PCr in the vastus lateralis muscle by ~50% from resting concentration with little 
change in pH (133).  Concentrations of phosphorus-containing compounds will be 
acquired for 90s before, during, and 10min following the contraction using the same 




All free induction decays will be analyzed using jMRUI v6.0beta.  Spectra will be 
zero-filled (2,048 points) and Fourier-transformed.  A 1Hz Lorentzian filter will be 
applied and the spectra will be manually phased.  After setting the PCr peak to 0 parts per 
million, the spectra will be line-fit using the AMARES algorithm and the area under the 
peaks corresponding to phosphomonoesters, Pi, phosphodiesters, PCr, and gamma ATP 
quantified (Figure 3.3, panel A).  The concentrations of Pi and PCr will be calculated 
assuming that [Pi] + [PCr] = 42.5mM in resting muscle (161).  Intracellular pH will be 
calculated based on the chemical shift (σ) of Pi relative to PCr (168). 
Once pH and the concentrations of PCr, Pi and ATP have been determined, the 
repletion of PCr during the 10 min recovery period will be fit with a monoexponential 
function and the rate constant (kPCr) determined, as shown in equation [3.3].  Examples of 
a 31P spectrum and monoexponential recovery of PCr are illustrated in Figure 3.3.  In 
equation [3.3], PCrex is [PCr] at the end of the contraction, and ΔPCr = (PCrrest – PCrex), 
where PCrrest is [PCr] at rest.  The rate constant of PCr recovery, kPCr (s-1), reflects the 
capacity for oxidative phosphorylation under these conditions.  This measure is highly 
reliable and well correlated with respirometry measures of maximally stimulated in vitro 
(i.e., state 3) respiration (129) and oxidative enzyme activities (134,156). 
 
 PCr t ∆PCr 1 e PCr  [Eq. 3.3] 
 
ATP Cost of Contraction 
Under conditions where there is no net change in [ATP], ATP production can be 
assumed to be equal to ATP consumption (20,226).  As a result, the rates of ATPCK, 
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ATPGLY, and ATPOX can be calculated during contractions.  These measures will be made 
during the 24s MVIC used to determine oxidative capacity, as well as during the first 24s 
of the moderate- and high-velocity fatigue protocols to address Aim 2. 
The MRS free induction decays will be analyzed using jMRUI v6.0beta.  For Aim 
2, spectra will be averaged to achieve 90s and 4s resolution at rest and during the first 24s 
of the fatigue protocol, respectively.  This time resolution was chosen to yield adequate 
signal-to-noise for calculating the bioenergetic flux calculations (128).   
Once averaged, spectra will be zero-filled (2,048 points) and Fourier-transformed.  
A 1Hz Lorentzian filter will be applied and the spectra will be manually phased.  After 
setting the PCr peak to 0 parts per million, the spectra will be line-fit using the AMARES 
algorithm and the area under the peaks corresponding to phosphomonoesters, Pi, 
phosphodiesters, PCr, and gamma ATP quantified (Figure 3.3, panel A).  The 
concentrations of Pi and PCr will be calculated assuming that [Pi] + [PCr] = 42.5mM in 
resting muscle (161).  Intracellular pH will be calculated based on the chemical shift (σ) 
of Pi relative to PCr (168).   
The rate of PCr breakdown by the CK reaction will be established by the rate of 
decline in PCr at each 4s time point during the 3 contraction protocols (i.e., 24s MVIC, 
120°.s-1, and 240°.s-1), as follows: 
 
 ATP  
∆PCr
∆t




Oxidative ATP synthesis will be quantified under the assumptions that the resting 
concentration of ATP is equal to 8.2mM (82), and the phosphorylation potential 
([Pi][ADP]/[ATP]) is regulated with a Km of 0.11 (235), as follows: 
 
 ADP  
ATP Pi
K PCr
 [Eq. 3.5] 
 
where [Pi] and [PCr] will be averaged every 4s during the contractions.  The equilibrium 
constant of the CK reaction, KCK, will be corrected for pH, as follows: 
 
 K 1.66 10 .  [Eq. 3.6] 
 
Intracellular pH will be calculated based on the chemical shift (σ) of Pi relative to 
PCr, in parts per million, as follows (168): 
 
 pH 6.75 log
σ 3.27
5.69 σ
 [Eq. 3.7] 
 
If Pi splitting is evident, the pH pH corresponding to each Pi pool will be calculated 
separately (based on the linefit of each of 2 Pi peaks), and the weighted average will be 









 [Eq. 3.8] 
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Glycolytic ATP synthesis will be calculated based on changes in pH and PCr during each 
24s contraction, using linear regression for the rate of change.  Proton consumption by 
the CK reaction, buffering, and oxidative proton production will also be taken into 









𝑚ATP  [Eq. 3.9] 
 
where β represents the total buffering capacity, which will be calculated as the sum of 
inherent buffering, and buffering from bicarbonate and Pi (108).  Proton production by 
oxidative phosphorylation is represented as m (108).  The proton stoichiometry of the CK 






 [Eq. 3.10] 
 
The total rate of ATP production (mM.s-1) will be calculated as the sum of ATP 
flux through the CK reaction, non-oxidative glycolysis, and oxidative phosphorylation 
(31).  Absolute quantities of ATP production (mM) will be determined by multiplying the 
total rate of ATP production (mM.s-1) by the duration of the contraction (i.e., 24 s).  To 
evaluate age-related differences in ME for each condition (i.e., isometric, 120°.s-1, and 
240°.s-1), the torque-time integral will be normalized to muscle volume and ATP 




Outcome Variables and Statistical Analyses 
The primary outcome variables for this dissertation include oxidative capacity 
(kPCr), [H+], [Pi], and [H2PO4-] during both fatigue trials, peak power (W), and the ME 
(Nm.cm-3.mM ATP-1) for isometric and dynamic contractions at 120°.s-1 and 240°.s-1.  
Group descriptive characteristics will include age, height, body mass, blood pressure, 
TUG, and SPPB-A.  All statistical analyses will be performed using SPSS v24.0 (SPSS 
Inc., Chicago, IL).  Significance will be accepted at the p≤0.05 level.  Exact p values, 
95% confidence intervals for the differences in group means, as well as mean±SE will be 
reported.  All data will be checked for violations of statistical assumptions (e.g., 
normality) and non-parametric alternatives will be performed where appropriate.  
Differences in group descriptive characteristics will be analyzed using independent t-
tests. Prior to hypothesis testing, all variables will be evaluated for differences by sex, 
and sex-by-age interactions.  In the event differences or interactions are detected, the 
statistical plan will be adjusted accordingly. 
Hypotheses 
Aim 1: 
H 1a: Baseline oxidative capacity of the vastus lateralis will be higher in young 
than older adults. 
H 1b: Cytosolic [H+], [Pi] and [H2PO4-] will increase to a greater extent in older 
than young muscle during the high velocity (240°.s-1) fatigue trial. 
H 1c: Neither fatigue nor cytosolic [H+], [Pi] and [H2PO4-] will differ between 
age groups during the moderate velocity (120°.s-1) fatigue trial. 
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H 1d: The proportion of ATP derived from oxidative phosphorylation will be 
lower in older than young muscle during the high velocity (240°.s-1) fatigue trial, but not 
between groups during moderate velocity (120°.s-1) fatigue trial. 
Aim 2: 
H 2a: Metabolic economy (Nm.s.cm-3.mM ATP-1) will be higher in older 
compared with young muscle during a 24s isometric contraction. 
H 2b: Metabolic economy (Nm.s.cm-3.mM ATP-1) will not be different between 
age-groups during contractions at 120°.s-1. 
H 2c: Metabolic economy (Nm.s.cm-3.mM ATP-1) will be lower in older 
compared with young muscle during contractions at 240°.s-1. 
Exploratory Aim: 
EH 1a: Muscle-tendon unit stiffness of the vastus laterlis will be greater in young 
compared with older adults. 
EH 1b: Muscle-tendon unit stiffness will be positively associated with fatigue 
(defined as % initial power) induced by high-velocity contractions (240°.s-1). 
 
Hypothesis 1a will be tested by comparing oxidative capacity (kPCr) between 
young and older groups using an independent t-test.  Hypotheses 1b will be tested by 
comparing [H+], [Pi], and [H2PO4-] using 2-way MIXED procedure repeated measures 
ANOVA’s (group × time).  For this analysis, metabolite concentrations over each 20s 
time period during the high velocity (240°.s-1) fatigue trial (i.e., 12 time points) will be 
used.  Hypothesis 1c will be tested in the same way as hypothesis 1b, but using the data 
from the moderate velocity (120°.s-1) fatigue trial.  Hypothesis 1d will be tested by 
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comparing group differences in the proportion of ATP derived from oxidative 
phosphorylation (ATPOX/ATPTOTAL) using 2-way MIXED procedure repeated measures 
ANOVA’s (group × time) for each fatigue trial.  If significant differences are found for 
hypotheses 1b-d and the null hypotheses are rejected, post-hoc testing on the differences 
between groups will be evaluated. 
Hypothesis 2a will be tested by comparing group differences in metabolic 
economy (Nm.cm-3.mM ATP-1) using a 2-way MIXED procedure repeated measures 
ANOVA (group × time) during the 24s MVIC.  Hypothesis 2b will be tested by 
comparing group differences in metabolic economy (Nm.cm-3.mM ATP-1) using a 2-way 
MIXED procedure repeated measures ANOVA (group × time) during the first 24s of the 
moderate velocity fatigue protocol.  Hypothesis 2c will be tested by comparing group 
differences in metabolic economy (Nm.cm-3.mM ATP-1) using a 2-way MIXED 
procedure repeated measures ANOVA (group × time) during the first 24s of the high 
velocity fatigue protocol. 
Exploratory hypothesis 1a will be tested by comparing group differences in 
muscle-tendon unit stiffness using an independent t-test.  The second exploratory 
hypothesis (1b) will be tested using a linear regression analysis to examine the 
relationship between muscle-tendon unit stiffness and muscle fatigue in response to the 

























Figure 3.3. 31Phosphorus spectrum and oxidative capacity from one young woman. Panel A 
shows a resting 31P Spectrum. Panel B shows the rate constant of PCr recovery obtained from 1 
young woman. PME, phosphomonoesters; Pi, inorganic phosphate; PDE, phosphodiesters; ɣ-





Figure 3.4. Representative torque and velocity trace during a maximal voluntary dynamic 
contraction. Peak torque was generated while velocity was constant at 240°.s-1. 
Chapter 3: Addendum 
Following the proposal of this dissertation in July 2017, several methodological 
amendments were made.  First of these was that we were unable to collect data on 20 
young (10 men) and 20 older (10 men) adults due to budget constraints.  As such, we 
recruited and collected data from 10 young (6 men) and 10 older (5 men) adults.  Pilot 
testing necessitated changes to the MR imaging sequence, high-velocity fatigue protocol, 
and MTU stiffness measurement.  Amendments from the originally proposed methods are 
outlined below, along with a rationale for those changes. 
Magnetic Resonance Imaging 
 The original proposal included the collection of T1-weighted MR images of the 
thigh musculature.  Pilot testing revealed a significant dielectric effect in the T1-weighted 
MRI’s using our Skyra 3T scanner (Siemens Medical Systems, Erlangen, Germany), as 
shown in upper panel of Figure 3.5.  This dielectric effect precluded accurate separation 
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of muscle and fat during offline quantification.  So that muscle and fat could be 
accurately quantified in all participants in the studies composing this dissertation, we 
used a 6-pt Dixon imaging technique (51,145).  A representative image collected using 
the 6-pt Dixon technique is shown in bottom panel of Figure 3.5.  To accurately quantify 
muscle and fat from these images, a custom MatLab (Mathworks, Natick, MA) program 
was written.  All images were analyzed by the same investigator. 
 
 
Figure 3.5. Representative T1-weighted and Dixon magnetic resonance images. A T1-weighted 
image with artefacts is shown in the upper panel. Note the difference in pixel intensity between 
muscle in left vs. right hand side of the image. A representative 6-point Dixon in-phase, opposite-
phase, and fat image are shown in the bottom panel. This technique allowed for more accurate 
quantification of contractile volume and fat deposition within the muscle at 3T. Data are from 1 
young man. 
High-Velocity Fatigue Protocol 
 For Study 1, we proposed 2 fatigue protocols; 4 min of dynamic contractions (1 
every 2s) at either a moderate or a high velocity.  All participants were able to 
successfully attain 120°.s-1, and were therefore able to complete the moderate-velocity 
65 
 
contractions.  However, the older adults were unable to achieve the target velocity 
(240°.s-1) required for the proposed high-velocity contractions (Figure 3.6).  Notably, 
there was no isovelocity period during these contractions.  Because of this, the torque and 
velocity varied throughout each contraction which would have resulted in a different 
fatigue protocol for the young and older adults.  To solve this issue, the high-velocity 
fatigue protocol was changed to 4min of dynamic contractions (1 every 2 s) at a load 
equivalent to 20% maximal isometric torque.  This protocol has been used to evaluate 
age-related differences in muscle fatigue during contractions inside the MR-environment 
(223). 
 
Figure 3.6. Representative torque and velocity traces at the beginning of the proposed high-
velocity fatigue trial. Torque (A) and velocity (B) are from 1 older woman. Note there is no 




MTU Stiffness Measurement 
 In Study 1, we planned to quantify in vivo muscle-tendon unit stiffness of the 
knee extensors by combining isometric dynamometry and real-time ultrasound imaging.  
Synchronization of the Biodex system 4 dynamometer (Biodex Medical Systems, Shirley, 
NY) and ultrasound imaging system (Affiniti 70, Philips Healthcare, Bothell, WA) was 
not straightforward.  To synchronize the equipment, raw torque, velocity, and position 
signals from the Biodex 4 dynamometer were streamed wirelessly, along with an EMG 
signal from the rectus femoris, to an offline PC using a ±5 V anaolg adapter (Trigno, 
Delsys Inc., Natick, MA).  These data were recorded in EMGWorks (Delsys Inc., Natick, 
MA).   
The torque signal was calibrated across the range of torques expected (14-points) 
by hanging weights off the Biodex lever arm.  The velocity signal was calibrated between 
-300 and 300°.s-1 (14-points) during pilot work.  Briefly, one young male volunteered to 
perform dynamic contractions at distinct velocities (60, 120, 180, 240, 300°.s-1 flexion 
and extension).  An additional calibration point (0°.s-1) was sampled while the 
dynamometers lever arm was stationary.  Lastly, the position signal was calibrated using 
14-points which captured the range of positions achieved during the familiarization trials.  
Torque, position, and velocity signals were sampled at 148 Hz due to the hardware 
constraints of the ±5 V anaolg adapter. 
Because real-time force-feedback was not possible within the EMGWorks 
software, real-time feedback was provided based on the RMS EMG signal, which was 
scaled from 0-100% based on the RMS EMG signal during the 3-5 s MVIC at baseline.  
The RMS EMG signal was sampled at baseline and over a 0.25 s period covering the 
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peak isometric torque during the 3-5 s MVIC trials.  The maximum RMS EMG signal 
and offset (i.e., baseline RMS EMG signal) was used to scale visual feedback during the 
30-s ramped isometric trials, which was clearly displayed on a 27 inch LED monitor 
positioned in front of the participant at eye-level.  After the deep and superficial 
aponeuroses were visualized on the ultrasound screen, a 5 V pulse was sent from the 
ultrasound system to EMGWorks via a trigger (Delsys Inc., Natick, MA), which initiated 
the 30-s ramped isometric contraction.  Real-time feedback was provided based on the 
RMS EMG signal, which was scaled to the maximal RMS EMG from the 3-5 s MVICs.  
Ultrasound videos and torque signals were saved for offline analysis. 
The sampling frequency of the ultrasound videos varied, depending on the depth 
of the acquired images (range: 26.3 to 41.8 Hz).  Because the sampling frequency was not 
identical to that of the torque signal, the torque data were downsampled to match the 
sampling frequency of the corresponding torque data using a piecewise cubic hermite 
interpolating polynomial function in MatLab (MathWorks, Natick, MA).  The 
EMGWorks software, which recorded the torque signals, was triggered to begin 
recording on the negative edge of the 5 V synchronization pulse.  Using an A/D board, 
we discovered that the time delay between the recording of the ultrasound and torque 
signals was 1-s.  To account for this, the ultrasound and torque signals were synchronized 





ROLE OF BIOENERGETICS IN AGE-RELATED DIFFERENCES IN KNEE 
EXTENSOR MUSCLE FATIGUE 
Abstract 
In response to a period of contractile activity, the capacity to produce torque or power is 
reduced; a phenomenon known as muscle fatigue.  Previous work has shown muscle 
fatigue is generally greater in older than young adults in response to high-velocity 
contractions, but similar between age groups in response to moderate-velocity 
contractions.  The purpose of this study was to evaluate whether age-related differences 
in muscle fatigue in response to two distinct bouts of contractions are due to differences 
in the accumulation of putative agents of fatigue (i.e., inorganic phosphate (Pi), 
diprotonated phosphate (H2PO4-), and pH).  We hypothesized in vivo oxidative capacity 
of the vastus lateralis would be lower in older compared with young adults in the 
unfatigued state. We further hypothesized that fatigue would be greater in older than 
young adults in response to 4 min of isotonic contractions against a load equivalent to 
20% maximal isometric torque (MVDC20%), and that this would be accompanied by 
greater [Pi] and [H2PO4-], and a lower pH in older muscle.  Conversely, we expected to 
observe no age-related differences in fatigue, [Pi], [H2PO4-], or pH in response to 4 min 
of isokinetic contractions performed at 120°.s-1.  Lastly, we hypothesized that the 
proportion of ATP derived from oxidative phosphorylation would be lower in older 
compared with young muscle during the MVDC20% bout of contractions, but not different 
between age groups during the MVDC120 protocol.  Phosphorus magnetic resonance 
spectroscopy (31P-MRS) was used to quantify [Pi], pH, and [H2PO4-] in the knee extensor 
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muscles in 10 young (YA; 27.5±1.2 yrs, 6 men) and 10 older (OA; 71.2±1.6 yrs, 5 men) 
healthy adults, matched for habitual physical activity, throughout both fatigue protocols.  
Muscle oxidative capacity, measured as the rate constant of PCr recovery following 24 s 
of maximal voluntary dynamic contractions at 120°.s-1 (1 every 2 s) was not different 
between groups (YA: 0.021±0.001 vs. OA: 0.022±0.001 s-1, p=0.632).  Fatigue (% initial 
power-time integral) was not different between groups in response to the MVDC20% 
protocol (YA: 69.6±3.4% initial, OA: 69.7±6.5%, p=0.546), despite a lower pH and 
greater [H2PO4-] in YA compared with OA muscle (main effects of group: p≤0.001).  
Coincident with these observations, ATP flux through non-oxidative glycolysis was 
higher in YA than OA during the MVDC20% protocol (main effect of group: p=0.032), 
and the initial velocity of PCr resynthesis (Vi[PCr]: a measure of oxidative ATP flux) 
increased from baseline to the end of the MVDC20% in OA (p=0.01) but not YA 
(p=0.577).  In contrast, fatigue was greater in YA than OA in response to the MVDC120 
protocol (40.8±3.0 vs. 60.8±5.7%, p=0.007), and accompanied by greater [Pi] and 
[H2PO4-], and lower pH in YA compared with OA (main effects of group: p≤0.001).  
There was a main effect of group on non-oxidative glycolytic ATP flux (p=0.001) during 
the MVDC120 protocol, such that it was higher in YA than OA.  Oxidative ATP 
production, measured as Vi[PCr], increased from baseline to the end of the MVDC120 
protocol in OA (p=0.025) but not YA (p=0.512).  Collectively, these results support a 
preponderance for oxidative ATP production during in vivo contractions of the knee 
extensor muscles, at two distinct loads, in OA compared with YA.  Further, these results 
suggest the contractile machinery may be more sensitive to changes in pH in older 








Muscle fatigue can be defined as the reduced capacity of a muscle to produce 
torque or power in response to a period of contractile activity (112).  Because activities of 
daily living, such as climbing stairs or walking, require repeated dynamic contractions 
(184), the ability to resist muscle fatigue may be especially important for older adults in 
order to maintain their quality of life (227).  Numerous studies have reported less fatigue 
in older (≥ 65 years) compared with young adults (≤ 40 years) in response to isometric 
contractions (28,35,60,114,130).  Conversely, greater fatigue has been observed 
repeatedly in older compared with young adults in response to high-velocity contractions 
(9,24,48,49,159).  This observation has been made in studies using both isokinetic and 
isotonic dynamic contractions (24,48,49,222).  Notably, fatigue is similar in young and 
older adults in response to contractions at slow or moderate velocities (e.g., ≤120°.s-1 in 
the knee extensor muscles (23,24,49,147). 
The relative fatigue resistance of older compared with young adults during 
isometric contractions is thought to arise from the greater proportion of ATP produced 
via oxidative phosphorylation (ATPOX) in older adults (25,128).  Because of this greater 
reliance on oxidative phosphorylation, inorganic phosphate (Pi), proton (H+), and 
diprotonated phosphate (H2PO4-), which are known to inhibit crossbridge kinetics 
(57,59,176), accumulate to a lesser extent in older compared with young muscle 
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(114,128).  Indeed, a computational model examining the etiology of age-related 
differences in muscle fatigue supported the notion that fatigue resistance during isometric 
contractions is due to a lower reliance on glycolytic ATP production (25).  However, the 
mechanisms responsible for age-related differences in fatigue during dynamic 
contractions are less well established. 
Recent work in our lab demonstrated that the greater muscle fatigue in older 
compared with young women in response to 4 min of high-velocity (240°.s-1) contractions 
of the quadriceps muscles was not due to greater deficits in voluntary activation or 
excitation-contraction coupling with age (Appendix G).  Others have also shown greater 
fatigue in older than young adults in response to high-velocity contractions of the knee 
extensor and plantar flexor muscles, and that this fatigue was not due to age-related 
deficits in voluntary activation (50,222).  Rather, Sundberg et al. reported that fatigue-
induced changes in the electrically-evoked twitch amplitude were strongly associated 
with fatigue in response to voluntary contractions, which was greater in older compared 
with young adults (222).  Collectively, these results suggest the age-related differences in 
fatigue are due to mechanisms localized within the muscle. 
One mechanism that does not appear responsible for the greater fatigue with age 
during high-velocity contractions is an increased myofiber sensitivity to [Pi] or [H+].  In 
isolated myofibers from the vastus lateralis of young and older men, force, velocity, and 
power were reduced to a similar extent when exposed to a fatigue-mimicking solution 
(pH 6.2 and 30 mM Pi) (221).  Although these data suggest that increased fatigue with 
age was not due to an increased myofilament sensitivity to [Pi] and [H+], these 
experiments were conducted in vitro and under saturating [Ca2+]; conditions which are 
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likely not present during fatigue in vivo because high [Pi] decreases Ca2+ release from the 
sarcoplasmic reticulum (236). 
Most investigators have reported lower oxidative capacity in the knee extensor 
muscles of older compared with young adults (41,100,133,136,213), while others have 
found no difference (223).  Overall, our systematic review and meta-analysis found the 
capacity for producing ATP via oxidative phosphorylation in the knee extensor muscles 
declines with age (73).  Coupled with the higher ATP demand of dynamic compared with 
isometric contractions (205), the deficit in oxidative capacity may require older muscle to 
rely more on non-oxidative ATP production than young muscle during dynamic 
contractions.  As a result of this reliance on non-oxidative ATP production, Pi, H+, and 
H2PO4- could accumulate more in older compared with young muscle, providing a 
metabolic basis for the greater fatigue in older muscle during high-velocity contractions.  
Because ATP consumption increases with contractions of short duration (13,89), due to 
the production of force being more costly than its maintenance (202), the energetic 
demands of moderate-velocity contractions may be sufficiently lower than that of high-
velocity contractions to prevent a greater reliance on non-oxidative ATP production in 
older compared with young muscle, and thus result in similar fatigue in young and older 
muscle in response to moderate-velocity contractions.  This hypothesis has not yet been 
tested. 
Therefore, the purpose of this study was to determine the extent to which 
differences in intracellular energy metabolism explain age-related differences in muscle 
fatigue in response to two distinct bouts of maximal voluntary dynamic contractions 
(MVDCs) of the knee extensor muscles.  We hypothesized that in vivo oxidative capacity 
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of the vastus lateralis, measured using the PCr recovery method in an unfatigued state, 
would be lower in older compared with young adults.  Further, we hypothesized that 
fatigue would be greater in older compared with young adults in response to 4 min of 
isotonic contractions against a load equivalent to 20% maximal isometric torque 
(MVDC20%), and that this fatigue would be accompanied by greater [Pi] and [H2PO4-], 
and lower pH in older than young muscle.  Conversely, we expected to observe no age-
related differences in muscle fatigue, [Pi], [H2PO4-], or pH in response to 4 min of 
isokinetic contractions at 120°.s-1 (MVDC120).  Lastly, we hypothesized that the 
proportion of ATP derived from oxidative phosphorylation would be lower in older 
compared with young muscle during the MVDC20%, but not different between age groups 





Ten young (24-35 yrs; n=6 men) and 10 older (66-80 yrs; n=5 men) adults were 
studied.  Prior to enrollment, each participant gave their written informed consent, as 
approved by the University of Massachusetts Amherst, and in accordance with the 
Declaration of Helsinki.  Physician’s consent to participate was obtained for all of the 
older volunteers prior to data collection.  Participants were sedentary by self-report, 
defined as completing less than two 30 min sessions of structured exercise per week.  
They also reported being healthy, as evaluated by a health-history questionnaire, and 
were not taking any medications known to affect physical function or muscle fatigue 
(e.g., beta-blockers, calcium channel blockers, sedatives).  Participants with significant 
arthritis in their lower extremities, cardiovascular symptoms upon exertion, metal 
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implants, or who were claustrophobic were excluded from the study prior to enrollment.  
Participants who answered ‘no’ to all questions on the Physical Activity Readiness 
Questionnaire (229) were enrolled. 
Experimental Design 
Participants reported to the University of Massachusetts Amherst for 3 visits.  At 
visit 1, physical function and muscle-tendon unit stiffness were measured, and 
participants were familiarized with the high- and moderate-velocity contraction protocols 
to be completed at visits 2 and 3.  At the beginning of visit 2, magnetic resonance (MR) 
images of the entire thigh were obtained and participants completed 1 of 2 fatigue 
protocols while supine inside the MR scanner.  The second fatigue protocol was 
completed at visit 3, which was at least 3 days following visit 2.  Prior to the fatigue 
protocol at either visit 2 or 3, participants completed a rest-contraction-recovery protocol 
to quantify in vivo muscle oxidative capacity. The order of the fatigue protocols and 
measurement of oxidative capacity were randomized between visits 2 and 3. 
Physical Function and Physical Activity 
Measures of mobility and physical activity were obtained in order to characterize 
the study groups.  Mobility was measured using the Timed-Up-and-Go (TUG; (188)) and 
advanced short physical performance battery (SPPB-A; (210)).  For the TUG test, 
participants were asked to stand up from a seated position, walk 3 m, return to the chair 
and sit down (188).  Participants completed this test twice at their usual walking speed, 
with 1 min of rest between each trial.  The fastest of the 2 trials was used for analysis.  
Participants also completed the SPPB-A, which combines chair rise time, standing 
balance time with 3 different foot positions, and gait speed over a 4 m path (210).  For the 
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chair rise task, participants were instructed to fold their arms across their chest and 
completely stand up and sit back down again 10 times, as fast as possible, in a standard 
chair (seat height = 45 cm).  For the balance tasks, participants stood with their feet in 3 
different positions (semi-tandem, tandem, and on one leg) for as long as possible, up to a 
maximum of 30 s.  The time taken to walk a straight, 4 m path was recorded as a measure 
of gait speed.  Participants completed this walking task twice, with 1 min of rest between 
trials.  They were instructed to walk at their preferred speed and the fastest trial was used 
for analysis.  The walking test was then repeated, with the participant instructed to stay 
within a 20 cm wide path, which was marked on the floor.  The time taken to complete 
each mobility test was recorded with a stopwatch and the SPPB-A was calculated as 
reported elsewhere (210). 
At the end of visit 1, participants were asked to wear a uniaxial accelerometer 
(Actigraph GT3X, Pensacola, FL) for 7 days.  Accelerometers were worn over the right 
hip, and data were recorded with a 60 s epoch.  Participants wore the accelerometer for a 
minimum of 10 hours per day on at least 4 days (3 weekdays and 1 weekend day).  These 
criteria have been shown to provide good reliability (>80%) for quantifying overall, light, 
and moderate-to-vigorous physical activity (153,154).  Average daily activity counts and 
minutes of moderate-to-vigorous physical activity were determined using ActiLife v6.13 
software (ActiGraph, Pensacola, FL) with established cutpoints (74). 
Muscle-Tendon Unit Stiffness 
 Muscle-tendon unit stiffness reflects the series elasticity of multiple structures in 
vivo, and is characterized by the torque-extension relationship (84).  A less compliant 
muscle-tendon unit is theoretically advantageous for producing torque rapidly.  As such, 
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the lower power produced by older compared with young muscle may have a structural 
basis.  The literature is equivocal with regard to age-related differences in muscle-tendon 
unit stiffness; some studies have demonstrated a decrease in muscle-tendon unit stiffness 
with age (125,150,219), while others have shown no effect of age (84,217).  We sought to 
quantify age-related differences in stiffness of the quadriceps muscle-tendon unit in vivo 
to explore the relationships between age, stiffness, and muscle fatigue.   
The length of the dominant thigh was determined using a tape measure and a 
small mark was made with indelible ink at the midpoint between the lateral femoral 
condyle and greater trochanter of the femur.  The participant’s dominant leg was 
determined by asking “which leg would you use to kick a ball?”  Participants were then 
seated on a Biodex 4 dynamometer (Biodex Medical Systems, Shirley, NY) in an upright 
position with hip and knee angles of 90° and 100°, respectively.  Next, the skin over the 
muscle belly of the rectus femoris was shaved and cleaned with 70% ethanol and a 
surface EMG electrode (Trigno, Delsys Inc., Natick, MA) was adhered to the skin.  The 
EMG signal was sampled at 2,000 Hz and recorded using EMGWorks (Delsys Inc., 
Natick, MA).  Torque, velocity, and position signals from the Biodex 4 dynamometer 
were streamed wirelessly to EMGWorks software for synchronization with the EMG 
signal using a ±5 V anaolg adapter (Trigno, Delsys Inc., Natick, MA).  The torque signal 
was calibrated across the range of torques expected (14 points) by hanging weights off 
the Biodex lever arm.  The velocity signal was calibrated between -300 and 300°.s-1 
(specifically: 60, 120, 180, 240, 300°.s-1 flexion and extension) during pilot work.  An 
additional calibration point (0°.s-1) was sampled while the dynamometer lever arm was 
stationary.  Lastly, the position signal was calibrated using 14 points that captured the 
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range of positions achieved during the familiarization trials.  Torque, position, and 
velocity signals were sampled at 148 Hz due to the hardware constraints of the ±5 V 
analog adapter. 
Participants completed two 3-5 s maximal voluntary isometric contractions 
(MVIC), with 1 min of rest between each contraction to prevent fatigue.  If these first 2 
trials differed by more than 10%, additional contractions were performed until the peak 
torque during 2 subsequent trials were within 10% of each other.  The root mean square 
electromyography (RMS EMG) signal was sampled at baseline and over a 0.25 s period 
encompassing the peak isometric torque during the 3-5 s MVIC trials.  The maximum 
RMS EMG signal and offset (i.e., baseline RMS EMG signal) was used to scale visual 
feedback during the 30 s ramped isometric trials, displayed on a 27 inch LED monitor 
positioned in front of the participant at eye-level.  Next, the vastus lateralis of the 
dominant thigh was visualized using an ultrasound system (Affiniti 70, Philips 
Healthcare, Bothell, WA).  Specifically, B-mode ultrasound was used with a linear array 
transducer (Philips model: L12-5) and an insonation angle of 60° (191).  The transducer 
was placed over the midpoint of the vastus lateralis, as previously identified and marked 
with indelible ink.  The probe was adjusted as necessary to obtain the best visualization 
of the muscle fascicles, and superficial and deep aponeuroses.  Next, participants 
performed 5 ramped MVICs (i.e., contractions which increased from 0-100% MVIC over 
30 s) while an ultrasound video of the participant’s vastus lateralis was recorded.   
Familiarization 
Participants were seated on the dynamometer with hip and knee angles of 135° 
and 110°, respectively.  These joint angles were selected to mimic the position used for 
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the contraction protocols in the MR scanner at visits 2 and 3.  The dynamometer was 
adjusted to ensure the axis of rotation of the lever arm was aligned with the axis of 
rotation of the participant’s knee joint.  The length of the lever arm was adjusted to each 
participant’s tibia length and secured with inelastic straps ~2 cm proximal to the malleoli.  
Additional inelastic straps were fastened across the participant’s torso and hips to prevent 
unwanted movement.  Participants were instructed not to hold onto any part of the 
dynamometer during the testing to ensure the torque and velocity measurements were 
generated predominantly by the knee extensor muscles.  Once positioned on the 
dynamometer correctly, each participant completed 2-3 MVICs (3-5 s each) to determine 
their maximal voluntary torque.  After each participant’s MVIC was determined, 
measures of muscle-tendon unit (MTU) stiffness were obtained (see below). 
Following the ultrasound measures, participants completed two 40 s trials of 
dynamic contractions with their dominant leg to familiarize them with the contraction 
protocols to be performed at visits 2 and 3.  Specifically, participants performed 40 s of 
maximal voluntary dynamic contractions (MVDCs) at 120°.s-1 and 240°.s-1, with 1 
contraction completed every 2 s and 2 min of rest between the practice trials at the 2 
velocities.  Each contraction was cued by an auditory signal and all contractions were 
performed over a 30° range of motion (110-140°).  Participants were instructed to ‘kick 
their leg out as hard and fast as possible’ for all contractions.  The investigators provided 
strong verbal encouragement throughout the familiarization protocols.  Visual torque-





Magnetic Resonance Imaging 
 Upon arriving for Visit 2, participants completed an MR safety questionnaire 
(Appendix C), removed all metal objects, and walked through an upright metal detector 
to ensure their safety.  Subsequently, participants were positioned supine inside a Skyra 3 
Tesla, 70 cm bore MR scanner (Siemens Medical Systems, Erlangen, Germany).  To 
avoid movement while inside the scanner, inelastic straps were fastened over the 
participant’s lower leg and hips.  A multi-echo (6-point), 2D gradient-echo Dixon 
sequence was applied with the following parameters: TR=35 ms, FOV=230, TE=2.46 
and 6.15 ms, 3.69 and 7.38 ms, and 4.92 and 8.61 ms, matrix=192 x 144, GRAPPA 
factor=2, flip angle=15°, 1 average.  These images were acquired using an 18-channel 
flex coil and a 32-channel spine coil.  Slices (6 mm thick) were obtained from the greater 
trochanter to the lateral epicondyle of the femur, and slices in which all four quadriceps 
muscles were visible were analyzed for muscle and fat content.  Water and fat images 
were reconstructed offline using the MatLab Fatty Riot algorithm (53).  A region of 
interest (ROI) was drawn around the quadriceps muscle group in each slice.  Fat fraction 
was calculated on a pixel-by-pixel basis from the ratio of separate water-only (W) and 
fat-only (F) images, using the equation (F/(W+F)) (51).  Fat-free muscle cross-sectional 
area (CSA, cm2) of the knee extensors was quantified using a custom-written MatLab 
program (MathWorks, Natick, MA; (145)).  Muscle volume was estimated as the sum of 
CSAs multiplied by the slice thickness.  To eliminate the possibility of inter-investigator 





Muscle Oxidative Capacity 
 Participants were randomly assigned to complete this measure at either visit 2 or 
3, prior to the fatigue protocol.  Each participant was positioned inside the MR scanner 
with a dual-tuned 31P/1H surface coil (8 x 10.5 cm) fastened over the vastus lateralis of 
their dominant leg using a bandage and velcro straps.  The knee and ankle of the 
dominant leg were strapped to an MR-compatible ergometer using velcro straps.  An 
additional strap was fastened over the participant’s hips to prevent unwanted movement.  
Our custom-made ergometer is capable of imposing and recording isometric, isokinetic, 
and isotonic contractions of the knee extensor muscles (96).  Gradient scout images were 
obtained to ensure correct placement of the surface coil and positioning within the 
isocenter of the MR scanner.  Subsequently, the homogeneity of the magnetic field was 
optimized by shimming on the proton signal. 
After optimization of the magnet for metabolic measures, participants completed 
three 5 s MVICs, and 3 sets of 6 MVDCs at either 120°.s-1 (MVDC120) or 20% MVIC 
(MVDC20%), separated by 2 min rest.  Because of the physical constraints of the MR 
scanner’s bore, the range of motion for all dynamic contractions was limited to 30° with a 
starting knee angle of ~110° (180° = full extension).  Participants then completed 24 s of 
MVDCs (1 every 2 s).  The number of contractions and duty cycle for this contraction 
protocol were selected based on pilot work showing that PCr was depleted by ~50% with 
minimal change in pH; conditions which are optimal for quantifying muscle oxidative 
capacity in vivo (6,162).  Following 15 dummy pulses, 31P spectra were acquired for 60 s 
before, during, and 10 min following the 12 contractions, using a 0.1 ms hard pulse, 
nominal 60° flip angle, 4,000 Hz bandwidth, 2,048 complex points, 2 s repetition time 
81 
 
and 0.15 ms echo time.  Representative spectra at rest and the end of both fatigue tasks 
from 1 young and 1 older man are shown in Figure 4.1. 
MVDC20% Fatigue Protocol 
 While positioned inside the MR scanner, participants completed a unilateral 
fatigue protocol consisting of 1 isotonic MVDC against a load equivalent to 20% MVIC 
every 2 s for 4 min.  Contractions were performed over a 30° range of motion (110-140°).  
The slower time to target velocity in older muscle (132) and limited range of motion 
possible within the MR-environment precluded the performance of high velocity 
isokinetic contractions from use in this study.  As a result of these limitations, we opted 
for isotonic fatiguing contractions to permit the older adults to achieve higher peak 
contraction velocities.  Participants received the same verbal instructions and 
encouragement, visual torque-feedback, and auditory cues for each contraction as 
described for the oxidative capacity measurement.  Representative torque and velocity 
traces for a contraction during the MVDC20% protocol from one young male are shown in 
Figure 4.2A. 
MVDC120 Fatigue Protocol 
While positioned inside the MR scanner, participants completed a unilateral 
fatigue protocol consisting of 1 isokinetic MVDC at 120°.s-1 every 2 s for 4 min with the 
same range of motion as the MVDC20% fatigue protocol.  The same instructions, verbal 
encouragement, and visual feedback were given to participants during this trial as was 
provided for the MVDC20% protocol.  Representative torque and velocity traces for a 




Measurements and Data Analyses 
Muscle-tendon unit stiffness 
 After the deep and superficial aponeuroses were visualized on the ultrasound 
screen, a 5 V pulse was sent from the ultrasound system to EMGWorks via a trigger 
(Delsys Inc., Natick, MA), which initiated the 30 s ramped isometric contraction.  Real-
time feedback was provided based on the RMS EMG signal, which was scaled to the 
maximal RMS EMG from the 3-5 s MVICs.  Ultrasound videos and torque signals were 
saved for offline analysis. 
The sampling frequency of the ultrasound videos varied, depending on the depth 
of the acquired images (range: 26.3 to 41.8 Hz).  Because the sampling frequency was not 
identical to that of the torque signal, the torque data were downsampled to match the 
sampling frequency of the corresponding ultrasound data using a piecewise cubic hermite 
interpolating polynomial function in MatLab (MathWorks, Natick, MA).  The 
EMGWorks software, which recorded the torque signals, was triggered to begin 
recording on the negative edge of the 5 V synchronization pulse.  Using an A/D board, 
we discovered that the time delay between the recording of the ultrasound and torque 
signals was 1 s.  To account for this, the ultrasound and torque signals were synchronized 
by removing the first 1 s of data from the ultrasound signal. 
To quantify muscle-tendon unit stiffness, the torque-extension relationship must 
be determined (84).  To quantify extension of the aponeurosis, multiple points on the 
ultrasound images were identified: one set of 8 superficial reference points evenly spaced 
near the skin, and a cluster of 8 points along the deep aponeurosis of the vastus lateralis 
(Figure 4.3).  The movement of all points was automatically tracked using a two-
83 
 
dimensional cross-correlation tracking algorithm, as described elsewhere (84).  As 
illustrated in Figure 4.3, there was movement of the superficial reference points and 
clustering of the tracking points on the deep aponeurosis which resulted in the extension 
of the aponeurosis not following the expected trajectory, preventing accurate 
quantification of aponeurosis extension.  Because of this, calculations of muscle-tendon 
unit stiffness were not possible. 
Muscle Torque, Velocity, and Power 
Position, torque, and velocity were sampled at 500 Hz using a custom-written 
MatLab user interface.  A separate MatLab post-processing program calculated the 
average torque, velocity and power, as well as the range of motion, and power-time 
integral, and the duration of each contraction.  Only the concentric phase of each 
contraction was analyzed, as shown in Figure 4.2.  Because the range of motion 
decreased in some participants during the fatiguing contractions, and there were some 
issues with the ergometer’s torque and velocity controllers (e.g., overshoot of torque and 
velocity) during the isotonic and isokinetic contraction modes, respectively, several 
indices of fatigue were visually inspected, including: average torque, velocity, and power.  
Because the power-time integral captures the fatigue-induced decline in torque, velocity, 
and range of motion, fatigue during the both contraction protocols was calculated using 
the power-time integral (PTI) as: 
 
 
average PTI over final 5 contractions
peak PTI during first 10 contractions





31P spectral analysis 
 All free induction decays were analyzed using jMRUI v6.0beta.  Spectra were 
zero-filled (2,048 points), filtered using a 1 Hz Lorentzian function, Fourier-transformed, 
and phased.  Once the PCr peak was set to 0 ppm, the spectra were line-fit using the 
AMARES algorithm and the areas under the peaks corresponding to phosphomonoesters, 
Pi, phosphodiesters, PCr, and gamma ATP were determined.  Concentrations of Pi and 
PCr were calculated assuming that [Pi] + [PCr] = 42.5 mM in resting muscle (161), and 
ATP was quantified assuming [ATP] = 8.2 mM in resting muscle (82).  Intracellular pH 
was calculated based on the chemical shift of Pi relative to PCr (168). 
Muscle oxidative capacity 
 Spectra were averaged to achieve 90 s temporal resolution at rest and 4 s 
resolution throughout the 24 s contraction period.  For the recovery period, spectra were 
averaged to achieved the following temporal resolutions: 4 s for the first 20 s, 8 s for the 
next 280 s, and 30 s for the remaining 5 min.  Once [PCr], [Pi], [ATP], and pH were 
determined, the repletion of PCr during the 10 min recovery period was fit with a mono-
exponential function and the rate constant (kPCr) determined, as shown in equation 4.2: 
 
 PCr t ∆PCr 1 e PCr  [Eq. 4.2] 
 
where ΔPCr = (PCrrest – PCrex), and PCrex is [PCr] at the end of the contraction.  The rate 
constant of PCr recovery, kPCr, reflects the capacity for oxidative phosphorylation under 
these conditions (117).  This measure is highly reliable and well correlated with in vitro 
respirometry measures of maximally-stimulated respiration (i.e., state 3) (129) and 




31P-MRS Acquisition during Fatigue Protocols 
Spectra were averaged to achieve 60 s and 10 s resolution at rest and during the 
fatigue protocol, respectively.  For the recovery period, spectra were averaged to achieve 
the same temporal resolution as for the oxidative capacity measurement.  Following 
determination of [PCr], [Pi], [ATP], and pH, ATP production rates by the creatine kinase 
reaction (ATPCK) and non-oxidative glycolysis (ATPGLY) were calculated. 
ATP Flux 
 Under conditions where there is no net change in [ATP], ATP production can be 
reasonably assumed to equal ATP consumption (20,226).  We calculated rates of ATPCK, 
ATPGLY, and ATPOX during both fatigue protocols.  The rate of PCr breakdown by the 
creatine kinase (CK) reaction was calculated as the rate of decline in PCr at each 10 s 
time point, as follows: 
 
 ATP  
∆PCr
∆t
 [Eq. 4.3] 
 
Intracellular pH was calculated based on the chemical shift (σ) of Pi relative to PCr, in 
parts per million, as follows (168): 
 
 pH 6.75 log
σ 3.27
5.69 σ
 [Eq. 4.4] 
 
Broadening and splitting of the Pi peak can occur due to distinct intracellular pH pools 
during contractions (180).  When Pi splitting was visibly evident, 2 Pi peaks were fit, the 
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pH corresponding to each Pi pool was calculated separately (based on the chemical shift 
of each Pi pool relative to PCr), and the weighted average determined (128): 
 






 [Eq. 4.5] 
 
The concentration of H2PO4- was calculated as (127): 
 
 H PO  
Pi
1 10 .
 [Eq. 4.6] 
 
Glycolytic ATP synthesis was calculated using linear regression to determine the rate of 
change in pH and PCr over each 10 s period for each fatigue protocol.  Proton 
consumption by the CK reaction, intracellular buffering, and oxidative proton production 
were also taken into account, as follows: 
 






V  [Eq. 4.7] 
 
where β represents the total buffering capacity; calculated as the sum of inherent 
buffering, and buffering from bicarbonate and Pi (108).  The pH dependent rate of H+ 
efflux (VEff) was measured in mM.s-1 at the end of each fatigue task.  The proton 









Oxidative ATP synthesis was calculated from the initial velocity of PCr resynthesis 
(Vi[PCr]), which reflects the rate of oxidative ATP production at the end of a bout of 
contractions (26,107). Vi[PCr] was calculated as the change in [PCr] measured over the 
first 4 s of the PCr recovery kinetics. 
Statistical Analyses 
All data were checked for normality and homogeneity of variance prior to any 
statistical comparisons using the Kolmogorov-Smirnov test and Levene’s statistic, 
respectively.  Differences in group descriptive characteristics, muscle morphology, 
maximal torque and power, muscle oxidative capacity, and fatigue (%initial power-time 
integral) were analyzed using independent t-tests.  Age-related differences in the average 
torque, velocity, power, range of motion, power-time integral, and duration of 
contractions throughout each fatigue trial were evaluated using a 2-way ANOVA 
(group×time).  Similarly, age-related differences in metabolites (PCr, Pi, pH, H2PO4-, 
PME, and ATP) throughout each fatigue trial were evaluated using a 2-way ANOVA 
(group×time).  Group differences in ATP flux (creatine kinase, non-oxidative glycolysis, 
and Vi[PCr]) were evaluated using a 2-way ANOVA (group×time). All statistical analyses 
were performed using the SPSS statistical software package (v24.0, IBM, Chicago, IL) 
with an alpha level of 0.05.  Data are reported as mean±SD, with exact p-values and 95% 
confidence intervals for differences in group means. 
Results 
Baseline Characteristics 
Group characteristics are reported in Table 4.1.  There were no group differences 
in height, body mass or BMI.  Additionally, groups were well matched for total daily 
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physical activity and minutes of moderate-to-vigorous physical activity.  We observed no 
difference between groups for measures of physical function, chair rise time, TUG, and 
SPPB-A. The rate constant of PCr recovery (kPCr) was not different between young and 
older adults. 
 Contractile volume was lower in older compared with young adults (p=0.025; 
Figure 4.4A, Table 4.2), despite no differences in the percentage of the femur analyzed 
(p=0.651), indicating that similar portions of the knee extensor muscles were sampled for 
the estimation of muscle volume in both groups.  Fat fraction was not different between 
groups (p=0.340; Figure 4.4C).  At baseline, maximal isometric torque and power during 
the MVDC120 and MVDC20% contractions were lower in older compared with young 
adults (p≤0.05; Figure 4.4D-F).  Specific isometric torque was not different between 
groups (p>0.05; Figure 4.4G).  In contrast, specific power during the MVDC120 (p=0.037; 
Figure 4.4H) and MVDC20% contractions (p=0.004; Figure 4.4I) was ~25% and ~30% 
lower in older compared with young adults, respectively. 
MVDC20% Fatigue Trial 
Ergometer Measurements 
There was no group difference in fatigue (% initial PTI) in response to 4 min of 
isotonic contractions (p=0.546).  Changes in the average torque, velocity and power, 
range of motion, power-time integral, and duration of contractions throughout the 
MVDC20% are shown in Figure 4.5.  There was no group×time interaction (p≥0.998) for 
changes in ergometer measurements.  There was an effect of group (p=0.001), but not 
time (p=0.100), on the average torque throughout the MVDC20%, indicating that our 
ergometer was able to control torque near the set-point of 20% MVIC. However, post-
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hoc analyses revealed the average torque was higher in young than older adults between 
20 and 60 s (p≤0.043). We observed main effects of group (p=0.001) and time (p=0.001) 
for changes in average velocity and power, range of motion, power-time integral, and the 
duration of contractions. Post-hoc analyses revealed the average velocity was higher in 
young than older muscle from 90 s onwards (p≤0.018), and declined from the initial 
value after 100 s in young (p≤0.04) and 80 s in older (p≤0.018) adults.  However, the 
average power was not different between groups at any timepoint (p≥0.187), but declined 
from the initial value after 90 s in young (p≤0.019) and 80 s in older (≤0.016) muscle, 
reflecting a similar rate of fatigue development in both groups in this condition.  The 
range of motion was lower in older than young muscle from 60 s onwards (p≤0.025), and 
declined from the initial value after 160 s in young (p≤0.029) and 100 s in older 
(p≤0.022) adults. The power-time integral was not different between groups at any 
timepoint (p≥0.097), but had fallen from the initial value after 130 s in young (p≤0.034) 
and 100 s in older muscle (p≤0.021). Lastly, the duration of contractions was longer in 
older than young adults at every timepoint (p≤0.026), did not increase with fatigue in 
young (p≥0.071), but increased from the initial duration after 170 s in older adults 
(p≤0.033). 
Metabolites 
Changes in [PCr], [Pi], pH, [H2PO4-], [PME], and [ATP] throughout the 4 min of 
contractions are illustrated in Figure 4.6.  There were no group×time interactions for 
changes in any metabolite during the trial (p≥0.695).  However, we observed main effects 
of group and time for changes in each metabolite (p≤0.016). Post-hoc analyses revealed 
no group differences in [PCr] or [Pi] throughout the trial (p≥0.193), but pH was lower in 
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young than older muscle from 210-240 s (p≤0.05; Figure 4.6C).  We observed a greater 
[H2PO4-] in young than older muscle at 210 s (p=0.037), but not at any other point during 
the contractions. The concentration of phosphomonesters was greater in young than older 
muscle at 180 and 190 s, but not at any other point during the fatigue trial. Intracellular 
[ATP] declined from resting concentrations in young and older muscle by 150 and 220 s, 
respectively (p≤0.032). 
ATP flux 
ATP flux through the creatine kinase reaction and non-oxidative glycolysis are 
reported in Table 4.3.  We did not observe a group×time interaction (p=0.773) or a main 
effect of group (p=0.813) on minute-by-minute changes in ATP flux through the creatine 
kinase reaction.  However, there was a main effect of time (p=0.001) such that ATPCK 
declined over the first 3 min (p≤0.028) but was not different between minutes 3 and 4 in 
either group (p≤0.977). There was no group×time interaction (p=0.280) for ATP flux 
through non-oxidative glycolysis, but we did observe main effects of group (p=0.032) 
and time (p=0.001). Post-hoc analyses revealed ATPGLY was higher in young than older 
muscle, but only during the second minute (p=0.009).  There was no difference in 
ATPGLY between minutes 1 and 2 (p≤0.225), or 3 and 4 (p≤0.473), but ATPGLY declined 
between minutes 2 and 3 (p≤0.001) in both groups. 
Under conditions where there is no net change in [ATP], ATP production can be 
reasonably assumed to equal ATP consumption (20,226).  Because [ATP] declined 
throughout the 4 min of isotonic contractions, in young and older adults (Figure 4.6F), we 
were unable to evaluate the oxidative contribution to ATP flux in the traditional manner.  
To circumvent this problem, we report changes in Vi[PCr] (Table 4.3) from baseline to the 
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end of the fatiguing contractions. There was no group×time interaction (p=0.124) and no 
main effect of group (p=0.209), but we did observe a significant effect of time (p=0.025).  
Post-hoc analyses revealed Vi[PCr] increased from baseline to post fatigue in older 
(p=0.01), with no difference observed in young muscle (p=0.577).  
MVDC120 Fatigue Trial 
Ergometer Measurements 
Fatigue (% initial PTI) in response to 4 min of isokinetic contractions was greater 
in young than older adults (p=0.007).  Changes in the average torque, velocity and power, 
range of motion, power-time integral, and duration of contractions throughout the 
MVDC120 are shown in Figure 4.7.  We observed a group×time interaction (p=0.001) for 
changes in the average torque during the MVDC120.  Post-hoc analyses revealed the 
average torque was lower in young compared with older adults from 110 s onward 
(p≤0.05).   
There was no group×time interaction for changes in the average velocity during 
the MVDC120 (p=0.999), but we did observe main effects of group (p=0.001) and time 
(p=0.001).  Post-hoc analyses revealed no clear trends for group differences in the 
average velocity, and where any differences were small and presumably due to a slower 
rate of torque development in older compared with young muscle because all contractions 
were isokinetic and performed at 120°.s-1.  Compared with that achieved in the first 10 s, 
the average velocity was not different at any timepoint in older adults (p≥0.0134), but 
was slower from 180 s onward in young adults (p≤0.028).  The latter finding is 
presumably due to a fatigue-induced slowing in the rate of torque development in young 
adults.  We also observed a group×time interaction for changes in the average power 
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(p=0.001), such that it was lower in young than older adults from 150 s onwards 
(p≤0.012). Similarly, there was a group×time interaction (p=0.001) for changes in the 
power-time integral, such that it was lower in young than older adults from 150 s 
onwards (p≤0.004).  We did not observe a group×time interaction for changes in the 
range of motion (p≥0.556), but there were main effects of group (p=0.001) and time 
(p=0.001).  Post-hoc analyses revealed no group differences in the range of motion at any 
timepoint (p≥0.072), nor changes at any timepoint compared with the first 10 s 
(p≥0.154).  There was no group×time interaction for the duration of contractions 
(p=0.999), but there were main effects of group (p=0.001) and time (p=0.007).  Although 
post-hoc testing showed no group differences at any timepoint (p≥0.056), the range of 
motion was lower at 240 s and 220 s in young and older adults, respectively, compared 
with that achieved over the first 10 s (p≤0.045). 
Metabolites 
Changes in [PCr], [Pi], pH, [H2PO4-], [PME], and [ATP] throughout the 
MVDC120 are shown in Figure 4.8. There were no group×time interactions for changes in 
any metabolite during the moderate-velocity fatigue trial (p≥0.064). However, we 
observed main effects of group and time for changes in [PCr], [Pi], pH, [H2PO4-], and 
[PME] (p≤0.001 for all). Post-hoc analyses revealed PCr was lower, and Pi higher, in 
young compared with older muscle after 40 s (p≤0.017), and both PCr and Pi fell from 
their initial concentrations by 10 s (p≤0.001). Intracellular pH was lower in young than 
older muscle from 80 s until the end of the contractions (p≤0.033), and was lower 
compared with rest by 60 and 70 s in young and older muscle, respectively (p≤0.001). 
The [H2PO4-] was higher at 60 s, and remained elevated for the rest of the contractions, in 
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young compared with older muscle (p≤0.028). By 30 s, [H2PO4-] was higher than at rest 
in both groups (p≤0.001). Post-hoc analyses revealed no group differences in [PME] at 
any timepoint, but [PME] was greater compared with rest by 50 s in young and 60 s in 
older muscle (p≤0.014).  There was a main effect of time (p=0.001), but not group 
(p=0.065), for changes in [ATP] during the MVDC120.  Post-hoc analyses revealed [ATP] 
declined from resting values by 130 s in young and 150 s in older muscle (p≤0.026). 
ATP flux 
ATP flux through the creatine kinase reaction and non-oxidative glycolysis are 
reported in Table 4.4.  We observed a group×time interaction for changes in ATP flux 
through the creatine kinase reaction (p=0.006).  Post-hoc analyses revealed ATPCK was 
greater in young than older muscle during the first minute of contractions (p=0.001), but 
not throughout the rest of the fatigue protocol (p≥0.296).  Further, ATPCK declined over 
the first 3 minutes in both groups (p≤0.001), but was not different between minutes 3 and 
4 (p=0.503).  There was no group×time interaction (p≥0.256) for changes in ATPGLY 
during the fatigue protocol, but main effects of age (p=0.001) and time (p=0.001) were 
observed. Post-hoc analyses revealed glycolytic ATP flux was greater in young than 
older muscle during the first (p≤0.015), but not final (p≥0.192), 2 min of the protocol.  
Further, ATPGLY did not decline until minute 3 (p=0.001) in either group. 
Throughout the 4 min of isokinetic contractions, [ATP] decline in both groups 
(Figure 4.8F).  Because of this, we report changes in Vi[PCr] (Table 4.4) from baseline to 
the end of the fatiguing contractions. There was no group×time interaction (p=0.243) and 
no main effect of group (p=0.422), but we did observe a significant effect of time 
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(p=0.041).  Post-hoc analyses revealed Vi[PCr] increased from baseline to post fatigue in 
older (p=0.025), with no difference observed in young muscle (p=0.512). 
Discussion 
This study was designed to evaluate whether age-related differences in muscle 
oxidative capacity might result in a greater accumulation of Pi and H2PO4-, and a lower 
pH, in older than young muscle and therefore be potential mechanisms for the expected 
age-related differences in fatigue in response to high-velocity contractions 
(24,48,49,222,223).  Additionally, we tested the hypothesis that the expected absence of 
age-related differences in fatigue in response to moderate-velocity contractions 
(23,24,49) would be explained by a similar accumulation of Pi and H2PO4-, and pH, in 
young and older muscle.  Lastly, we hypothesized that the proportion of ATP derived 
from oxidative phosphorylation would be lower in older than young muscle during the 
MVDC20%, but not different between groups during the MVDC120, fatigue protocol. 
In contrast with our first hypothesis, muscle oxidative capacity was not different 
between young and older adults in this study (Table 4.1).  Fatigue (% initial PTI) in 
response to the MVDC20% was also not different between groups (Figure 4.5).  No age-
related differences in [Pi] were observed during the MVDC20%, and [H2PO4-] was only 
different at one timepoint.  However, pH was lower in young than older muscle for the 
final 30 s of the MVDC20% (Figure 4.6).  ATP flux through non-oxidative glycolysis was 
greater in young than older muscle, but only during the second minute of the MVDC20% 
(Table 4.3).  No change in Vi[PCr] from baseline to post-fatigue was observed in young, 
but it did increase in older muscle (Table 4.3).  Fatigue (% initial PTI) in response to the 
MVDC120 was greater in young than older muscle (Figure 4.7).  We observed greater [Pi] 
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and [H2PO4-], and lower pH, in young than older muscle during the MVDC120 (Figure 
4.8).  ATP flux through the creatine kinase reaction was greater in young than older 
muscle during the first minute of the MVDC120, but not at any other timepoints (Table 
4.4).  Similarly, we observed a greater ATP flux through non-oxidative glycolysis in 
young than older muscle during the first, but not final, 2 min of the MVDC120 protocol.  
We observed no change in Vi[PCr] from baseline to post-fatigue in young muscle, but it 
increased in older adults (Table 4.4).  Overall, these results provide a bioenergetic basis 
for the task-dependent conditions under which age-related differences in muscle fatigue 
are observed.  
Baseline 
Contractile volume of the knee extensors was lower in older than young adults 
(Figure 4.4, Table 4.2), which is consistent with previous work in this area (90).  
However, we observed no group differences in fat fraction, evaluated by Dixon MR 
imaging, indicating fat deposition in the knee extensors is similar in young and older 
adults.  This observation is in contrast with previous reports that used either T1-weighted 
(24) or Dixon MR imaging (90).  Thus, the lack of group differences in fat fraction do not 
appear to be related to the imaging sequence used.  A noteworthy point, however, is that 
the fat fraction values obtained in this study are considerably higher than those reported 
by Hogrel et al. (90).  Specifically, those authors reported fat fractions of ~2.7 and 4.6% 
in young and older quadriceps, respectively.  In contrast, the mean fat fraction was 8.4 




Although maximal isometric torque was higher in young than older adults, we 
observed no difference in specific torque between groups (Figure 4.4, Table 4.2).  
However, peak power at 120°.s-1 and against a load equivalent to 20% MVIC were higher 
in young than older adults both in absolute terms and when normalized to muscle 
volume.  These observations are consistent with previous reports (3,24,113) and indicate 
that the age-related loss of maximal isometric torque is primarily due to the loss of 
muscle mass with age while the loss of peak power in the aged cannot be explained by 
muscle atrophy alone.  Other factors that may contribute to a lower peak power in older 
adults include a more compliant muscle-tendon unit (52,198) and a lower maximal motor 
unit discharge rate (104,119).  Muscle-tendon unit stiffness affects the torque-velocity 
and force-length relationships of muscle such that a less stiff, or more compliant, muscle-
tendon unit reduces the torque produced at a given velocity (106); an observation 
commonly seen in older compared with young adults (24,132).  The motor unit discharge 
rate during the maximal rate of torque development of an isometric contraction is 
markedly lower in older than young adults (119).  Moreover, the age-related decline in 
the maximal rate of torque development was greater during rapid isometric torque 
development than during electrically-evoked twitch contractions, suggesting maximal 
motor unit discharge frequency limits the torque produced during fast voluntary 
contractions in older adults (119).  The extent to which a lower maximal motor unit 
discharge rate affected torque production at different velocities in the current study is not 
known, but is worthy of further investigation. 
Our observation of similar muscle oxidative capacity in the knee extensors of 
young and older adults is in contrast with a systematic review and meta-analysis (73), but 
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in agreement with a recent study (223).  The lack of difference in muscle oxidative 
capacity observed here is likely not due to the age (i.e., old vs. very old) or physical 
activity of the older adults because Larsen et al. (2012) observed lower oxidative capacity 
in the knee extensors of older compared with young adults when matched for physical 
activity (133).  Moreover, the age of the groups in the current study are similar to those in 
previous studies that have observed an age-related reduction in oxidative capacity of the 
knee extensors (133,136), suggesting the lack of difference observed in this study was not 
because the older group were too young.  A noteworthy point is that our values of kPCr for 
older adults were similar to those reported previously (133).  However, the kPCr values 
observed in this study are only ~70% of those reported by Larsen et al. (133). Potential 
reasons for the slower kPCr in young groups the current study and previous work are not 
clear.  Because mitochondrial energetics are closely associated with maximal aerobic 
capacity and walking speed in older adults (38), future studies should try to elucidate the 
participant characteristics that are associated with a reduced muscle oxidative capacity 
with age.  
MVDC20% Fatigue Trial 
Previous work has consistently shown greater fatigue in older than young adults 
in response to high-velocity contractions (i.e., ≥ 240°.s-1) of the knee extensors 
(24,48,49,222,223) and other muscles groups (50,234).  Further, a systematic review and 
meta-analysis of the available literature observed greater muscle fatigue in older than 
young adults in studies where dynamic contractions were performed or muscular power 
was used as the index of fatigue (33).  In contrast with these reports, we observed no age-
related differences in muscle fatigue (% initial PTI) in response to the MVDC20% 
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protocol, as illustrated by the almost identical reductions in the power-time integral 
between young and older adults in response to this task (Figure 4.5E).  During the 
MVDC20% the torque imposed by the ergometer was set to 20% of each individuals 
MVIC.  With the exception of a higher average torque in young compared with older 
adults over the first 20-60 s of the 4 min MVDC20% protocol, our MR-compatible 
ergometer was able to control torque near the 20% MVIC target.  Due to the limited 
range of motion within an MR-environment (30° in this study), the average contraction 
velocity over the first 10 s of the MVDC20% protocol was ~180 and 120°.s-1 in the young 
and older adults, respectively. Although we observed a greater slowing of contraction 
velocity with fatigue in older relative to young adults, the absolute velocities achieved at 
the beginning of the MVDC20% protocol were likely too slow to elicit age-related 
differences in muscle fatigue.  Indeed, previous work has shown similar fatigue in young 
and older women when contractions were performed at the velocity associated with 50% 
MVIC, which was 250±18 and 200±12°.s-1 in young and older women, respectively (24).  
The slower contractile velocity of older adults in the MVDC20% protocol resulted in a 
longer contraction duration throughout this protocol compared with young muscle 
(Figure 4.5F).  Additionally, both groups lost their full range of motion during the 
MVDC20% protocol (Figure 4.5D), but the decline in range of motion was greater in older 
adults. 
We observed no difference in [PCr] or [Pi] between groups throughout the 
MVDC20% protocol (Figure 4.6).  Conversely, [H2PO4-] was higher in young than older 
muscle, although this was only significant at 210 s and not at any other point during the 
protocol.  However, pH was lower in young than older muscle during the final 30 s of the 
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protocol.  Notably, [ATP] was lower than at rest from 150 s and 220 s onward in young 
and older muscle; the decline was ~25% decline by the end of the protocol in both 
groups.   
These observations appear to be in contrast with a recent report evaluating age-
related differences in muscle fatigue and bioenergetics in response to 4 min of maximal 
voluntary contractions against a load equivalent to 20% MVIC (223).  Specifically, those 
authors observed similar PCr depletion, but greater [Pi] and [H2PO4-], and a lower pH in 
older than young muscle.  Notably, in that study no change in [ATP] was observed 
throughout the fatiguing contractions.  The source of the discrepancies between studies is 
not entirely clear.  However, Sundberg et al. reported similar [PCr] and [Pi] in young and 
older muscle at rest, and similar depletion of PCr between groups despite a ~10 mM 
greater [Pi] in older than young muscle at the end of the fatiguing contractions.  The 
source of the additional ~10 mM of phosphate in the older muscle in their study is 
unclear; the intracellular phosphate pool should remain relatively constant.   
Part of the discrepancy between studies may also be due to the position of the 
participants inside the MR-scanner and the recruitment patterns of the knee extensors in 
those positions.  Participants in our study were supine and performed contractions over a 
30° range of motion (110-140°, 180° = full extension).  Although Sundberg et al. reported 
an angular displacement of ~25-30° in their study, the starting angle of the contractions 
was not reported.  Thus, participant’s muscles may have been performing over different 
portions of the force-length relationship which could explain the lower absolute velocity 
of contractions in our study because the force-length relationship affects the torque-
velocity relationship (22,132). 
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One of the notable findings in the present study is the ~25% decline in [ATP] in 
both young and older muscle during the MVDC20% protocol (Figure 4.6E).  Cytosolic 
[ATP] is generally very well maintained during muscular contractions, until extreme 
levels of fatigue are observed (226).  A previous study observed [ATP] was reduced in 
some, but not all, participants in response to maximal intermittent fatiguing contractions 
of the forearm musculature (226).  Those authors reported a greater decline in PCr 
(17±5% of resting value) and lower pH (6.12±0.04) in the participants where [ATP] 
declined compared with those participants in which [ATP] was unchanged (26±5% for 
PCr and 6.37±0.09 for pH).  In the present study, [ATP] declined in all participants 
during the MVDC20% protocol, so such comparisons are not possible.  Phosphocreatine 
declined to 8.5±0.8% and 12.6±2.2% of the resting value in young and older muscle, 
respectively.  During the MVDC20% protocol we also observed significant increases in the 
concentration of phosphomonoesters (PME) in both groups; PME generally increases 
during intense contractions due to an accumulation of sugar phosphates (e.g., glucose-6-
phosphate, inosine monophosphate) (12).  However, the decline in [ATP] likely to 
contributed to the increase in [PME] during the contractions in Study 1 because adenine 
nucleotide breakdown results in the formation of inosine monophosphate (163), which 
contributes to the PME pool in the 31P spectrum. 
 Our observations of similar [Pi] but lower pH in young compared with older 
muscle, despite no age-related differences in muscle fatigue, suggests that the contractile 
machinery may be more sensitive to changes in pH with age.  At the molecular level, 
elevated cytosolic [H+] depresses muscular force production due to prolonged attachment 
of myosin to actin as a result of slowed ADP release (57,58,123,239).  Therefore, we 
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would have expected to observe greater fatigue in the young than older group.  Although 
a recent study observed similar depressive effects of high [Pi] and [H+] on skeletal 
muscle fiber force, velocity, and power production in young and older men (221), those 
experiments were conducted at saturating [Ca2+].  However, the force-pCa2+ relationship 
shifts leftward in type I, IIa, and IIx fibers with aging and the difference is greatest at 
submaximal [Ca2+] (220).  Therefore, whether the contractile machinery of older muscle 
is more sensitive to changes in pH under submaximal [Ca2+] is not clear and is worthy of 
further investigation. 
We observed no age-related differences in ATP flux through the creatine kinase 
reaction during the MVDC20% protocol (Table 4.2).  However, glycolytic ATP flux was 
greater in young compared with older muscle during the second minute of this protocol, 
consistent with previous observations during maximal isometric contractions of the 
dorsiflexors (128).  The lower glycolytic ATP flux in older compared with young muscle 
does not appear to be due to an impairment in the glycolytic pathway with age (130).  
Although Vi[PCr] was not different between groups at baseline, we observed a trend for it 
to be higher in older than young muscle at the end of the MVDC20% (p=0.051).  In sum, 
the proportion of ATP derived via oxidative phosphorylation may have been greater in 
older compared with young muscle. 
MVDC120 Fatigue Trial 
Previous work has shown fatigue is similar between young and older adults in 
response to 4 min of isokinetic contractions at 120°.s-1 (23).  In contrast with these 
studies, we observed greater fatigue (% initial PTI) in young than older muscle during the 
MVDC120 protocol, as illustrated in Figure 4.7E.  During the MVDC120 the velocity was 
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constrained to 120°.s-1, as shown in Figure 4.2.  The average concentric contraction 
velocity was similar in young and older adults (Figure 4.7), and declined by 180 s in 
young, but not older, adults.  The cause of the slower average velocity was likely due to 
less time spent at the target velocity as visual inspection of the data confirmed the target 
velocity was achieved during each contraction.  The average concentric torque and power 
declined to a greater extent in young than older muscle, and all participants were able to 
maintain the full range of motion during the MVDC120 protocol.   
In agreement with our observation of greater fatigue in young than older muscle 
in response to moderate-velocity contractions, some authors have reported greater fatigue 
in young than older adults at moderate contraction velocities (131); although others have 
observed no difference in fatigue with age under these conditions (23,24,49).  Previous 
work suggests that age-related differences in fatigue might be explained by the intrinsic 
characteristics of the torque-velocity relationship, which shifts leftward with age 
(24,132).  The torque-velocity relationship was likely shifted leftward in our study due to 
the lower range of motion possible within an MR environment (30° in this study) 
compared with that possible using conventional dynamometry (e.g., 70° in a study by 
Callahan & Kent-Braun; (24)).  This leftward shift in the torque-velocity relationship 
likely occurs because the time spent at the target velocity is shorter and thus the time 
available for torque development is lower.  Consistent with this speculation, Callahan and 
Kent-Braun reported the torque produced during isokinetic contractions at 120°.s-1 to be 
~70 and 60% MVIC in young and older women, respectively.  Conversely, in our study 
the young and older adults performed the MVDC120 contractions at ~50 and 35% MVIC 
at the beginning of the fatigue protocol (data not shown).  Thus, young adults produced 
103 
 
relatively greater torque during the MVDC120 compared with older adults, which may 
explain the greater fatigue in this group. 
As might be expected with greater fatigue, we observed higher [Pi] and [H2PO4-], 
and a lower pH in young than older muscle throughout the MVDC120 protocol (Figure 
4.8).  These observations are consistent with previous studies of age-related differences in 
fatigue in response to maximal isometric contractions (114,128).  In further agreement 
with these results, Callahan et al. developed a computational model to understand the 
mechanisms of age-related differences in fatigue during isometric contractions, and 
reported the greater fatigue in young than older adults is largely due to a higher glycolytic 
ATP flux in young muscle (25).  We observed a greater glycolytic ATP flux in young 
than older muscle during the first, but not final, 2 min of the MVDC120 protocol (Table 
4.3).  A higher glycolytic ATP flux in young than older muscle has been reported during 
isometric contractions (128,130).  The reason for the lower glycolytic ATP flux in older 
muscle is not clear but is not due to an impairment in the glycolytic pathway because 
when blood flood is impeded with cuff-induced ischemia, the peak glycolytic rate is 
similar in young and older dorsiflexors (130). 
The Vi[PCr] did not change from baseline to post-fatigue in the young group, but it 
increased in older muscle, reflecting an increase in oxidative phosphorylation in older 
muscle by the end MVDC120 protocol.  Although only one timepoint, this observation is 
consistent with previous work showing a greater contribution from oxidative ATP 
production in older than young muscle (128,130). In sum, the fatigue resistance of older 
compared with young muscle during the MVDC120 was likely due to a greater proportion 
of ATP being derived from oxidative sources. 
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Similar to the MVDC20% protocol, during the MVDC120 we observed a ~25% 
decline in [ATP] in both groups (Figure 4.8E).  In concert with this observation, PCr 
declined to 7.7±0.6% and 14.0±2.3% of the resting value in young and older muscle, 
respectively.  Further, [PME] increased relative to resting concentrations by 50 and 60 s 
in young and older muscle during the MVDC120.  As discussed above, the decline in 
[ATP] likely contributed to the increase in [PME] because nucleotide breakdown results 
in the formation of inosine monophosphate (163), which contributes to the PME pool in 
the 31P spectrum.  The observation of declining [ATP] during both protocols suggests that 
the energetic cost of the contractions was greater than could be sustained by ATP 
production in vivo. 
A notable observation in both fatigue protocols is the lower pH in young than 
older muscle at the end of the fatiguing contractions.  This observation is consistent with 
several reports (114,128,136).  One potential explanation for this is the fiber composition 
of young and older muscles.  Repeated cycles of denervation-reinnervation with age 
resulting in the grouping of fiber types (87), which becomes more pronounced at 
advanced ages (≥80 years).  A long-held belief is that type II muscle fibers are 
preferentially impacted by the aging process.  In contrast with this view, atrophy of type I 
muscle fibers with age may be concealed by co-expression of the myosin heavy chain 
(192,200), a preferential atrophy of fast muscle fibers with old age is not always observed 
(27), and some authors have reported a shift towards a greater proportion of type II muscl 
fibers with age (75).  Therefore, the greater acidosis observed in young compared with 
older muscle may not due to shifts in myosin heavy chain expression with age.  
Alternatively, a decline in lactate dehydrogenase activity with age has been observed 
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(102,135,182).  In addition, lactate dehydrogenase may shift away from a muscle-specific 
isoenzyme with age (135,211), which would result in greater accumulation of cytosolic 
pyruvate.  Pyruvate is the precursor to the Krebs cycle and therefore, a greater 
accumulation of cytosolic pyruvate may explain the relatively lower glycolytic ATP flux 
in older muscle observed in this study and others (128,130); the lactate dehydrogenase 
isoenzyme in older muscle may favor formation of pyruvate, and thus oxidative energy 
production.  However, whether age-related changes in lactate dehydrogenase isoenzyme 
and activity can fully explain the lower pH in young than older muscle remains to be 
determined. 
Limitations 
There were several technical limitations with this study.  One of these technical 
issues was our inability quantify muscle-tendon unit stiffness.  This may have been 
partially due to participant’s receiving real-time feedback based on their RMS EMG 
signal rather than joint torque.  Although the RMS EMG signal is loosely associated joint 
torque, the signal is likely not linear due to the confounding effects of motor unit 
recruitment and discharge rate.  Further to this, the real-time feedback was based on the 
RMS EMG signal of the rectus femoris muscle and the ultrasound video, to visualize 
aponeurosis extension, was recorded from the vastus lateralis.  This approach was 
necessary because the software did not allow for real-time torque feedback and the 
placement of the ultrasound probe precluded using surface EMG on the vastus lateralis.  
Perhaps a bigger problem, however, was the offline tracking of aponeurosis extension.  
The MatLab program used a two-dimensional cross-correlation tracking algorithm to 
track points of interest of the deep aponeurosis and just beneath the skin.  However, this 
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program was developed to track displacement of the aponeuroses in the ankle 
dorsiflexors and plantar flexors captured with a different ultrasound system (84).  The 
image resolution of the ultrasound system used previously (720 x 480) is lower than that 
achieved with the system in the current study (800 x 600).  Thus, the sensitivity of the 
tracking algorithm may need to be optimized for tracking aponeurosis displacement with 
modern ultrasound systems. 
Another limitation of this study is that the absolute contraction velocity in the 
MVDC20% was likely lower than necessary to observe age-related differences in muscle 
fatigue.  Although previous studies have observed greater fatigue in older than young 
muscle using both isotonic (48,49,222,223) and isokinetic contractions (24), the range of 
motion was greater in those studies due to the contractions being performed on a full-
sized dynamometer and thus not limited by the MR environment.  A recent study, 
conducted within an MR environment, observed greater fatigue in older compared with 
young adults using a similar contraction protocol and range of motion (25-30°) to the 
MVDC20% one reported here.  The reasons for the discrepancy between studies were 
discussed above (see MVDC20%).  During the MVDC20% protocol, the range of motion 
declined in both groups, but was greater in older than young adults (Figure 4.6).  
Although this does not explain the unexpected observation of similar fatigue between 
groups (a smaller range of motion would negatively affect power production), the main 
effect of age on the range of motion does complicate the interpretation of the results 
because the two groups were not performing the same contractions. 
Lastly, the exclusion of 1 older male’s data from the MVDC20% protocol resulted 
in reduced statistical power.  This participant’s data were excluded because their power-
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time integral was higher at the end compared with the beginning of the MVDC20% 
protocol, suggesting they did not exert maximal effort throughout the duration of the task 
but were pacing themselves.  Although the exclusion of this participant’s data reduced 
our statistical power, significant age-related differences in muscle fatigue and 
bioenergetics were observed in a recent study with only 7 participants in their young and 
older groups (223). 
Conclusions 
We observed similar fatigue in young and older adults in response to maximal 
dynamic contractions at a low relative load (MVDC20%).  Coincident with this 
observation, pH was lower in young than older muscle during the MVDC20% protocol 
suggesting the contractile machinery may become more sensitive to changes in pH with 
age.  We also observed greater fatigue in young than older adults in response to maximal 
dynamic contractions performed at 120°.s-1.  During that protocol, pH was lower and 
H2PO4- higher in young than older muscle.  These metabolites are putative agents of 
fatigue at the molecular level.  During the first half of both fatigue protocols, we 
observed a greater glycolytic ATP flux in young compared with older muscle, which 
provides a bioenergetic basis for the age-related differences in muscle fatigue observed in 
this study.  Future investigations should try to elucidate the mechanisms for the lower pH 







Table 4.1. Group characteristics 
 Young (n=10) Older (n=10) 95% CI P 
Age (yrs) 27.5 ± 3.9 71.2 ± 5.0 - - 
Height (m) 1.69 ± 0.1 1.64 ± 0.11 -0.46, 0.15 0.286 
Body mass (kg) 75.3 ± 14.0 67.8 ± 12.4 -4.91, 19.87 0.221 
BMI (kg.m-2) 26.0 ± 2.7 24.9 ± 2.2 -1.27, 3.45 0.344 
PA (counts.d-1000) 238.7 ± 102.0 238.6 ± 99.5 -94.65, 94.73 0.999 
MVPA (min.d-1) 38.3 ± 17.8 27.2 ± 23.3 -8.39, 30.55 0.247 
4m gait speed (m.s-1) 1.13 ± 0.14 1.16 ± 0.15 -0.16, 0.11 0.657 
Chair rise time (s) 16.1 ± 4.0 19.7 ± 5.2 -7.85, 0.81 0.105 
TUG (s) 9.0 ± 1.5 9.5 ± 0.8 -1.70, 0.53 0.280 
SPPB-A 2.82 ± 0.28 2.57 ± 0.28 -0.02, 0.12 0.067 
kPCr (s-1) 0.021 ± 0.004 0.022 ± 0.004 -0.004, 0.003 0.632 
Values are mean±SD. 95% CI, 95 % confidence intervals for the difference between group 
means; BMI, body mass index; PA, physical activity; MVPA, moderate- to vigorous-intensity 
physical activity; TUG, timed up-and-go; SPPB-A, advanced short physical performance 
battery; kPCr, rate constant of PCr recovery. 
 
Table 4.2. Age-related differences in muscle size, maximal torque, and power 
 Young (n=10) Older (n=10) 95% CI P 
Contractile volume (cm3) 1125.6 ± 347.5 803.5 ± 228.7 45.7, 598.4 0.025 
Femur length analyzed (%) 46.1 ± 4.9 45.0 ± 5.7 -3.9, 6.1 0.651 
Fat fraction (%) 8.4 ± 1.1 9.2 ± 2.1 -2.2, 0.81 0.340 
Isometric torque (Nm) 252.0 ± 64.6 187.9 ± 62.9 4.2, 124.0 0.037 
Isokinetic power (W) 238.5 ± 96.5 133.5 ± 62.1 28.7, 181.3 0.010 
Isotonic power (W) 367.7 ± 135.4 178.1 ± 84.5 29.4, 96.8 0.002 
Specific MVIC (Nm.cm-3) 0.232 ± 0.051 0.232 ± 0.034 -0.1, 0.1 0.826 
Specific MVDC120 (W.cm-3) 0.218 ± 0.070 0.161 ± 0.040 0.1, 0.1 0.037 
Specific MVDC20% (W.cm-3) 0.328 ± 0.075 0.219 ± 0.072 0.1, 0.2 0.004 
Values are mean±SD. 95% CI, 95 % confidence intervals for the difference between group 
means. MVIC, maximal voluntary isometric contraction; MVDC120, maximal voluntary 
dynamic contraction at 120°.s-1; MVDC20%, maximal voluntary dynamic contraction against a 










Table 4.3. Changes in ATP flux throughout the MVDC20% fatigue protocol 
 Young (n=10) Older (n=10) 95% CI P 
Creatine kinase* 
Minute 1 2.82 ± 0.45 2.85 ± 0.32 -0.23, 0.16 0.736 
Minute 2 0.58 ± 0.23 0.52 ± 0.13 -0.12. 0.27 0.439 
Minute 3 0.18 ± 0.11 0.21 ± 0.12 -0.23, 0.17 0.752 
Minute 4 0.11 ± 0.06 0.17 ± 0.05 -0.26, 0.14 0.553 
Non-oxidative glycolysis*# 
Minute 1 1.70 ± 0.55 1.67 ± 0.44 -0.27, 0.40 0.707 
Minute 2 1.74 ± 0.48 1.31 ± 0.40 0.11, 0.78 0.009 
Minute 3 0.80 ± 0.24 0.64 ± 0.26 -0.14, 0.54 0.237 
Minute 4 0.52 ± 0.19 0.54 ± 0.32 -0.31, 0.36 0.893 
Oxidative ATP production* 
Baseline Vi[PCr] 0.44 ± 0.11 0.43 ± 0.11 -0.11, 0.13 0.835 
End fatigue Vi[PCr] 0.47 ± 0.09 0.59 ± 0.18 -0.24, 0.01 0.051 
Values are mean±SD. 95% CI, 95 % confidence intervals for the difference between group 
means; Vi[PCr], initial velocity of PCr recovery. *Main effect of time (p≤0.001), #main effect of 
age (p=0.032). 
 
Table 4.4. Changes in ATP flux throughout the MVDC120 fatigue protocol 
 Young (n=10) Older (n=10) 95% CI P 
Creatine kinase* 
Minute 1 3.08 ± 0.21 2.81 ± 0.26 0.13, 0.40 0.001 
Minute 2 0.47 ± 0.16 0.47 ± 0.14 -0.14, 0.13 0.933 
Minute 3 0.12 ± 0.06 0.20 ± 0.11 -0.21, 0.07 0.296 
Minute 4 0.12 ± 0.06 0.08 ± 0.11 -0.11, 0.17 0.635 
Non-oxidative glycolysis*# 
Minute 1 2.15 ± 0.47 1.71 ± 0.49 0.14, 0.75 0.005 
Minute 2 1.79 ± 0.29 1.40 ± 0.48 0.08, 0.69 0.015 
Minute 3 0.66 ± 0.25 0.46 ± 0.18 -0.10, 0.51 0.192 
Minute 4 0.37 ± 0.17 0.33 ± 0.21 -0.26, 0.35 0.764 
Oxidative ATP production* 
Baseline Vi[PCr] 0.44 ± 0.11 0.43 ± 0.10 -0.08, 0.10 0.793 
End fatigue Vi[PCr] 0.47 ± 0.10 0.53 ± 0.08 -0.16, 0.03 0.166 
Values are mean±SD. 95% CI, 95 % confidence intervals for the difference between group 







Figure 4.1. Representative 31P spectra at rest and the end of each fatigue protocol.  
Representative 31P spectra at rest and the end of the MVDC20% in a young (A) and older (B) male.  
Representative spectra at rest and the end of the MVDC120 in a young (C) and older (D) male are 




Figure 4.2. Representative torque and velocity traces.  Traces are shown from the MVDC20% (A) 
and MVDC120 (B) protocols.  The shaded area illustrates the concentric period.  Data are from 1 




Figure 4.3. Ultrasound tracking of aponeurosis displacement during a ramped maximal isometric 
contraction.  Ultrasound stills from the start (A) and end (B) of a maximal voluntary contraction 
of the knee extensors.  The multi-coloured dots are points of interest, including a set of reference 
points near the skin and a set of points along the deep aponeurosis of the vastus lateralis. We 
attempted to track the motion of points throughout 30 s ramped isometric contractions using an 
automated cross-correlation algorithm. Comparisons of the location of the multi-coloured points 
in A and B, shows the reference points near the skin have moved and the points on the deep 
aponeurosis have bunched together, resulting in minimal net extension and precluding analysis of 




Figure 4.4. Age-related differences in muscle size, maximal torque and power.  *p<0.05; ns, 




Figure 4.5. Age-related differences in fatigue during the MVDC20% fatigue protocol.  No group 





Figure 4.6. Metabolite concentrations in young and older muscle throughout the MVDC20% 




Figure 4.7. Age-related differences in fatigue during the MVDC120 fatigue protocol.  Fatigue (% 










EFFECTS OF OLD AGE AND CONTRACTION VELOCITY ON KNEE 
EXTENSOR MUSCLE METABOLIC ECONOMY IN VIVO 
Abstract 
Dynamic contractions are more energetically costly than isometric contractions.  
Metabolic economy (ME; mass-normalized torque or power produced per unit ATP 
consumed) is similar between young and older adults during isometric contractions, but 
less is known about age-related differences in ME during dynamic contractions.  The 
purpose of this study was to examine age-related differences in ME during maximal 
effort isometric, isokinetic, and isotonic contractions of the knee extensor muscles. We 
hypothesized that age-related differences in ME would be present only during dynamic 
contractions.  Ten young (Y; 27.5±1.2 yr, 6 men) and 10 older (O; 71.2±1.6, 5 men) 
healthy adults performed three 24-s bouts of maximal knee extensor contractions: 1) 
sustained isometric contraction (MVIC), 2) isokinetic contractions (120°ꞏs-1 (MVDC120; 
0.5 Hz), and 3) isotonic contractions with a load of 20% MVIC (MVDC20%; 0.5Hz).  
Phosphorus magnetic resonance spectroscopy of the vastus lateralis was used to calculate 
ATP flux through the creatine kinase reaction, non-oxidative glycolysis, and oxidative 
phosphorylation.  Quadriceps muscle contractile volume was measured using serial fat-
water magnetic resonance images. All spectroscopy and imaging data were acquired 
using a whole-body 3T magnetic resonance system. The torque-time integral (TTI) 
during the MVIC, and power-time integral (PTI) during MVDC120 and MVDC20%, were 
calculated.  Total ATP flux was used to determine the ATP cost of each 24-s bout, and 
ME was calculated as specific TTI or PTI, divided by ATP cost.  Differences between 
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groups were evaluated using independent samples t-tests.  ME was not different between 
young (0.12±0.01 Nm.s.cm-3.mM ATP-1) and older (0.11±0.01 Nm.s.cm-3.mM ATP-1; 
p=0.765) muscle during the MVIC.  However, during both MVDC120 and MVDC20%, ME 
was greater in young than older muscle (MVDC120: 0.011±0.001 vs. 0.007±0.001 
W.s.cm-3.mM ATP-1; p=0.002, respectively; and MVDC20%: 0.011±0.001 vs. 
0.009±0.001 W.s.cm-3.mM ATP-1; p=0.031, respectively).  These results show an age-
related deficit in ME that is evident only during dynamic contractions, potentially due to 
the higher energy demand of these contractions. 
Key words: bioenergetics, metabolism, mitochondria, creatine kinase, glycolysis, 
oxidative phosphorylation, efficiency 
Introduction 
Old age is accompanied by multiple changes within the neuromuscular system 
including slower maximal motor unit discharge rates and contractile properties 
(24,42,103,114,119), declines in maximal torque and power production (24,49), slowed 
crossbridge kinetics (164), atrophy of muscle fibers and fiber-type grouping (141-143).  
The greater maximal torque and power produced by young compared with older adults 
(24,49) is likely due to a loss of muscle mass (24,90) and slower maximal contraction 
velocities (132,232) with age.  Structural changes with age, such as increased compliance 
of the muscle-tendon unit (125,150,219), may also affect maximal torque and power 
production.  Although some of these age-related changes within the neuromuscular 
system may improve muscle metabolic economy (ME; mass-normalized torque or power 
produced per unit ATP consumption), others may negatively affect ME.  Studies in rat 
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muscle have shown age-related differences in ME (55,88), yet relatively scant data are 
available in human muscle in vivo (31). 
Developing an understanding of the conditions where age-related differences in 
ME are present, and the mechanisms responsible for those differences, is necessary for 
identifying the cause of the increased energetic cost of daily activities, such as walking, 
in older adults (76).  Moreover, developing such an understanding may help explain why 
older adults experience less, similar, or greater muscle fatigue compared with young 
adults (23,24,49). 
In vivo, ME of muscle contraction is likely influenced by metabolic and neural 
factors, as well as mechanical properties.  For example, type I fibers are more economical 
than type II fibers (43,77,80,85).  The cause of this greater efficiency in type I compared 
with type II fibers stems from slower crossbridge kinetics and a lower cost of calcium 
resequestration in type I fibers (85,224).  There is some evidence that older adults have a 
greater proportion of type I muscle fibers (141-143), which is thought to result from 
recurring denervation-reinnervation cycles (214).  Additionally, crossbridge kinetics are 
slower in older than young muscle (164).  These observations of age-related changes in 
muscle morphology and function may result in lower ME in young than older muscle.  
However, a 12-year longitudinal study observed an increase in the proportion of type II 
fibers in older men (75).  This discrepancy may, at least in part, be explained by the 
muscle group being investigated, because shifts toward a faster and slower phenotype 
have been observed in different muscles with age (166), and fiber co-expression (5,192).  




To determine ME in vivo, phosphorus magnetic resonance spectroscopy (31P-
MRS) can be used to non-invasively quantify ATP production rates during muscle 
contractions (20).  Because [ATP] is maintained until extreme levels of fatigue (226), the 
rate of ATP production can reasonably be assumed to equal its rate of consumption 
(128,226).  Using this approach, the ATP cost of dynamic contractions has been shown to 
be greater than isometric contractions (205).  This observation is consistent with in vitro 
studies in rat diaphragm muscle, where the actomyosin ATPase rate was ~3x greater 
when myofibers were contracting at 33% maximal shortening velocity compared with an 
isometric contraction (209).  The increased ATP cost of dynamic compared with 
isometric contractions is likely due to the greater energetic cost of producing, rather than 
maintaining, force (202). 
Only one study has examined age-related differences in ME in vivo (31), while 
more studies have examined age-related differences in the ATP cost of contraction (i.e., 
torque or power per unit ATP) (136-139).  Some authors have reported lower (130) or 
similar (31) ME in young compared with older muscle during maximal isometric 
contractions.  Christie et al. reported no differences in ME of the dorsiflexors during a 
sustained 12-s MVIC between young and older adults (31).  Similarly, no age-related 
difference in the ATP cost of contraction was observed during a sustained 24-s MVIC of 
the knee extensors (136).  However, during intermittent MVICs of the knee extensors, 
where metabolic demand is greater than during a sustained MVIC, the torque produced 
per unit ATP was greater in young compared with older adults (136), suggesting there is 
an age-related increase in the cost of developing, but not maintaining force.  Age-related 
differences in the ATP cost of dynamic contractions have also been observed (137-139).  
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The ATP consumed per Watt is significantly lower in young compared with older muscle 
during submaximal (138,139) and supramaximal contractions of the plantar flexors (137).  
However, the question of whether ME is changed with old age remains uncertain.  
Specifically, we are not aware of any studies that have examined age-related differences 
in the ME of dynamic contractions in the knee extensors. 
Although energy demand is higher during dynamic than isometric contractions 
(205), and the ATP cost of producing force is greater than maintaining it (202), whether 
age-related differences in ME are more pronounced as the metabolic demand increases is 
unclear.  To address this knowledge gap, we examined age-related differences in muscle 
ME during isometric, isokinetic, and isotonic contractions of the knee extensor muscles.  
Consistent with faster crossbridge kinetics in the vastus lateralis (164), and greater 
fatigue in response to isometric contractions (28,35,60,114,130), of young compared with 
older adults we hypothesized that ME would be lower in young compared with older 
adults during a 24-s MVIC.  We also hypothesized, based on observations of similar 
fatigue in young and older adults in response to moderate-velocity isokinetic contractions 
(23,24,49,147), that ME would be similar in young and older muscle during 24s of 
isokinetic contractions at 120°.s-1.  Lastly, we hypothesized, based on the observation of 
less fatigue in young compared with older adults in response to high-velocity contractions 
(24,48,49,159,222,223), that ME would be higher in young than older muscle during 24s 







Ten young (24-35 yrs; n=6 men) and 10 older (66-80 yrs; n=5 men) adults were 
studied.  Prior to enrollment, each participant gave their written, informed consent, as 
approved by the University of Massachusetts Amherst, and in accordance with the 
Declaration of Helsinki.  Physician’s consent to participate was obtained for all older 
participants.  Participants were sedentary by self-report, defined as completing less than 
two 30-min sessions of structured exercise per week.  They also reported being healthy, 
as evaluated by a health-history questionnaire, and were not taking any medications 
known to affect physical function or muscle fatigue (e.g., beta-blockers, calcium channel 
blockers, sedatives, etc.).  Participants with significant arthritis in their lower extremities, 
symptoms upon exertion, metal implants, or claustrophobia were excluded from the study 
prior to enrollment.  Participants answered ‘no’ to all questions on the Physical Activity 
Readiness Questionnaire (229), and were thus suitable for performing the contraction 
protocols. 
Experimental Design 
Participants reported to the University of Massachusetts Amherst for 3 visits.  At 
visit 1, physical function was measured and participants were familiarized with the 
contraction protocols to be completed at visits 2 and 3.  At the beginning of visit 2, 
magnetic resonance images of the entire thigh were obtained and participants completed 
2 of the 3 contraction protocols (see below), with at least 10 min of rest between each.  
The third contraction protocol was completed at visit 3, which was at least 3 days after 
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visit 2.  The order of the contraction protocols (see Muscle oxidative capacity and 
Contraction protocols) was randomized. 
Physical Function and Activity 
Measures of mobility and physical activity were obtained in order to characterize 
the study groups.  Mobility was measured using the Timed-Up-and-Go (TUG; (188)) and 
an advanced version of the short physical performance battery (SPPB-A; (210)).  For the 
TUG test, participants were asked to stand up from a seated position, walk 3m, return to 
the chair and sit down (188).  Participants completed this test twice at their usual walking 
speed, with 1 min of rest between each trial.  The fastest of the 2 trials was used for 
analysis.  Participants next completed the SPPB-A, which combines chair rise time, 
balance time with 3 different foot positions, and gait speed over a 4 m path (210).  For the 
chair rise task, participants were instructed to fold their arms across their chest and 
completely stand up and sit back down again 10 times, as fast as possible, using a 
standardized chair (seat height = 45cm).  For the balance tasks, participants stood with 
their feet in semi-tandem and tandem positions, and on one leg, for as long as possible, 
up to a maximum of 30 s.  To measure gait speed, the time taken to walk along a straight, 
4 m path was recorded.  Participants completed this walking task twice at their preferred 
speed, with 1 min of rest between trials.  The walking test was then repeated, with the 
participant instructed to stay within a 20cm path.  The time taken to complete each 
mobility test was recorded with a stopwatch. 
At the end of visit 1, participants were asked to wear a uniaxial accelerometer 
(Actigraph, Pensacola, FL) for 7 days.  Accelerometers were worn over the right hip, and 
data were recorded with a 60-s epoch.  Participants wore the accelerometer for a 
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minimum of 10 hours per day, and at least 4 days (3 weekdays and 1 weekend day).  
These criteria have been shown to provide good reliability (>80%) for quantifying 
overall, light, and moderate-to-vigorous physical activity (153,154).  Average daily 
activity counts and minutes spent in moderate-to-vigorous physical activity were 
determined using ActiLife v6.13 software (ActiGraph, Pensacola, FL) with established 
cutpoint thresholds for uniaxial ActiGraph accelerometers (74). 
Familiarization 
Participants were seated on a dynamometer (Biodex system 4, Biodex Medical 
Systems, Shirley, NY), with hip and knee angles of 135° and 110°, respectively.  These 
joint angles were selected to mimic the position used for the contraction protocols in the 
MR scanner at visits 2 and 3.  The dynamometer was adjusted to ensure the axis of 
rotation of the dynamometer’s lever arm was aligned with the axis of rotation of the 
participant’s knee joint.  The length of the lever arm was adjusted to each participant’s 
tibia length and secured with inelastic straps ~2cm proximal to the malleoli.  Additional 
inelastic straps were fastened across the participant’s torso and hips to prevent unwanted 
movement.  Participants were instructed not to hold onto any part of the dynamometer 
during the testing to ensure the torque and velocity measurements were generated 
predominantly by the knee extensor muscles.  Once correctly positioned on the 
dynamometer, participant’s completed 2-3 maximal voluntary isometric contractions 
(MVIC) followed by two 40-s trials of maximal voluntary dynamic contractions 
(MVDCs) at 120°.s-1 and 240°.s-1, with 1 contraction completed every 2s.  Each 
contraction was cued by a metronome, and all contractions were performed over a 30° 
range of motion (110-140°).  Participants were instructed to ‘kick their leg out as hard 
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and fast as possible’ for all contractions.  The investigators provided strong verbal 
encouragement throughout the familiarization protocols.  Visual torque-feedback was 
provided via a computer monitor, positioned at the participants eye-level.  All 
contractions were performed with the dominant leg (preferred kicking leg) to familiarize 
participants with the contraction protocols to be performed at visits 2 and 3. 
Contractile Volume Measurement 
 Upon arriving for Visit 2, participants completed an MRI safety questionnaire 
(Appendix C) and walked through an upright metal detector to ensure their safety.  
Subsequently, participants were positioned supine inside a Skyra 3T MR scanner 
(Siemens Medical Systems, Erlangen, Germany).  To avoid movement while inside the 
MR scanner, inelastic straps were fastened over the participant’s lower leg and hips.  A 
multi-echo (6-point), 2D gradient-echo Dixon sequence was applied with the following 
parameters: TR=35 ms, FOV=230, TE=2.46 and 6.15ms, 3.69 and 7.38ms, and 4.92 and 
8.61 ms, matrix=192 x 144, GRAPPA factor=2, flip angle=15°, 1 average.  These images 
were acquired using an 18-channel flex coil and a 32-channel spine coil.  Axial slices 
(6mm) were obtained from the greater trochanter to the lateral epicondyle of the femur, 
and slices in which all four quadriceps muscles were visible were analyzed for muscle 
and fat content.  Water and fat images were reconstructed offline using the MatLab Fatty 
Riot algorithm (53).  A region of interest (ROI) was drawn around the quadriceps muscle 
group on each slice.  Fat fraction was calculated on a pixel-by-pixel basis from the ratio 
of separate water-only and fat-only images, using the equation (F/(W+F)) and expressed 
as mean±SD of multiple measurements.  Fat-free muscle cross-sectional area (CSA, cm2) 
of the knee extensors was quantified using a custom-written MatLab program 
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(MathWorks, Natick, MA).  Contractile volume was calculated as the sum of CSAs, 
multiplied by the slice thickness.  To eliminate the possibility of inter-investigator error, 
the same investigator analyzed all MR images. 
Muscle Oxidative Capacity 
 Participants were randomly assigned to complete the muscle oxidative capacity 
protocol at either visit 2 or 3.  Participants were positioned inside the MR scanner with a 
dual-tuned 31P/1H surface coil (8x10.5 cm) fastened over the vastus lateralis of their 
dominant leg using a bandage and velcro straps.  The knee and ankle of the dominant leg 
were strapped to an MR-compatible ergometer.  An additional strap was fastened over the 
participants hips to prevent unwanted movement.  Gradient scout images were obtained 
to ensure correct placement of the surface coil and positioning within the isocenter of the 
MR scanner.  Subsequently, the homogeneity of the magnetic field was optimized by 
localized shimming on the proton signal. 
After optimization of the magnet for metabolic measures, participants completed 
three 5-s MVICs, and 3 sets of 6 maximal isokinetic contractions at 120°.s-1 (MVDCIsoK), 
and 3 sets of 6 maximal isotonic contractions at 20% MVIC (MVDCIsoT), separated by 2 
min of rest.  These contractions were performed to obtain baseline measures of knee 
extensor torque and power and to ‘warm-up’ participants muscles. 
Participants then completed 24s of MVDCIsoK’s (1 every 2s).  The number of 
contractions and duty cycle for this contraction protocol were selected based on pilot 
work demonstrating that PCr was depleted by ~50% with minimal change in pH; 
conditions which are optimal for quantifying muscle oxidative capacity in vivo (6,162).  
Phosphorus spectra were acquired for 60s before (plus 15 dummy pulses), during, and 
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10-min following the 12 contractions with a 0.1 ms hard pulse, 60° flip angle, 4,000 Hz 
bandwidth, 2,048 complex points, 2s repetition time and 0.15 ms echo time.  Figure 5.2 
illustrates a representative 31P spectrum at rest, spectra throughout the muscle oxidative 
capacity measurement, and the PCr recovery kinetics from 1 older male. 
Contraction Protocols 
Following the 10-min recovery period from the oxidative capacity measurement, 
participants completed one of 2 contraction protocols.  The order of these 2 contraction 
protocols was randomly assigned between visits 2 and 3 such that participants either 
completed a total of 2 contraction protocols at visit 2 or 3 (MVDCIsoK (muscle oxidative 
capacity) and MVIC or MVDCIsoT). 
For one of the contraction protocols, participants completed a 24-s maximal 
voluntary isometric contraction (MVIC).  For the other contraction protocol, participants 
completed 24s of maximal isotonic contractions against a load equivalent to 20% of their 
MVIC (MVDCIsoT).  Phosphorus spectra were collected for 90-s prior and throughout 
each 24-s protocol.  Torque and velocity traces from each of the 3 contraction protocols 
(MVIC, MVDCIsoK, and MVDCIsoT) are shown for 1 representative young male in Figure 
5.1.  
Measurements and Data Analyses 
Mechanical Torque and Power 
Position, torque, and velocity were sampled at 500Hz using a custom MatLab user 
interface, and these data were post-processed offline using MatLab.  Power was 
calculated as the product of the instantaneous torque and velocity signals.  The post-
processing program calculated the torque-time and power-time integrals for the 3 
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contraction protocols.  The power-time integral for both dynamic contraction protocols 
(MVDCIsoK and MVDCIsoT) was calculated using only the concentric phase of each 
contraction, as illustrated in Figure 5.1.  Torque and power were integrated using the 
Riemann sum.   
31P Spectral Analysis 
 All free induction decays were analyzed using jMRUI v6.0beta.  Spectra were 
zero-filled (2,048 points) and Fourier-transformed.  A 1Hz Lorentzian filter was applied 
and spectra were phased manually.  Once the PCr peak was set to 0 ppm, spectra were 
line-fit using the AMARES algorithm and the area under the peaks corresponding to 
phosphomonoesters, Pi, phosphodiesters, PCr, alpha and gamma ATP quantified.  
Concentrations of Pi and PCr were calculated assuming that [Pi] + [PCr] = 42.5mM in 
resting muscle (161).  Intracellular pH was calculated based on the chemical shift (σ) of 
Pi relative to PCr (168). 
PCr Recovery 
For the recovery period, spectra were averaged to achieve the following temporal 
resolution: 4s for the first 20s, 8s for the next 280s, and 30s for the remaining 5-min.  
Once [PCr], [Pi], [ATP], and pH were determined, the repletion of PCr during the 10-min 
recovery period was fit with a mono-exponential function and the rate constant (kPCr) 
determined, as shown in equation [5.1]: 
 




where ΔPCr = (PCrrest – PCrex), and PCrex is [PCr] at the end of the contraction.  The rate 
constant of PCr recovery, kPCr, reflects the capacity for oxidative phosphorylation under 
these conditions (117).  This measure is highly reliable and well correlated with 
respirometry measures of maximally stimulated in vitro (i.e., state 3) respiration (129) 
and oxidative enzyme activities (134,156). 
ATP Flux 
 Under conditions where there is no net change in [ATP], ATP production can be 
reasonably assumed to equal ATP consumption (20,226).  We calculated rates of ATP 
production through the creatine kinase reaction (ATPCK), non-oxidative glycolysis 
(ATPGLY), and oxidative phosphorylation (ATPOX) during the MVIC, MVDCIsoK, and 
MVDCIsoT contraction protocols.  The first 15 resting spectra (30s) were discarded as 
dummy pulses.  Spectra were averaged to achieve 60s and 4s resolution at rest and during 
the contraction protocols, respectively. 
The rate of PCr breakdown by the CK reaction was calculated as the rate of decline in 
PCr at each 4s time point, as follows: 
 
 ATP  
∆PCr
∆t
 [Eq. 5.2] 
 
 Oxidative ATP synthesis was quantified under the assumptions that the resting 
concentration of ATP is equal to 8.2mM (82), and the phosphorylation potential 




 𝐴𝑇𝑃  
𝑉
1 0.11/ 𝑃𝑖 𝐴𝐷𝑃 / 𝐴𝑇𝑃
 [Eq. 5.3] 
 
where Vmax (mM ATP/s), the theoretical maximal muscle oxidative capacity, was 
calculated as the product of the rate constant of PCr recovery following the MVDCIsoK 
trial (kPCr) and [PCr] at rest (161).  [ADP] was calulcated assuming that free creatine and 
Pi are equal (235), as follows: 
 
 ADP  
ATP Pi
K PCr
 [Eq. 5.4] 
 
where KCK is the equilibrium constant of the CK reaction, which was corrected for pH 
assuming [Mg2+] equals 1mM (78): 
 
 K 1.66 10 .  [Eq. 5.5] 
 
 Intracellular pH was calculated based on the chemical shift (σ) of Pi relative to 
PCr, in parts per million, as follows (168): 
 
 pH 6.75 log
σ 3.27
5.69 σ
 [Eq. 5.6] 
 
 Broadening and splitting of the Pi peak can occur due to distinct pH pools during 
contractions (180).  When Pi splitting was visibly evident, the pH corresponding to each 
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Pi pool was calculated separately (based on the chemical shift of each Pi pool relative to 









 [Eq. 5.7] 
 
Glycolytic ATP synthesis was calculated based on changes in pH and PCr during 
each 24s contraction protocol, using linear regression for the rate of change.  Proton 
consumption by the CK reaction, buffering, and oxidative proton production were also 









V  [Eq. 5.8] 
 
where β represents the total buffering capacity; calculated as the sum of inherent 
buffering, and buffering from bicarbonate and Pi (108).  The pH dependent rate of H+ 
efflux (VEff) was measured in mM.s-1 at the end of each fatigue task.  The proton 







 [Eq. 5.9] 
 
The total rate of ATP production (mM.s-1) was calculated as the sum of ATP flux 
through the CK reaction, non-oxidative glycolysis, and oxidative phosphorylation (31).  
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Absolute quantities of ATP production (mM) were determined by multiplying the total 
rate of ATP production (mM.s-1) by the duration of the contraction (i.e., 24s).   
Metabolic Economy 
Because our study design required the use of 3 different contraction modes 
(isometric, isokinetic, and isotonic), ME was determined using the torque-time integral 
(TTI) for the MVIC protocol, and the power-time integral (PTI) for the MVDCIsoK and 
MVDCIsoT contraction protocols.  To determine the ME for the MVIC protocol, the TTI 
was normalized to contractile volume and ATP production (Nm.s.cm-3.mM ATP-1), as 
previously reported by our lab (31).  For both the MVDCIsoK and MVDCIsoT protocols, 
ME was calculated as the PTI normalized to contractile volume and ATP production 
(W.s.cm-3.mM ATP-1) 
Statistical Analyses 
All data were checked for normality and homogeneity of variance prior to any 
statistical comparisons using the Kolmogorov-Smirnov test and Levene’s statistic, 
respectively.  If the assumptions of normality or homogeneity of variance were violated, 
non-parametric statistical comparisons were performed.  Differences in group descriptive 
characteristics, muscle contractile volume, maximal torque and power, and oxidative 
capacity were analyzed using independent t-tests or Mann-Whitney U tests.  Age-related 
differences in muscle metabolic variables and ATP flux across each 24-s contraction 
protocol were evaluated using repeated measures ANOVA (age × time).  Where 
significant effects were found, post-hoc pairwise comparisons were performed.  Group 
differences in TTI or PTI, total ATP flux, ATP cost of contraction, and ME were 
evaluated for each contraction protocol using independent t-tests.  All statistical analyses 
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were performed using the SPSS statistical software package (v25.0, IBM, Chicago, IL) 
with an alpha level of 0.05.  Data are reported as mean±SE, with exact p-values and 95% 
confidence intervals for differences in group means in the Tables and text. 
Results 
Baseline Characteristics 
Group characteristics are reported in Table 5.1.  There were no differences in 
height, body mass, or BMI between groups.  Additionally, habitual physical activity and 
average daily moderate-to-vigorous physical activity were similar between young and 
older groups.  We observed no difference between groups for measures of physical 
function, including chair rise time, TUG, and SPPB-A. 
 Peak contractile CSA and contractile volume were larger in young compared with 
older muscle (p≤0.025; Table 5.2), whereas fat fraction was similar between groups 
(p=0.340).  At baseline, maximal isometric torque (MVIC) and power during the 
MVDC120 and MVDC20% trials were greater in young compared with older adults (Table 
5.2).  Specific isometric torque was similar between young and older adults (Table 5.2).  
However, maximal specific power during the MVDC120 and MVDC20% trials was ~25% 
and ~30% greater in young compared with older adults, respectively (Table 5.2).  The 
rate constant of PCr recovery (kPCr) was not different between young and older groups 
(Table 5.2). 
 The torque- and power-time integrals during the MVIC, isokinetic, and isotonic 
contractions are shown in Figure 5.3. We observed no age-related differences in the TTI 
during the MVIC, regardless of whether data were expressed in absolute terms (p=0.096) 
or normalized to muscle volume (p=0.739). However, PTI was greater in young 
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compared with older adults during the isokinetic contractions both in absolute terms 
(p=0.003) and when normalized to muscle volume (p=0.0022). During the isotonic 
contractions, the PTI was greater in young than older adults in absolute terms (p=0.003), 
but no difference was observed between groups when the PTI was normalized to muscle 
volume (p=0.128). 
 Changes in PCr, pH, and ATP throughout the MVIC, isokinetic, and isotonic 
contractions are illustrated in Figures 5.4, 5.5, and 5.6, respectively.  There were no 
effects of age and no age×time interactions for changes in PCr during any of the 3 
contraction protocols (p≥0.123), although there was a main effect of time for each 
protocol (p<0.001).  We observed no age×time interactions for changes in pH during any 
of the protocols (p≥0.268).  However, there was a main effect of age on changes in pH 
during the MVIC and isokinetic contractions (p≤0.002), but not the isotonic contractions 
(p=0.093).  Post-hoc analyses revealed group differences in pH at 20 and 24s during the 
MVIC protocol and only at 16s during the isokinetic contractions.  There was a main 
effect of time on changes in pH for each of the 3 contraction protocols (p≤0.001).  We 
observed no age×time interaction or main effect of time for changes in [ATP] during the 
MVIC, isokinetic, or isotonic contractions (p≥0.068), indicating the assumption of 
unchanging [ATP] necessary for ATP flux calculations was appropriate in this study 
(20,226).  However, there was a main effect of age on [ATP] during the MVIC (p=0.002) 
and isotonic contractions (p=0.018), but not isokinetic contractions (p=0.144), such that 
[ATP] was higher in older than young muscle. Nonetheless, these differences were small 
(~0.5mM) and [ATP] appeared relatively constant in both groups, suggesting our 
calculations of ATP flux are valid. 
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ATP Flux during the MVIC 
There was a main effect of time (p≤0.001) for changes in ATP flux the creatine 
kinase reaction and oxidative phosphorylation (p≤0.001; Figure 5.4), but no age×time 
interaction and no main effect of age (p≥0.647).  Post-hoc analyses revealed ATP from 
PCr breakdown decreased over the first 12s (p≤0.023), while oxidative ATP flux 
increased over the first 8s (p≤0.026).  There was a main effect of age (p=0.017), but no 
main effect of time and no age×time interaction for the glycolytic ATP flux (p≥0.513).  
Post-hoc analyses revealed greater glycolytic ATP flux in young compared with older 
adults at 20s (p=0.036), but no other time points (p≥0.164). 
 When expressed as a percentage of total ATP flux, we observed no age×time 
interaction (p≥0.413) for the contributions from each bioenergetic pathway (Figure 5.7).  
However, we did observe main effects of time (p≤0.032) for the contribution from each 
bioenergetic pathway.  Post-hoc analyses revealed the contribution from the creatine 
kinase reaction decreased over the first 12 and 16s in older and young adults, respectively 
(p≤0.048).  The ATP contributed by oxidative phosphorylation increased over the first 
12s in young and older adults (p≤0.046).  There was no effect of age (p≥0.103) on the 
contribution to total ATP flux by the creatine kinase reaction nor oxidative 
phosphorylation.  However, a main effect of age was observed for the contribution to 
total ATP flux by non-oxidative glycolysis (p=0.005), and post-hoc analyses revealed a 
greater relative ATP contribution from glycolysis at 20s (p=0.005). 
ATP Flux during the Isokinetic Contractions 
There was a group×time interaction (p=0.021) for changes in ATP flux through 
the creatine kinase reaction (Figure 5.5).  Post-hoc analyses revealed PCr breakdown was 
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lower in young than older adults during the first 4s (p=0.004), but not different between 
groups at any other time points (p≥0.155).  After increasing over the initial 4s in young 
(p=0.001), but not older adults (p=0.152), ATP flux through the creatine kinase reaction 
decreased from 8-16s in both groups (p≤0.016).  There was no main effect of age 
(p=0.892) or time (p=0.062), and no age×time interaction (p=0.150) for changes in 
glycolytic ATP flux.  Lastly, there was a main effect of time (p=0.001), but no main 
effect of age (p=0.579) and no age×time interaction (p=0.994) for changes in oxidative 
ATP flux.  Post-hoc analyses revealed oxidative ATP flux increased over the initial 12s 
in young and older (p≤0.014). 
 When expressed as a percentage of total ATP flux, we observed no age×time 
interaction (p≥0.186) for the contributions from each bioenergetic pathway (Figure 5.7).  
However, there was a main effect of age on the contributions from the creatine kinase 
reaction and oxidative phosphorylation (p≤0.017), but not non-oxidative glycolysis 
(p=0.868).  Post-hoc analyses revealed the contribution to total ATP flux by creatine 
kinase was greater in young compared with older muscle at 16 and 24s (p≤0.01), and the 
contribution from oxidative phosphorylation was lower in young compared with older 
muscle at 24s (p=0.019).  Main effects of time were observed for the contributions from 
each bioenergetic pathway (p≤0.001).  Post-hoc analyses revealed ATP flux through the 
creatine kinase reaction decreased between 8 and 16s (p≤0.002), and 20 and 24s 
(p≤0.012) in both groups.  The ATP contribution from glycolysis fluctuated between ~15 
and 20% in young and older muscle throughout the 24s contraction period.  Oxidative 
contributions to total ATP flux gradually increased over the first 16s in both young and 
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older muscle (p≤0.015), but were not different between successive time points after 16s 
in either group (p≥0.059). 
ATP Flux during the Isotonic Contractions 
There was no age×time interaction (p≥0.792) and no main effect of age (p≥0.641) 
for changes in ATP flux through the creatine kinase reaction, non-oxidative glycolysis, or 
oxidative phosphorylation (Figure 5.6).  However, main effects of time were observed for 
the contributions from each bioenergetic pathway (p≤0.001).  Post-hoc analyses revealed 
PCr breakdown decreased over the first 8 and 12s in older and young adults, respectively 
(p≤0.012).  Glycolytic ATP flux decreased over the first 8s in young and older muscle 
(p≤0.013), while oxidative ATP flux increased over the first 12s in young and older 
muscle (p≤0.041). 
 When expressed as a percentage of total ATP flux, we observed no age×time 
interaction (p≥0.842) nor main effect of age (p≥0.590), but main effects of time 
(p≤0.006) for the contributions from each bioenergetic pathway (Figure 5.7).  Post-hoc 
analyses revealed the contribution to total ATP flux through the creatine kinase reaction 
increase over the first 16s in both groups (p≤0.049).  The contribution of non-oxidative 
glycolysis to total ATP flux fluctuated between ~15 and 20% throughout the 24s 
contraction period in both groups.  Oxidative ATP flux gradually increased over the first 
16s in both groups (p≤0.049). 
Metabolic Economy 
The total ATP flux, ATP cost of contraction, and ME for the MVIC, isokinetic, 
and isotonic contractions are shown in Figure 5.8.  Total ATP flux, ATP cost of 
contraction, and ME were not different between groups during the MVIC (p≥0.095).  
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Although the total ATP flux was not different between groups during the isokinetic or 
isotonic contractions (p≥0.827), the ATP cost of contraction, and ME were greater in 
young compared with older muscle during both dynamic contraction protocols (p≤0.031). 
Discussion 
 This study was designed to evaluate age-related differences in muscle ME during 
24s of maximal isometric, isokinetic, and isotonic contractions.  We hypothesized that 
ME would be: 1) lower in young compared with older adults during a 24-s MVIC, 2) 
similar between age groups during 24s of isokinetic contractions at 120°.s-1, and 3) 
greater in young compared with older adults during 24s of isotonic contractions against a 
load equivalent to 20% MVIC.  These hypotheses were based on previous observations of 
greater, similar, and less fatigue in young compared with older muscle in response to 
isometric (28,35,60,114,130), moderate-velocity (23,24,49,147), and high-velocity 
contractions (24,48,49,159,222,223), respectively.  Our data do not support our first 
hypothesis as we observed no age-related differences in muscle ME during the 24-s 
MVIC.  Similarly, our data do not support our second hypothesis; we observed greater 
muscle ME in young compared with older muscle during the isokinetic contractions.  
However, our data support our third hypothesis; muscle ME was greater in young 
compared with older adults during the isotonic contractions.  These results extend 
previous working examining age-related differences in muscle ME in the dorsiflexors 
(31), and ATP cost of contraction in the plantar flexors and knee extensors (136-139).  
Our results suggest that the source of age-related differences in muscle ME may arise 
from the increased energy demand, as a result of the intermittent nature of force 




Peak contractile CSA and volume were greater in young compared with older 
muscle (Table 5.2), consistent with the majority of the literature in this area (24,90,231).  
However, we observed no age-related differences in fat fraction, which is in disagreement 
with some studies which demonstrate an increase in intramuscular lipid with age (24,90).  
The cause of this discrepancy is not clear at this time, but might be due to the amount of 
moderate-to-vigorous physical activity of the older adults in the present study (Table 5.1). 
At baseline, maximal isometric torque was ~30% greater in young compared with 
older adults (Table 5.2), which is consistent with previous work (3,23,24).  No age-
related differences in specific torque (i.e., maximal isometric torque normalized to 
contractile volume) were observed, consistent with previous work (24,113).  Peak power 
during the isokinetic and isotonic contractions were ~55 and ~70% greater in young 
compared with older adults (Table 5.2).  The magnitude of these age-related decrements 
in peak power are considerably larger than has been reported elsewhere in the knee 
extensors (23,24).  The cause of the discrepancy between previous studies and our current 
results is likely due to the larger range of motion possible with a full-sized dynamometer 
compared with that inside the MR environment (70 vs. 30° range of motion) and the 
leftward shift in the torque-velocity relationship with aging (24).  Indeed, the time to 
target velocity is longer in older than young adults during isokinetic contractions (132); a 
smaller range of motion would reduce the time available to reach target velocity and 
likely exacerbate age-related differences in the torque produced at a given velocity.  
Therefore, one would expect the torque produced at a given velocity to be lower in older 
than young adults, and for this to be exacerbated with a smaller range of motion.  Age-
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related differences in peak power during the isokinetic and isotonic contractions were still 
observed after normalizing to contractile volume.  The latter observation indicates that 
the decline in muscular power with age is not exclusively due to the age-related loss of 
muscle mass. 
A systematic review and meta-analysis of the available literature in 2016 revealed 
oxidative capacity is higher in the knee extensor muscles of young compared with older 
adults (73).  In contrast, we observed no difference in the rate constant (kPCr) of PCr 
recovery between groups (Table 5.2).  This observation is consistent with some more 
recent reports of age-related differences in knee extensor oxidative capacity (83,223).  
The reasons for the lack of differences observed in muscle oxidative capacity here are not 
currently clear, but are likely not due to the age of the older adults or group differences in 
physical activity.  Larsen et al. observed higher oxidative capacity of the knee extensors 
in young compared with older adults matched for physical activity (133).  Moreover, the 
age of the participants in Larsen et al. closely matches the age of the groups in the current 
study and participants in the present study were well matched for physical activity (Table 
5.1).  Understanding the participant characteristics that lead to reduced muscle oxidative 
capacity with age requires further study. 
ATP Flux 
Resting [PCr] and pH were not different between groups for the 3 conditions 
(Figures 5.4, 5.5, and 5.6), indicating a similar intracellular milieu was present in young 
and older muscle prior to each contraction protocol, as has been reported previously 
(133,136,223).  [PCr] at the end of each 24s contraction protocol was also similar 
between young and older muscle.  However, pH at the end of the 24-s MVIC was lower 
142 
 
in young compared with older adults (Figure 5.3).  This observation is consistent with 
previous work where young muscle acidified to a greater extent than older muscle during 
a sustained isometric contraction (114,136).  Despite this, no age-related differences were 
observed in pH at the end of either dynamic protocol, which may be, at least in part, due 
to the relatively brief nature of the contraction protocols in the present study because 
young muscle has been shown to acidify less than older muscle during high-velocity 
dynamic contractions to fatigue (223). 
With the exception of the first 4s during the isokinetic contractions, we observed 
no age-related differences in the absolute or normalized contribution to ATP flux from 
the creatine kinase reaction (Figures 5.4, 5.5, 5.6, and 5.7).  This observation is consistent 
with previous reports during isometric contractions in the tibialis anterior (31,128,130), 
plantar flexors (137), and knee extensors (136).  These results indicate that PCr 
breakdown is able to meet the immediate energy demands in young and older muscle 
and, given that resting [PCr] was similar between groups for all conditions, suggests that 
creatine kinase activity is unchanged with age. 
Some studies have demonstrated a decline in the activities of lactate 
dehydrogenase (102,135,182) and hexokinase (182) with age.  These observations would 
suggest there is an age-related decline in the capacity for non-oxidative glycolysis.  
However, these observations may be muscle-specific, as enzyme activity of lactate 
dehydrogenase and hexokinase were greater in the rectus abdominus but not the vastus 
lateralis or gluteus maximus muscles of young compared with older adults (182).  To 
determine if there is an age-related impairment in non-oxidative glycolysis in vivo, Lanza 
et al. used 31P-MRS to determine the rate of non-oxidative glycolysis in young and older 
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men during a 60-s MVIC of the ankle dorsiflexors (128).  The authors observed a faster 
rate of non-oxidative glycolysis in the young compared with older men, consistent with a 
difference in the use of this bioenergetic pathway with age.  To determine if the lower 
rate of non-oxidative glycolysis in older muscle was due to an impairment in this 
pathway, Lanza et al. performed a similar experiment with and without blood flow to the 
ankle dorsiflexors (130).  The results confirmed the previous finding of faster rates of 
non-oxidative glycolysis in young compared with older muscle when blood flow was 
intact.  However, during ischemia the rate of non-oxidative glycolysis increased in older 
muscle, such that it was similar in young and older muscle.  Together, these studies 
suggest that there is no age-related impairment in non-oxidative glycolysis, although 
whether these findings in the ankle dorsiflexors can be generalized to other muscle 
groups is not clear.  In the present study, we only observed a greater glycolytic ATP flux 
in young compared with older muscle after 20s of the MVIC protocol, but no differences 
during either dynamic protocol (Figures 5.4, 5.5, 5.6, and 5.7).  These findings suggest 
there is no age-related impairment in non-oxidative glycolysis with age. 
Activity of citrate synthase, a classic marker of mitochondrial bioenergetic 
capacity, has been observed to be greater in young compared with older muscle 
(69,92,182), suggesting the capacity for ATP production via oxidative phosphorylation 
declines with age.  Measures of state III respiration (i.e., maximally stimulated 
respiration) and ATP production in isolated mitochondria (64,186) have supported this 
notion.  However, caution is urged when interpreting some of these findings as age-
related differences in state III respiration have been shown to be exacerbated when 
isolated mitochondria rather than muscle bundles are examined (186,187).  In order to 
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study the intact system, 31P-MRS has been used to measure the PCr recovery kinetics and 
infer the oxidative capacity (6,161,162).  Our systematic review and meta-analysis 
revealed muscle-specific age-related changes in muscle oxidative capacity, such that it is 
higher in the knee extensors, unchanged in the plantar flexors and elbow flexors, and 
lower in the dorsiflexors of young compared with older adults (73).  However, the present 
data did not support this observation as oxidative capacity was not different between 
young and older adults (Table 5.2).  Further, we observed no age-related differences in 
the rate of oxidative phosphorylation during the MVIC or isotonic contractions, and the 
oxidative ATP contribution was only different between groups at 24s during the 
isokinetic contractions.  These observations suggest there is no age-related impairment in 
oxidative ATP production during isometric nor dynamic contractions of the knee 
extensors. 
Metabolic Economy 
In contrast to our hypothesis, TTI, total ATP flux, ATP cost of contraction, and 
ME during the MVIC were not different between young and older adults (p>0.05; 
Figures 5.3 and 5.8).  Although we hypothesized ME would be similar between groups 
during the isokinetic contractions, PTI, ATP cost of contraction, and ME were higher in 
young compared with older muscle (p≤0.003; Figures 5.3 and 5.8), despite no difference 
in total ATP flux between groups (p=0.827; Figure 5.8).  Consistent with our hypothesis, 
PTI, ATP cost of contraction, and ME during the isotonic contractions were higher in 
young compared with older muscle (p≤0.031; Figures 5.3 and 5.8). Notably, the total 
ATP flux during the isotonic contractions was not different between groups (p=0.861; 
Figure 5.8).  
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Previous work has shown the energetic cost of dynamic contractions is greater 
than isometric contractions (205), an observation due at least in part to the ATP cost of 
generating force being higher than maintaining force (202).  In a preparation of canine 
gastrocnemius muscle, Hogan et al. reported greater estimates of ATP utilization rate in 
contractions of short (0.25s) compared with long (1s) duration (89).  Using an in vivo 
approach, some authors have reported lower (130) or similar (31) ME in young compared 
with older muscle during sustained MVICs of the ankle dorsiflexors.  Layec et al. 
observed no age-related differences in the ATP cost of contraction of the knee extensors 
during a sustained 24-s MVIC (136).  However, during intermittent MVICs of the knee 
extensors, the ATP consumed per unit power was lower in young compared with older 
adults (136), suggesting there is an age-related increase in the cost of developing, but not 
maintaining force.  Our observation of similar ME between young and older adults during 
the MVIC, but not during either bout of dynamic contractions, is consistent with these 
previous observations. 
Only a few studies have examined age-related differences in the ATP cost of 
dynamic contractions (31,136-139).  Layec et al. reported the ATP consumed per unit 
power during contractions of the plantar flexors at 40% of each participant’s maximal 
work rate to be lower in young compared with older muscle (139).  Similarly, during 
plantar flexion at 120% of maximal aerobic power the ATP consumed per unit power was 
lower in young compared with older muscle (137).  Further, in rat diaphragm muscle 
ATP consumption by myosin ATPase has been shown to be ~3x greater when myofibers 
are contracting at 33% maximal shortening velocity compared with an isometric 
contraction (209).  Collectively these observations suggest ME during dynamic 
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contractions might decline with age.  Our results support this suggestion as ME was 
greater in young compared with older adults during both the isokinetic and isotonic 
contraction protocols. 
An age-related shift in fiber-type is unlikely to account for our results.  Although 
type I muscle fibers are more economical than type II fibers (80,85), if there was a shift 
toward a slower muscle phenotype with age then older muscle would presumably be 
more economical than young muscle under various conditions.  Further, whether muscle 
fiber composition changes with age is not currently clear; shifts toward a slower 
phenotype (141-143), faster phenotype (75), and no change in fiber type with age (164) 
have been reported.  Part of this discrepancy may be due to the method used to determine 
muscle fiber composition (see (193) for review).  Another possible explanation for this 
discrepancy is the age and physical activity levels of the older adults studied.  For 
example, there is growing evidence that recurrent cycles of denervation and reinnervation 
result in myofiber co-expression (200), and the capacity to reinnervate those myofibers is 
greater in octogenarian master athletes than in pre-frail/frail older women (214). 
Considering our observations of age-related differences in the ATP cost of 
contraction and ME across 3 different contraction modes, and those of prior 
investigations (31,136-139), there may be an age-related increase in the energetic cost of 
generating, but not maintaining, force.  This idea has been suggested before (136), but 
that study did not match the total TTI between sustained and intermittent isometric 
contractions.  Therefore, this hypothesis has not yet been directly tested.  Nonetheless, an 
age-related increase in the energetic cost of generating, but not maintaining, force could 
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explain why ME is often observed to be greater in young compared with older adults 
during intermittent isometric and dynamic, but not sustained isometric contractions. 
The cause of an age-related increase in the cost of generating force is not clear at 
this time.  Notably, where age-related differences in ME were observed in the present 
study the total ATP flux was not different between groups (Figure 5.8) but the work 
done, as measured by the PTI, was greater in young than older adults (Figure 5.3).  A 
similar observation has been made in rat muscle, where maximal force production was 
greater in young than older animals despite no differences in myosin ATPase activity 
with age (148).  Further, those authors noted the apparent rate constant for strongly-
bound myosin’s dissociation from actin was ~30% lower in young compared with older 
muscle, consistent with a greater flux of myosin from the strong- to weakly-bound state 
during an isometric contraction.  Conversely, work in single human muscle fibers has 
shown slower crossbridge kinetics, characterized by a longer myosin-actin attachment 
time, in older compared with young muscle (164). Thus, whether a faster dissociation 
from a strong- to weakly-bound state in older muscle is exacerbated during dynamic 
contractions is unclear at this time, but might explain the current results. 
Another potential explanation for the greater ME of young compared with older 
muscle during dynamic, but not isometric, contractions is a decline in the series elasticity 
of the muscle-tendon unit with age.  With a more compliant muscle-tendon unit, power- 
or torque-amplification is lower (198).  During short, rapid contractions such as the 
dynamic contractions performed in the present study, power-amplification would likely 
be exacerbated by a less stiff muscle-tendon unit.  However, during a sustained isometric 
contraction, the elasticity of the muscle-tendon unit is largely irrelevant to the 
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maintenance of torque as the muscle is operating on the steep part of the force-extension 
relationship.  Although the evidence for greater muscle-tendon unit stiffness in young 
compared with older adults is equivocal (84,125,150,217,219), computer simulations 
using physiologically-relevant modeling parameters from young and older rat muscle 
demonstrated a compromised ability of older muscle-tendon units to store elastic energy 
and produce positive work (52).  Therefore, evaluating the effects of old age on the 
relationship between in vivo muscle ME and muscle-tendon unit stiffness is worthy of 
further investigation.   
Another avenue worthy of further investigation is determining the relative 
contributions from each site of ATP consumption during different contraction modes.  
Approximately 30-50% of the total ATP cost of contraction is associated with the Na2+-
K+ and Ca2+ ATPases; the majority of which is attributed to SERCA pump activity (8).  
The remaining 50-70% is consumed by myosin ATPase in the crossbridge cycle (8).  
However, these percentages may change during different contraction modes; a premise 
that has been used to examine age-related differences in ATP cost from ion pumping and 
crossbridge cycling (136), but is not yet clear.   
Conclusion 
This study adds important new information regarding the conditions under which 
age-related differences in ME are present.  We have shown that ME is similar in young 
and older muscle during a sustained MVIC, but greater in young than older muscle 
during isokinetic and isotonic contractions at 2 distinct velocities.  Our observations, 
along with those of previous investigations (136), suggest there is an age-related increase 
in the energetic cost of developing, but not maintaining, force.  Because activities of daily 
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living largely require dynamic contractions, these results may be important for 
understanding the increase in mobility-disability with advanced age. 
 
Table 5.1. Group characteristics 
 Young (n=10) Older (n=10) 95% CI P 
Age (yrs) 27.5 ± 1.2 71.2 ± 1.6 - - 
Height (m) 1.69 ± 0.03 1.64 ± 0.03 -0.46, 0.15 0.286 
Body mass (kg) 75.3 ± 4.4 67.8 ± 3.9 -4.91, 19.87 0.221 
BMI (kg.m-2) 26.0 ± 0.9 24.9 ± 0.7 -1.27, 3.45 0.344 
PA (counts.d-1000) 238.7 ± 32.3 238.6 ± 31.5 -94.65, 94.73 0.999 
MVPA (min.d-1) 38.3 ± 5.6 27.2 ± 7.4 -8.39, 30.55 0.247 
Chair rise time (s) 16.1 ± 1.3 19.7 ± 1.6 -7.85, 0.81 0.105 
TUG (s) 9.0 ± 0.5 9.5 ± 0.3 -1.70, 0.53 0.280 
SPPB-A 2.82 ± 0.09 2.57 ± 0.09 -0.02, 0.12 0.067 
Values are mean±SE. 95% CI, 95 % confidence intervals for the difference between group 
means; BMI, body mass index; PA, physical activity; MVPA, moderate- to vigorous-intensity 
physical activity; TUG, timed up-and-go; SPPB-A, advanced short physical performance 
battery. 
 
Table 5.2. Muscle characteristics 
 Young (n=10) Older (n=10) 95% CI P 
Muscle morphology 
Peak contractile CSA (cm2) 68.7 ± 5.7 51.2 ± 4.1 2.6, 32.2 0.023 
Contractile volume (cm3) 1125.6 ± 109.9 803.5 ± 72.3 45.7, 598.4 0.025 
Fat Fraction (%) 8.4 ± 0.3 8.8 ± 1.1 -2.2, 0.8 0.340 
Femur length analyzed (%) 46.1 ± 1.5 45.0 ± 1.8 -3.9, 6.1 0.651 
Peak torque and power 
MVIC (Nm) 252.0 ± 20.4 187.9 ± 19.9 4.2, 124.1 0.037 
MVDCIsoK (Nm) 113.3 ± 14.2 66.0 ± 9.7 11.4, 83.4 0.013 
MVDCIsoK (W) 238.5 ± 30.5 133.5 ± 19.6 28.7, 181.3 0.010 
MVDCIsoT (W) 367.7 ± 42.8 178.1 ± 26.7 29.4, 96.8 0.002 
MVDCIsoT (deg/s) 266.2 ± 6.0 203.1 ± 14.3 82.1, 297.6 0.002 
Specific torque and power 
MVIC (Nm/cm3) 0.232 ± 0.02 0.232 ± 0.01 -0.04, 0.4 0.826 
MVDCIsoK (W/cm3) 0.218 ± 0.02 0.161 ± 0.01 0.004, 0.1 0.037 
MVDCIsoT (W/cm3) 0.328 ± 0.02 0.219 ± 0.02 0.04, 0.2 0.004 
Muscle oxidative capacity 
kPCr (s-1) 0.021 ± 0.001 0.022 ± 0.001 -0.01, 0.01 0.632 
Values are mean±SE. 95% CI, 95 % confidence intervals for the difference between group 
means; MVIC, maximal voluntary isometric contraction; MVDCIsoK, maximal voluntary 
isokinetic contraction at 120°.s-1; MVDCIsoT, maximal voluntary isotonic contraction at 20% 






Figure 5.1. Representative torque and velocity traces from each protocols.  Torque for the 24-s 
MVIC (A), and torque and velocity traces for the isokinetic (B) and isotonic contractions (C). 
One 24-s MVIC was performed with a target torque of 100% MVIC (dotted line). A total of 12 
isokinetic contractions were performed at 120°.s-1 over a 24-s period (IsoK; note that target 
velocity, shown by the dotted line, was attained in each contraction). A total of 12 isotonic 
contractions were performed at a load equivalent to 20% MVIC over a 24-s period (MVDC20%; 
target torque is shown by the dotted line). Representative data are from 1 young man. The shaded 




Figure 5.2. Quantitation of in vivo muscle mitochondrial capacity using 31-phosphorus magnetic 
resonance spectroscopy.  Spectrum at rest illustrates metabolites of interest in human quadriceps 
muscle (A); stack plot shows changes in PCr and Pi during 24-s of isokinetic contractions at 
120°.s-1 followed by 10-min recovery (B); mono-exponential fit of PCr recovery which yields the 
rate constant for PCr recovery (kPCr) reflecting the oxidative capacity of the muscle (C). 




Figure 5.3. Torque- and power-time integrals during the 24-s isometric, isokinetic, and isotonic 
contractions. TTI, torque-time integral; PTI, power-time integral; MVIC, maximal voluntary 
isometric contraction; IsoK, maximal voluntary isokinetic contractions; IsoT, maximal voluntary 





Figure 5.4. Changes in metabolites and rates of ATP flux during the 24-s MVIC.  ATPCK, ATP 
flux through creatine kinase; ATPGLY, ATP flux through non-oxidative glycolysis; ATPOX, ATP 




Figure 5.5. Changes in metabolites and rates of ATP flux during the isokinetic contractions. 
ATPCK, ATP flux through creatine kinase; ATPGLY, ATP flux through non-oxidative glycolysis; 




Figure 5.6. Changes in metabolites and rates of ATP flux during the isotonic contractions. 
ATPCK, ATP flux through creatine kinase; ATPGLY, ATP flux through non-oxidative glycolysis; 




Figure 5.7. Relative contributions from each bioenergetic pathway to total ATP flux throughout 
the isometric, isokinetic, and isotonic contractions.  MVIC, maximal voluntary isometric 
contraction; IsoK, maximal voluntary isokinetic contractions; IsoT, maximal voluntary isotonic 
contractions.  ATPCK, ATP flux through creatine kinase; ATPGLY, ATP flux through non-oxidative 




Figure 5.8. Total ATP flux, ATP cost of contraction, and metabolic economy during the 24-s 
MVIC, isokinetic, and isotonic contractions.  ME, metabolic economy; MVIC, maximal voluntary 
isometric contraction; IsoK, maximal voluntary isokinetic contractions; IsoT, maximal voluntary 





The goals of this dissertation were to elucidate if there is a bioenergetic basis for 
the age-related differences in muscle fatigue that might be, at least in part, explained by a 
lower metabolic economy in older than young adults during high-velocity contractions.  
Previous work has shown that fatigue is: a) greater in young than older adults in response 
to maximal isometric contractions (28,35,60,114,130), b) similar between age groups in 
response to contractions at intermediate velocities (23,24,49,147), and c) lesser in young 
than older adults in response to maximal contractions at high velocities 
(24,48,49,159,222,223).  Although the cause of age-related differences in muscle fatigue 
in response to maximal isometric contractions appears to be related to a greater [Pi] and 
[H2PO4-], and lower pH in young compared with older muscle (114,128), the mechanisms 
for the lesser muscle fatigue in young compared with older muscle in response to high-
velocity contractions are not clear.  Additionally, the physiological basis for the similar 
fatigue in young and older muscle in response to moderate-velocity contractions is not 
yet established.  Nonetheless, because activities of daily living, such as climbing stairs or 
walking, require repeated dynamic contractions (184), the ability to resist muscle fatigue 
may be especially important for older adults in order to maintain their quality of life 
(227).  Therefore, there is a desire to understand the cause of age-related differences in 
muscle fatigue and develop strategies to resist it and maintain independence into old age.  
Together, the studies presented in this dissertation provide novel insight into the impact 
of old age on muscle fatigue, metabolic economy, and bioenergetics in vivo. 
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Study 1 (Chapter 4) examined the potential bioenergetic mechanisms for age-
related differences in muscle fatigue during dynamic contractions of the knee extensors.  
A summary of the age-related differences at baseline and in response to each bout of 
fatiguing contractions observed in Study 1 are shown in Table 6.1.  We observed lower 
muscular power production during isotonic contractions against a load equivalent to 20% 
MVIC (MVDC20%) and isokinetic contractions at 120°.s-1 (MVDC120) in older compared 
with young adults at baseline.  In contrast with our hypothesis (H 1a), in vivo oxidative 
capacity was similar in young and older knee extensor muscles, demonstrating the 
capacity for oxidative ATP production was similar between groups in this dissertation.  
Although this finding is in disagreement with the majority of studies that have evaluated 
the effects of old age on oxidative capacity of the knee extensors (73), a recent study 
observed the same result (223).  We expected to observe less fatigue in young compared 
with older adults in response to the MVDC20% protocol, which we hypothesized would be 
accompanied by lower [Pi], [H+], and [H2PO4-] in the young than older muscle (H 1b).  In 
contrast with this, we observed an almost identical decline in the power-time integral (% 
initial) and similar [Pi] between groups in response to the MVDC20%.  However, [H2PO4-] 
was higher, and pH lower, in young compared with older muscle towards the end of this 
protocol.  In concert with this, glycolytic ATP flux was higher in young than older 
muscle during the first 2 min of the MVDC20% protocol, and Vi[PCr] (a measure of 
oxidative ATP production) did not change with fatigue in young but increased in older 
muscle.  Collectively, this indicates glycolytic and oxidative ATP production is lower and 
higher, respectively, in older than young muscle.  The accumulation of protons, and Pi, 
during fatiguing contractions is well known to inhibit force production at the crossbridges 
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(57-59,123,225,239).  The observation of similar fatigue and [Pi], but lower pH, in young 
compared with older muscle suggests that the contractile machinery may be more 
sensitive to changes in pH in older compared with young muscle in vivo.  Although this 
suggestion is in contrast with a recent report that observed no effect of old age on single 
fiber sensitivity to [Pi] and [H+] (221), that experiment was performed under maximally 
activated conditions (i.e., saturating [Ca2+]).  Whether there are age-related differences in 
single fiber sensitivity to the inhibitory effects of high [Pi] and [H+] at submaximal [Ca2+] 
is yet to be established, but is worthy of further investigation. 
We expected to observe no age-related differences in fatigue and similar [Pi], 
[H+], and [H2PO4-] between groups in response to the MVDC120 protocol (H 1c).  Our 
results did not support this hypothesis; fatigue (% initial PTI) was greater in young than 
older muscle.  The greater fatigue in young muscle was accompanied by higher [Pi] and 
[H2PO4-], as well as a lower pH compared with older muscle.  Although others have 
observed no age-related differences in muscle fatigue of the knee extensors in response to 
isokinetic contractions at 120°.s-1 (23), the range of motion in those studies was 70° 
whereas it was 30° in this study.  We observed that torque production, relative to MVIC, 
was markedly lower in older than young adults over 30° compared with what might be 
expected over a 70° range of motion.  This suggests that the torque-velocity relationship 
shifts further left in older than young when contractions are performed over a 30 vs. 70° 
range of motion.  However, this requires further investigation.  Nonetheless, given the 
well-established effects of high [Pi] and [H+] on force production at the molecular level 
(57-59,123,225,239), the age-related difference in fatigue observed in response to the 
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MVDC120 protocol can likely be attributed to the greater metabolic perturbation observed 
in the young muscle.   
We expected oxidative ATP production to be lower in older than young muscle 
during the MVDC20%, but similar between groups during the MVDC120 protocol.  In 
contrast with this hypothesis, we observed no group differences in Vi[PCr] at baseline nor 
the end of the fatigue protocols.  However, we did find no change in oxidative ATP 
production from baseline to post-fatigue in the young, but an increase in Vi[PCr] in the 
older group.  The latter observation suggests fatigue did not impair Vi[PCr] in older muscle 
and supports previous reports of a preponderance for oxidative ATP production in older 
compared with young muscle (128,130). 
We were also unable to test our exploratory hypotheses, where we expected 
muscle-tendon unit stiffness to be greater in young than older adults (EH 1a) and 
positively associated with fatigue during the MVDC20% (EH 1b).  Although these data 
were collected, we were unable to analyze them due, at least in part, to issues with the 
tracking algorithm used to quantify extension of the force-Δlength relationship. 
Collectively, in Study 1, we observed similar fatigue between groups in response 
to the MVDC20%, and greater fatigue in young than older adults in response to the 
MVDC120 protocol.  During the MVDC20% protocol, [Pi] was similar in young and older 
muscle, but [H2PO4-] was greater and pH lower in young than older muscle.  These data 
suggest that the contractile machinery may be more sensitive to changes in pH in older 
compared with young muscle.  During the MVDC120 protocol, [Pi] and [H2PO4-] were 
higher and pH lower in young compared with older muscle.  These data provide a 
bioenergetic basis for the greater fatigue we observed under this condition.  Thus, the 
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results reported in this dissertation may be explained by age-related changes in myofiber 
sensitivity to metabolites known to inhibit force production by the crossbridges (i.e., [Pi], 
[H2PO4-], and [H+]). 
Study 2 (Chapter 5) evaluated age-related differences in muscle metabolic 
economy during isometric, isokinetic, and isotonic contractions of the knee extensors.  To 
date, I am aware of only one study that has examined in vivo muscle metabolic economy 
(31).  Thus, whether age-related differences in metabolic economy depend upon the 
metabolic demand was unclear.  A summary of the age-related differences in the torque- 
and power-time integral, contribution from each bioenergetic pathway, ATP cost, and 
muscle metabolic economy from the three contraction modes in Study 2 are shown in 
Table 6.2.   
The first hypothesis for Study 2 (H 2a) was not supported; metabolic economy 
during a 24-s maximal isometric contraction was similar in young and older adults.  In 
contrast with our second hypothesis (H 2b), but in support of our third hypothesis (H 2c), 
metabolic economy was higher in young than older muscle during both dynamic 
contraction modes in Study 2.  Integrating these results with previous literature on in vivo 
muscle metabolic economy (31) and ATP cost of contraction (136), we postulate that 
age-related differences in metabolic economy are not due to contraction mode per se, but 
are likely due to an increased cost of force production, but not maintenance, with age.  
This postulation is supported by prior work showing a higher ATP cost of contraction in 
older than young knee extensor muscles during brief intermittent versus a sustained 
isometric contraction (136).  Thus, there may be an age-related increase the cost of 
generating, but not maintaining, force.  Although the cause of an age-related increase in 
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the cost of generating force is not clear at this time, where age-related differences in 
metabolic economy were observed in Study 2 the total ATP turnover was not different 
between groups but the work done, as measured by the PTI, was greater in young than 
older adults.  A similar observation has been made in rat muscle, where maximal force 
production was greater in young than older animals despite no differences in myosin 
ATPase activity with age (148).  Further, those authors noted the apparent rate constant 
for strongly-bound myosin’s dissociation from actin was ~30% lower in young compared 
with older muscle, consistent with a greater flux of myosin from the strong- to weakly-
bound state during an isometric contraction.  Conversely, work in single human muscle 
fibers has shown slower crossbridge kinetics, characterized by a longer myosin-actin 
attachment time, in older compared with young muscle (164). Therefore, the interplay 
between crossbridge kinetics, force production, and metabolic economy with age requires 
further investigation to try and elucidate the molecular mechanism for an age-related 
decline in in vivo muscle metabolic economy during dynamic, but not isometric, 
contractions. 
Significance 
This dissertation addressed the potential bioenergetic mechanisms for the age-
related differences in fatigue, and the effect of old age on in vivo muscle metabolic 
economy during 3 distinct bouts of knee extensor contractions.  Although a systematic 
review and meta-analysis of the available literature in 2016 demonstrated the capacity for 
oxidative ATP production is impaired in the knee extensors of older compared with 
young adults (73), we observed similar oxidative capacity in young and older muscle in 
this dissertation.  This is an important observation because mitochondrial energetics are 
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closely associated (r2=0.647) with preferred walking speed, a measure of mobility, in 
older adults (38), suggesting the mitochondria play an important role in gait speed.  
Another novel finding of this dissertation was the lack of age-related differences in 
fatigue of the knee extensors in response to the MVDC20% protocol.  Notably, we 
observed a greater [H2PO4-] and lower pH in young compared with older muscle during 
that fatiguing task.  These observations suggest that the contractile machinery may be 
more sensitive to changes in pH in older compared with young muscle in vivo.  This 
extends previous research and, if true, may offer a translatable explanation for age-related 
differences in muscle fatigue during other contraction protocols.  Another new finding 
from Study 1 is the ~25% decline in [ATP] in young and older muscle during dynamic 
contractions to fatigue, which suggests that the energetic demand outweighs its supply 
during these contractions.  Notably, [ATP] did not fully recover after 10 min.  During 
both bouts of fatiguing contractions, we also observed significant increases in the 
concentration of phosphomonoesters (PME in both groups; PME generally increases 
during intense contractions due to an accumulation of sugar phosphates (e.g., glucose-6-
phosphate, inosine monophosphate) (12).  However, the decline in [ATP] likely 
contributed to the increase in [PME] during these contractions because adenine 
nucleotide breakdown results in the formation of inosine monophosphate (163), which 
contributes to the PME pool in the 31P spectrum. 
Study 2 of this dissertation confirmed previous observations where no age-related 
differences in the in vivo muscle metabolic economy were observed during a maximal 
isometric contraction (31).  A novel finding of this dissertation was that in vivo muscle 
metabolic economy was higher in young compared with older muscle during dynamic 
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contractions, regardless of the power output.  Together, these observations suggest that 
the cost of generating, but not maintaining force, is lower in young than older muscle.  
Older adults should be aware of this lower metabolic economy during dynamic 
contractions as it could affect their ability to sustain activities of daily living that require 
repeated dynamic contractions.  However, all of the contractions performed in this study 
were maximal.  Activities of daily living are likely performed at submaximal intensities, 
so future research should attempt to address this gap by evaluating age-related differences 
in muscle metabolic economy of large locomotor muscles, such as the knee extensors, 
during submaximal dynamic contractions to provide a more generalizable context for the 
observations in this dissertation.  Such experiments may provide a bioenergetic basis for 
the greater energy cost of walking in older compared with young adults (76).  
Future Directions 
 This dissertation provides novel information about the bioenergetic mechanisms 
for age-related differences in muscle fatigue during two bouts of contractions with 
different loads, and the effects of old age on in vivo muscle metabolic economy.  A recent 
study observed similar myofiber sensitivity to high [Pi] and [H+] in young and older men 
(221), which is inconsistent with our findings in Study 1.  One possible reason for this 
discrepancy is that the previous study was performed at saturating [Ca2+]; conditions 
which are likely not present during fatigue in vivo (140,236).  Therefore, the effects of 
high [Pi] and [H+] on single-fiber force and power production should be evaluated in 
young and older muscle at submaximal [Ca2+].  This would help elucidate the effects of 
high concentrations of these metabolites on single-fiber force and power production in 
conditions that are more physiologically relevant during fatigue. 
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Additionally, our results in Study 1 are in contrast with a recent report that used a 
similar fatiguing protocol, within the MR environment, to ours (223).  Because the cause 
of this discrepancy is not clear, further work is needed to help clarify the mechanisms 
responsible for age-related differences in muscle fatigue.  The absolute velocity of 
contractions during the MVDC20% were markedly lower in older adults than reports 
where age-related differences in muscle fatigue have been observed (24,48,49,222), and 
this likely explains a large portion of the discrepancy between studies.  To help interpret 
the results of future studies, researchers should evaluate whether the lower range of 
motion affects the torque-velocity and power-load relationships to a lesser extent in 
young than older adults.  Indeed, evaluating the role of bioenergetics on age-related 
differences in muscle fatigue while controlling for the effects of old age on the torque-
velocity and power-load relationships may prove fruitful in interpreting these results and 
extend our results to explain why older adults are resistant to fatigue during isometric 
contractions (28,35,60,114,130), experience similar fatigue to young adults during 
moderate-velocity contractions (23,24,49,147), and fatigue more than young adults 
during high-velocity contractions (24,48,49,159,222,223).  Although aging is associated 
with mitochondrial dysfunction and reduced in vivo muscle oxidative capacity 
(73,185,186), we observed relatively greater oxidative ATP production at the end of both 
bouts of fatiguing contractions in older than young muscle.  The mechanism responsible 
for this is unclear and warrants further investigation.  
In Study 2, we confirmed previous observations of a greater glycolytic ATP flux 
in young compared with older muscle during a sustained isometric contraction (128,130).  
However, we also observed similar glycolytic ATP flux in young and older muscle 
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during 24 s of isokinetic and isotonic contractions.  The mechanism for the greater 
glycolytic ATP flux in young compared with older muscle during isometric contractions 
does not appear to be due to blood flow (130), and is worthy of further investigation.  
In Studies 1 and 2 we evaluated age-related differences in muscle fatigue and 
metabolic economy in vivo by comparing young and older adults matched for physical 
activity.  However, relatively little is known about these variables in middle-aged adults.  
Because we found marked differences in in vivo muscle metabolic economy, and the 
trajectory of these changes with age are unknown, future studies should quantify 
metabolic economy across the lifespan so that researchers can begin to understand how 
these variables change with age.  Such studies would help elucidate when in the lifespan 
metabolic economy begins to decline.  Additionally, including participants who are 
physically active and sedentary would help clarify if an active lifestyle can prevent or 
slow the decline in metabolic economy with age. 
All of the participants in these studies were relatively healthy, with no mobility 
impairments.  To date, only one study has evaluated muscle metabolic economy in vivo in 
older adults with mobility impairments (31).  In that study, metabolic economy was lower 
in older, mobility-impaired compared with older and young adults during submaximal, 
but not maximal isometric contractions.  In Study 2, we also observed no age-related 
differences in metabolic economy of the knee extensor muscles during a 24 s maximal 
isometric contraction.  Whether muscle metabolic economy is lower in older, mobility-
impaired compared with older adults during dynamic contractions is not clear at this time 
and warrants investigation.  Indeed, this may help elucidate a mechanism to explain why 
older adults with mobility impairments have a slower gait speed than healthy older adults. 
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The goal of this dissertation was to evaluate the potential bioenergetic mechanisms of 
age-related differences in muscle fatigue.  Our data indicate that maximal dynamic 
contractions are more energetically costly for older adults even when the muscular power 
is normalized to the muscle volume.  Older adults should be cognisant of this if they are 
performing maximal effort work and, when necessary, consider taking more breaks than 
their younger counterparts.  The greater energetic cost of dynamic contractions may 
result in impaired force and power production if the activity is long enough.  This could 
ultimately lead to an increased risk of falls in older adults.  Identifying the molecular 
mechanisms responsible for the age-related differences in metabolic economy during 
maximal dynamic contractions in vivo may help elucidate potential targets to counteract 
this decline in old age.  Such experiments might lead to the development of training 
protocols to reduce the lower metabolic economy of dynamic contractions with age, 
which may help minimize the risk of falls in older adults.  A combination of behavioural 
modifications (e.g., taking breaks when necessary) and training, or pharmaceutical, 
interventions may lead to an improved healthspan and quality of life in older adults, 
prevent some of the detrimental health outcomes that occur as a result of falls, and 




Table 6.1. Summary of the results from Study 1 
 Baseline MVDC20% MVDC120 
Y vs. O Y vs. O Y vs. O 
Ergometer measurements 
PTI (% initial)  ↔ ↑O 
Metabolic variables 
PCr (rest)  ↔ ↔ 
Pi (rest)  ↔ ↔ 
pH (rest)  ↔ ↔ 
H2PO4- (rest)  ↔ ↔ 
PCr (end contractions)  ↔ ↑O 
Pi (end contractions)  ↔ ↓O 
pH (end contractions)  ↑O ↑O 
H2PO4- (end contractions)  ↓O ↓O 
ATPCK (minute 1)  ↔ ↓O 
ATPCK (minute 2)  ↔ ↔ 
ATPCK (minute 3)  ↔ ↔ 
ATPCK (minute 4)  ↔ ↔ 
ATPGLY (minute 1)  ↔ ↓O 
ATPGLY (minute 2)  ↓O ↓O 
ATPGLY (minute 3)  ↔ ↔ 
ATPGLY (minute 4)  ↔ ↔ 
Vi[PCr] ↔ ↑O* ↔ 
kPCr ↔   
Arrows represent where differences (p≤0.05) were lower (↓), higher (↑), or similar (↔) in 
young and older adults at baseline, and during the high-velocity (MVDC20%) or moderate-
velocity fatigue protocols (MVDC120). The * symbol represents p=0.051.  Shaded boxes 
indicate data not collected.  PTI, power-time integral; PCr, phosphocreatine; Pi, inorganic 
phosphate; H2PO4-, diprotonated phosphate; Vi[PCr], initial velocity of PCr resynthesis; kPCr, 





Table 6.2. Summary of the results from Study 2 
 MVIC MVDCIsoK MVDCIsoT 
 Y vs. O Y vs. O Y vs. O 
Ergometer measurements 
Specific TTI ↔   
Specific PTI  ↓O ↓O 
Metabolic variables 
ATPCK ↔ ↔ ↔ 
ATPGLY ↓O ↔ ↔ 
ATPOX ↔ ↔ ↔ 
ATP cost ↔ ↓O ↓O 
Metabolic economy ↔ ↓O ↓O 
Arrows represent where differences (p≤0.05) were lower (↓), higher (↑), or similar (↔) in 
young and older adults for the isometric (MVIC), isokinetic (MVDCIsoK), and isotonic 
(MVDCIsoT) contractions.  Shaded boxes indicate data not collected.  TTI, torque-time 
integral; PTI, power-time integral; ATPCK, ATP flux through the creatine kinase reaction; 
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University of Massachusetts 
Amherst, MA 01003 
 
Project Title: Muscle Fatigue and Aging 
 
Principal Investigator: Jane A. Kent, Ph.D 
 
Co-Investigators: Liam F. Fitzgerald, Miles F. Bartlett, Joseph A. Gordon, Julia D. Miehm, and 
Rajakumar Nagarajan, PhD 
 
Your written informed consent is required before you can participate in this project.  Please read 
this document carefully and then sign your name on the last page if you agree to participate.  This 
document is in accordance with regulations for the Protection of Human Research Subjects (45 
CFR 46).  You are encouraged to ask questions at any time before, during, or after participating. 
 
Purpose: Older adults experience greater muscle fatigue than young adults during fast 
contractions that produce movement.  However, when performing slower contractions, muscle 
fatigue is similar between young and older adults.  Although there are several causes of muscle 
fatigue, chemical factors such as muscle acidity and the build-up of metabolic by-products are 
two leading contributors to fatigue.  However, at this time, we do not know if these chemical 
factors contribute to the greater muscle fatigue that older adults experience during fast 
contractions.  Therefore, the purpose of this study is to investigate the potential impact of muscle 
structure and biochemistry on fatigue in young and older adults during medium and high speed 
contractions. 
 
Eligibility: To participate in this study you must be healthy, age 25-40 or 65-80 years of age, and 
complete ≤ two 30 minute bouts of exercise per week.  You may not have any: neurological or 
neuromuscular disease; a history of stroke, peripheral vascular disease, cardiac or pulmonary 
disease; be a smoker, significant arthritis of the lower limbs; or a history of any metabolic 
diseases/disorders. You may not be pregnant. You may not have any metal implants or anything 
that would prevent you from undergoing a magnetic resonance imaging (MRI) exam. 
 
Procedures:  Prior to your first visit, you will be screened by telephone interview for general 
health, medical history, current medications, usual physical activity habits, and eligibility for the 
study.  If you qualify and agree to participate, you will be invited to the Human Testing Center 
(HTC) at the University of Massachusetts Amherst for your first visit.  At this visit you will 
complete the consent process and we will measure your muscle’s stiffness and be familiarized 
with the procedures for the second and third visits, which will take place at the human Magnetic 
Resonance Center (hMRC).  
  
Visit 1 (~1 hour): Paperwork, Physical Function Measures, Muscle-Tendon Unit Stiffness and 
Familiarization (HTC) 
Upon arriving at the HTC, you will be asked to read this Informed Consent document.  At 
this time, we will also answer any questions you may have about any of the study procedures.  
Following completion of this consenting procedure, you will be asked to complete a Physician’s 
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Clearance Form (older adults only), Medical History Form, Physical Activity Readiness 
Questionnaire, and Magnetic Resonance Safety Form.  Next, we will measure your blood 
pressure while you are seated, and then obtain your height and weight.  We will then measure 
your walking speed and you will complete two mobility tests; the Timed-Up-and-Go (TUG) test 
and the Advanced Short Physical Performance Battery (SPPB-A). For the TUG, you will stand up 
from a seated position, walk approximately 10 feet out to a standardized marker (a cone), and 
then return to the chair and sit down. You will complete this mobility test twice with 
approximately 1 minute rest between each trial. The SPPB-A test involves 3 parts: 
1) Completing 10 chair raises without using the hands, as quickly as possible 
2) Walking a straight, 6-meter path at their usual speed, repeated 4 times 
3) Standing with 4 different foot positions, each for up to 30 seconds. The 4 foot positions 
are: feet parallel to each other (side-by-side), the heel of one foot beside the ball of the 
other foot (semi-tandem), one foot in front of the other (tandem), and on one foot. 
You will be asked to sit on a machine that we will use to measure your leg strength.  Your 
foot, hips, and torso will be strapped securely to this machine, to prevent unwanted movement.  
You will be asked to fold your arms across your chest and then straighten your leg as hard and 
fast as possible while the machine measures your strength.  Your leg will not move during this 
measurement. We will repeat this exercise several times to allow you to learn the required 
technique.  Next we will ask you to repeat the static strength measure, but this time you will take 
~30 seconds to reach your maximum.  During this contraction your target effort will be shown to 
you on a computer screen so that you can gradually increase the strength of your contraction.  
Throughout the contraction, an ultrasound transducer will be applied to your thigh muscles, and 
we will capture a video of your muscle while you contract it. 
Next, you will be shown the exercise apparatus, and you will practice the fatigue protocol 
that you will perform during your second and third visits.  This apparatus is similar to some 
weight machines used at fitness gyms and will be used to measure your knee extension strength.  
We will also show you the magnet (located at hMRC) that you will lay in for the fatigue studies, 
which will be completed at your second and third visits. Lastly, we will give you a uniaxial 
accelerometer, which is a small activity monitor that will record the amount and intensity of 
physical activity you perform over the next 7 days. You will be instructed on how and when to 
use it and how to keep a simple physical activity log book. The accelerometer and log will be 
returned to the lab at Visit 2. 
Visit 2 (~1.5 hours): Imaging and Fatigue Protocol #1 (hMRC) 
Before entering the magnet room, we will review your Magnetic Resonance Safety Form, 
and have you remove all jewelry and change into paper scrub pants.  We will then scan you for 
metal using a hand-held metal detector.  Next, you will be escorted to the Magnet Room, where 
you will be positioned in the MR scanner on your back, with your arms resting comfortably at 
your side.  We will lay a flexible mat on the thigh of your dominant leg, and use this mat to 
obtain images of your thigh muscles.  This will take about 15 minutes.  We will then remove that 
mat and position you with your leg on top of our leg exercise apparatus.  Your lower leg will be 
strapped to the apparatus just above your ankle and at your knee using Velcro straps.  Inelastic 
straps will also be secured over your hips to prevent unwanted movement during the muscle 
contractions that you will perform. A specially designed copper coil encased in a plastic box will 
be secured over your thigh muscles using Velcro straps.  This coil will be used to measure 
changes in your muscle biochemistry during the contractions.  Headphones will be provided to 
you to limit the amount of noise from the MR scanner, and to enable clear and constant 
communication between you and the investigators.  We will talk with you and explain each set of 
measures as we go along.  These measures are described next. 
173 
 
We will position your thigh muscle in the center of the MR scanner, and then “tune” the 
magnet to your muscle.  This will require you to lay quietly for about 15 minutes.  We will then 
prepare for the fatigue protocol by first determining your strength during 2-3 maximal static 
contractions, each lasting 3-4 seconds.  For these, you will attempt to straighten your leg as 
quickly and forcefully as possible.  The strap across your leg will prevent it from moving, but we 
will be able to measure your strength during each contraction.  You will be given 1-2 minutes of 
rest between each of these contractions.   
We will then ask you to perform 2 sets of 3 rapid, maximal dynamic contractions (i.e., 
“with movement”), during which your leg will move as you straighten your leg at the knee.  
These contractions will be used to determine your maximal dynamic strength.  You will be given 
1-2 minutes of rest between each of these 2 sets.  You will then perform one of 2 fatigue 
protocols (fast or medium speed), which will consist of 4 minutes of maximal dynamic 
contractions, one every 2 seconds.  We will encourage you to give your best effort throughout this 
protocol, which is designed to tire your leg.  At the end of this 4 minutes, you will again rest 
quietly in the magnet for 10 minutes while we continue to monitor your muscle’s biochemistry.  
Immediately after this 10 minute recovery period, you will perform a final maximal static 
contraction and set of 3 maximal dynamic contractions, to evaluate your muscle’s recovery from 
fatigue.  In total, we expect Visit 2 to last approximately 90 minutes. 
Visit 3 (~1.5 hours): Aerobic Capacity and Fatigue Protocol #2 (hMRC) 
All procedures for Visit 3 are identical to those of Visit 2, with two exceptions.  First, we 
will measure your aerobic capacity instead of obtaining images of your thigh muscles.  Once you 
are positioned inside the MR scanner with your leg on the exercise apparatus, we will ask you to 
complete 2-3 maximal isometric (i.e., ‘static’) contractions to determine your maximal strength.  
We will allow you 1-2 minutes of rest between each of these contractions.  Next, we will ask you 
to repeat this effort, but this time you will maintain the maximal static contraction for 24 seconds.  
After this, we will ask you to lay quietly inside the MR scanner, without moving, for 10 minutes.  
This procedure allows us to measure the thigh muscle’s “aerobic” capacity. 
 Second, you will be asked to perform the fatigue protocol you did not complete at Visit 2 
(i.e., fast or medium speed).  This fatigue protocol will consist of 4 minutes of maximal dynamic 
contractions, one every 2 seconds.  Again, we will encourage you to give your best effort 
throughout this protocol, which is designed to tire your leg.  At the end of this 4 minutes, you will 
be asked to rest quietly, without moving, in the MR scanner for 10 minutes while we continue to 
monitor your muscle’s biochemistry.  Immediately after this 10 minute recovery period, you will 
perform a final maximal static contraction and set of 3 maximal dynamic contractions, to evaluate 
your muscle’s recovery from fatigue.  In total, we expect Visit 3 to last approximately 90 
minutes. 
Subject Enrollment/Length of Study:  We expect to enroll 60 participants in this study.  Your 
participation will include 3 visits.  The first visit will last about 1 hour and the second and third 
visits about 1.5, for a total of approximately 4 hours.  
 
Possible Risks and Discomforts:  There are minimal risks associated with the procedures used in 
this research study.  You may experience soreness in your muscles in the days following the 
testing, but this would be a normal response and should be temporary.  Injury is possible if you 
have any metal in or on you during the magnetic resonance testing, but we will check you 




Magnetic Resonance Spectroscopy (MRS) and Imaging (MRI) – The United States Food and 
Drug Administration (FDA) has established guidelines for magnet strength and exposure to radio 
waves, and we carefully observe those guidelines.  No ill effects have been reported for the radio 
wave exposure associated with this protocol.  Some people may feel uncomfortable or anxious 
while in the MR scanner, which is a large magnet.  If this happens to you, you may ask to stop the 
study at any time and we will take you out of the MR scanner.  On rare occasions, some people 
might feel dizzy, get an upset stomach, have a metallic taste, feel tingling sensations, or 
experience muscle twitches.  These sensations usually go away quickly but please tell the 
research staff if you have them.  
  
MRI and MRS pose some risks for certain people.  If you have a pacemaker or certain types of 
metal objects inside your body, you may not be in this study because the strong magnet used for 
these MR studies might harm you.  Another risk is a metallic object flying through the air toward 
the magnet and hitting you.  To reduce this risk we require that all people involved with the study 
remove all metal from their person and all metal objects from their pockets.  Nothing metal can 
be brought into the magnet room at any time.  Also, once you are in the magnet, the door to the 
room will be closed so that no one accidentally bring a metal object near the magnet while you 
are in it. 
 
 Please read the Magnetic Resonance Safety Form and complete it very carefully.  Those 
questions are for your safety.  Take a moment now to be sure that you have read this Form and be 
sure to ask any questions and tell us any information you think might be important.  Even if you 
think that it is probably okay, we would rather have you ask us to make sure. 
  
If you experience significant claustrophobia during the MR testing, you will be removed 
immediately.  You will be positioned feet-first in the magnet and your head will remain near the 
opening in order to minimize claustrophobia. 
 
What if there is an unexpected finding on my MRI scan?  The investigators for this research 
project are not licensed or trained diagnosticians or clinicians.  The testing performed in this 
project is not intended to find abnormalities, and the images or data collected do not constitute a 
diagnostic or clinical study.  The investigators and the University of Massachusetts Amherst are 
not responsible for failing to find abnormalities.  However, on occasion the investigators may 
perceive an abnormality.  When this occurs, the UMass Amherst researchers will consult with a 
specialist.  If the specialist determines that additional inquiry is warranted, the researcher will 
contact you.  In such a case, you are advised to consult with a licensed physician to determine 
whether further examination or treatment would be prudent.  The investigators, radiologist, and 
the University of Massachusetts Amherst are not responsible for any decision you make with 
regard to examination or treatment.  Although the data collected for this research project do not 
constitute a diagnostic or clinical study, the images can be made available to you for clinical 
follow-up. 
Confidentiality: Steps are taken to protect the identities of participants and the data collected in 
this study.  The Informed Consent, Physical Activity Readiness Questionnaire, and MR Safety 
Form (all of which will have your name on them) will be stored and locked in a filing cabinet 
within a locked office.  All other data collection sheets will be coded with your participant 
number and the study name instead of your name, so that no potential identifiers can be linked 
back to you.  Data collection sheets and lists of participant codes and names are kept separate 
from all other study materials.  Paper documents with names or codes will be stored in separate 
locked filing cabinets located in a locked office.  All electronic data will be kept on a password-
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protected computer in a locked office.  Any data that are published or used in a presentation will 
not include any names or identifiers that could link back to you. 
 
In Case of Injury: In the unlikely event of an injury resulting directly from participation in this 
study, we will do everything we can to assist you in seeking medical treatment.  The University 
of Massachusetts does not have a program for compensating subjects for injury or complications 
related to human subject research.  
 
Benefits: You will receive no direct benefit from participating in this study.   
 
Costs and Reimbursement: There is no cost to participate in this study.  You will be given a $30 
gift card if you complete all visits of this study.  There is no compensation if you do not complete 
all visits. 
 
Withdrawal from Participation: Participation in this research is voluntary.  You have the right 
to refuse to continue or withdraw from the study at any point, without prejudice.    
  
Alternative Procedures:  The procedures described above are non-invasive techniques that are 
commonly used in muscle research.  There are no other non-invasive techniques that can be used 
to obtain the information necessary in this study. 
 
Request for Additional Information:  You are encouraged to ask questions about the study.  
The investigators will attempt to answer all of your questions to the best of their knowledge.  The 
investigators fully intend to conduct the study with your best interest, safety, and comfort in 
mind. Please address any questions regarding the study to the Muscle Physiology Laboratory.  
Our phone number is (413) 545-5305.  We can also be reached by email at 
umassmplab@umass.edu.  You may also address questions to Prof. Kent by calling her at (413) 
545-9477 or by emailing her at jkent@kin.umass.edu.  If you would like to speak with someone 
not directly involved in the research study, you may contact the Human Research Protection 
Office at the University of Massachusetts via email at humansubjects@ora.umass.edu; telephone 
(413) 545-3428; or mail at the Human Research Protection Office, Research Administration 
Building, University of Massachusetts Amherst, 70 Butterfield Terrace, Amherst, MA 01003-
9242. 
 
Subject Statement of Voluntary Consent:  By signing this form, I am agreeing to voluntarily 
enter this study.  I understand that, by signing this document, I do not waive any of my legal 
rights.  I have had a chance to read this consent form, and it was explained to me in a language 
that I use and understand.  I have had the opportunity to ask questions and have received 
satisfactory answers.  A copy of this signed Informed Consent Form will be given to me. 
 
             
Participant’s name     Address 
 
    
Signature     Phone Number    Date 
 
STUDY REPRESENTATIVE STATEMENT: 
The investigator has read and understands the federal regulations for the Protection of Human 
Research Subjects (45 CFR 46) and agrees to comply with all of its clauses to the best of his 
ability.  The investigator also pledges to consider the best interests of the participant beyond the 
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explicit statement contained in these regulations, and to exercise professional expertise to protect 




Signature of Person Obtaining Consent Date 
 
_________________________________ 





Jane A. Kent, Ph.D. Date 





TELEPHONE SCREENING FORM 
Screened by:     Date:    Group:    Status:   
 
1) Name________________________________  
 
2) Phone # (Circle preferred contact):       Best time/day to contact:     
a. Home      Message?      Yes     No     
b. Work      Message?      Yes     No     
c. Cell      Message?      Yes     No     
 
3) Email:             
 
4) Age:        Sex:      
Height    Weight:    BMI:     (calculate)  
 
5) Current health status (general):          
 
6) Do you have any physical limitations?         
 
7) Do you smoke or have you ever smoked before?    
For how long?    Quit?     
 
8) Do you have any allergic reactions?          
 
9) Do you have any significant past medical history? (e.g. hypertension, CAD, etc.) 
              
             
 
10) Do you experience pain of any sort while exercising? 
             
 
11) Do you have a history of muscle cramps or pain?        
 
12) Is fatigue a problem for you?     Leg fatigue?      
 
13) Have you been diagnosed with hypertension or hypercholesterolemia?     
 
14) Do you have a pacemaker?        
 
15) Have you had any surgeries?         
             
 
16) Does your medical history include any of the following?  
Stroke    Diabetes   Neurological/Neuromuscular    




If yes, explain:            
             
17) Current medications: 
Drug Name  Classification Dose Frequency Duration Prescribed for? 
           
           
           
           
           
 
18) Current physical activity level (regular exercise, none, UMASS athlete, etc.) 
              
    
19) Has your Doctor ever told you not to exercise?        
 
20) What was the date of your last doctor’s visit?        
 
21) When did you start your last menstrual cycle?        
 
22) Have you ever taken or are you currently using hormone replacement therapies? 
             
 
23) How did you find out about this study?         
 
24) Are you currently participating in any other research studies? 
If yes, describe:           
 
25) Would you like to be contacted again for future studies (circle one)?     Yes    No 
 
Comments:            
            





MAGNETIC RESONANCE SAFETY FORM 
MR Safety Screening Questionnaire 
 
Participant’s Name (print):          Today’s date:    
Study Name:         Investigator:        Participant ID:    
Year of birth:         Sex:       Height:        Weight:    
 
Please read the following questions carefully. It is very important for us to know if you have any 
metal devices or metal parts anywhere in your body. If you do not understand a question, please 
ask us to explain! 
1. Yes   No   Do you get upset or anxious in small spaces (claustrophobia)? 
2. Yes   No   Did you ever have an aneurysm clip implanted during brain surgery? 
3. Yes   No   Do you have embolization coils (Gianturco) in your brain? 
4. Yes   No   Do you have Carotid Artery Vascular clamp? 
5. Yes   No   Do you have a “shunt” (a tube to drain fluid) in your brain, spine, or 
heart? 
6. Yes   No   Do you have a Vagus nerve stimulator to help you with convulsions or 
with epilepsy? 
7. Yes   No   Have you ever had metal removed from your eyes by a doctor? 
8. Yes   No   Have you worked with metal? (For example, in a machine shop)? 
9. Yes   No   Do you have implants in your eyes? Have you ever had cataract 
surgery? 
10. Yes   No   Do you wear colored contact lenses or permanent eye liner? 
11. Yes   No   Do you have shrapnel or metal in your head, eyes, or skin? 
12. Yes   No   Do you have implants in your ear (like cochlear implants) or a hearing 
aid? 
13. Yes   No   Do you wear braces on your teeth or have a permanent retainer? 
14. Yes   No   Do you have a heart pacemaker or a heart defibrillator? 
15. Yes   No   Do you have a filter for blood clots (Umbrella, Greenfield, bird’s nest)? 
16. Yes   No   Do you have any stents (small metal tubes used to keep blood vessels 
open)? 
17. Yes   No   Did you ever have a device implanted in your body such as a nerve 
stimulator? 
18. Yes   No   Do you have an implanted pump to deliver medication? 
19. Yes   No   Do you have metal joints, rods, plates, pins, screws, nails, or clips in any 
part of your body? 
20. Yes   No   Have you ever had a gunshot wound? Or a B-B gun injury? 
21. Yes   No   Do you wear a patch to deliver medicines through the skin? 
22. Yes   No   Do you have any devices to make bones grow (like bone growth or bone 
fusion stimulators)? 
23. Yes   No   Do you have an unremoved body-piercing or tattoo? 
24. Yes   No   Have you ever had any surgery? Please list all: 
 
FOR WOMEN 
25. Yes   No   Do you use a diaphragm, IUD, or cervical pessary? 
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26. Yes   No   Do you think there is any possibility that you might be pregnant? 
IMPORTANT INSTRUCTIONS: Before entering the Magnet Room, you must remove all 
metallic objects including hearing aids, dentures, partial plates, keys, beeper, cell phone, 
eyeglasses, hair pins, barrettes, jewelry (including body piercing jewelry), watch, safety pins, 
paperclips, money clip, credit cards, bank cards, magnetic strip cards, coins, pens, pocket knife, 
nail clipper, tools, clothing with metal fasteners, and clothing with metallic threads in the 
material. 
I attest that the above information is correct to the best of my knowledge. I have read and 
understand the entire contents of this form and have had the opportunity to ask questions 
regarding the information on this form and regarding the MR procedure that I am about to 
undergo. 
 
Participant Signature:           Date:     
 





MEDICAL HISTORY FORM 
Health History Questionnaire 
 
Please fill out and sign in ink. This record is confidential. 
 
Medical History 
Do you take any prescribed or over-the-counter medications? Please include vitamins, herbs, or 
other dietary supplements. If yes, please list the dose, frequency, and the duration of use. 
            
            
             
 
Have you ever been told by a physician that you should not exercise? 
 
Yes:   No:   If yes, please explain:        
 
Do you have or have you EVER had any of the following problems? Check if YES and provide 
details in the space provided below. 
____ Heart disease/rheumatic fever  ____ Thyroid disorder  ____ Asthma 
____ High blood pressure    ____ Claustrophobia  ____ Allergies 
____ Elevated Cholesterol               ____ Anemia   ____ Stroke 
____ Epilepsy or seizure disorder    ____ Diabetes   ____ Dizziness 
____ Blurred or double vision 
____ Orthopedic or joint problems (e.g., arthritis) 
____ Shortness of breath or difficulty in breathing 




Do you smoke cigarettes?  Yes ____ No ____ 
Do you drink alcohol?    Yes ____ No ____ 
Have you had surgery?    Yes ____ No ____ 
If yes: 
What was the surgery for? _____________        
             
 
When was your surgery? _____________        
             
 
Is there any other information or concerns you have that you feel we should know about before 
you participate in the study? If yes, please explain.   
            
            
            
            





PHYSICAL ACTIVITY READINESS QUESTIONNAIRE 
PHYSICAL ACTIVITY READINESS QUESTIONNAIRE 
 
1. Has a doctor ever said you have a heart condition and recommended only medically 
supervised activity? 
  YES_______  NO_______ 
 
2. Do you have chest pain brought on by physical activity? 
  YES_______  NO_______ 
 
3. Have you developed chest pain in the last month? 
  YES_______  NO_______ 
 
4. Do you tend to lose consciousness or fall over as a result of dizziness? 
  YES_______  NO_______ 
 
5. Do you have a bone or joint that could be aggravated by the proposed physical activity? 
  YES_______  NO_______ 
 
6. Has a doctor ever recommended medication for your blood pressure or a heart condition? 
  YES_______  NO_______ 
 
7. Are you aware through your own experience, or a doctor’s advice, of any other physical 
reason against your exercising without medical supervision? 
  YES_______  NO_______ 
 
Note:  If you have a temporary illness, such as a common cold, or are not feeling well at this 
time, you must postpone your participation in the study at this time. 
 





PHYSICAL ACTIVITY LOG 
Date:         Participant ID:    
DAY 1 
Wake up time:       Bed time:     
Monitor on time:      Monitor off time:     
1) Please list any physical activities you completed (e.g., long walks, yard work, fitness club, 
etc.), as well as any naps you took today: 
 
Activity:   Approximate Time of Day:   Duration: 
            
            
            
            
            
             
 
2) Did you wear the monitor during all waking hours, except for showering/bathing? 
 
☐ Yes  ☐ No, times not worn:         
 
3) Was there anything out of the ordinary about your activity pattern today? 
 
☐ Yes, explain below  ☐ No 
            
            
            





EFFECTS OF OLD AGE ON KNEE EXTENSOR FATIGUE AND RECOVERY 
FROM HIGH-VELOCITY MUSCLE CONTRACTIONS 
Effects of Old Age on Knee Extensor Fatigue and Recovery From High-Velocity 
Muscle Contractions 
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Although high-velocity contractions elicit greater muscle fatigue in older compared with 
young adults, the mechanisms of this difference are not clear.  We examined the potential 
roles of resting muscle architecture and baseline contractile properties, as well as changes 
in voluntary activation and low-frequency fatigue during fatigue (fall of peak power) due 
to high-velocity knee extensor work.  Vastus lateralis muscle thickness, pennation angle, 
and fascicle length were determined in rested muscle by ultrasonography in 8 young 
(23.4±1.8 yrs) and 8 older (69.6±1.1) women.  Maximal voluntary dynamic (MVDC) and 
isometric (MVIC), and stimulated (80Hz and 10Hz, 500ms) isometric contractions were 
performed before and immediately after 120 MVDCs (240°.s-1, one every 2s).  
Architecture variables did not differ between groups (p≥0.209), but the half-time of 
torque relaxation (T1/2) was longer in older than young at baseline (151.9±6.0 vs. 
118.8±4.4 ms, respectively, p=0.001).  Older fatigued more than young (to 33.0±4.7% vs. 
56.1±4.4% initial power, respectively; p=0.005), with no evidence of voluntary activation 
failure (∆MVIC:80Hz torque) in either group (p≥0.317).  Low-frequency fatigue 
(∆10:80Hz torque) occurred in both groups (p=0.001), as did slowing of T1/2 (p=0.001), 
with no differences by age in these changes.  Baseline T1/2 was inversely associated with 
fatigue in older (r2=0.591, p=0.043), but not young (r2=0.145, p=0.351).  These results 
indicate that muscle architecture, voluntary activation, and low-frequency fatigue do not 
explain the greater fatigue of older compared with young during high-velocity 
contractions.  The inverse association between baseline T1/2 and fatigue in older women 
suggests that slowing of muscle contractile properties may help protect against fatigue 
during fast, repetitive contractions in aging. 
186 
 
Key Words: power, contractile properties, excitation-contraction coupling, muscle 
architecture, low-frequency fatigue, neural activation 
 
Introduction 
Maximal torque and power production are lower in older compared with younger 
adults (24,132,157,184,228,232), due to factors such as a loss of muscle mass 
(24,90,115,141,231), slower maximal contraction velocities (50,132,232), and lower 
maximal motor unit discharge rates (104).  These changes have significant consequences 
for older adults because deficits in muscular power are associated with an increased 
likelihood of falling, which may place older adults at risk of injury, poor mobility and 
subsequent loss of independence (11,155).  In particular, power production by the knee 
extensor muscles is important due to its association with physical function in aging (44), 
as well as the concept that rapid contraction of the knee extensors appears to be crucial 
for preventing falls following a balance perturbation (152). 
The decline in maximal torque and power with old age might be explained, at 
least in part, by changes in muscle architecture such as muscle thickness, pennation 
angle, and fascicle length (146).  Generally, muscles with a greater pennation angle have 
more sarcomeres in parallel, whereas muscles with longer fascicles contain more 
sarcomeres in series (19). Conceptually, a greater number of sarcomeres in parallel 
allows for greater torque production, while more sarcomeres in series allows for greater 
velocity of shortening (215).   
In aging, the loss of muscle mass results in architectural remodeling (170); 
fascicles can become shorter and less pennate (173).  Previous work has shown fascicle 
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length and pennation angle of the vastus lateralis to be ~12% shorter and ~25% smaller, 
respectively, in older compared with young men (191).  Given the apparent lack of sex-
related differences in the decline of quadriceps muscle volume with age (90), similar age-
related changes in muscle architecture may be expected in women.  However, Kubo et al. 
observed an age-related decrease in fascicle length in the vastus lateralis in men but not 
women (124).  Changes in fascicle length may account for ~20% of the age-related 
difference in maximal shortening velocity of the medial gastrocnemius in men (228).  
Thus, age-related differences in fascicle length could place older muscles at a 
disadvantage for generating power during high-velocity contractions (24,48-50,234).  To 
date, the extent to which architectural remodeling affects age-related differences in 
muscle fatigue is not known. 
Muscle fatigue is defined as the reduced capacity to produce torque or power in 
response to a period of contractile activity (112).  Mechanisms of fatigue can include 
transient impairments at any site along the pathway of force or power production, from 
the brain to the myofilaments (112).  The literature generally supports the observation of 
less muscle fatigue in older (≥65 years) compared with young (≤40 years) adults in 
response to isometric contractions (33).  Conversely, during dynamic contractions at high 
velocities, or when fatigue is expressed as a decline in power, older adults fatigue to a 
greater extent than young adults (24,48-50,222,234).  Despite consistent observations of 
these age-related differences in muscle fatigue, the mechanisms for greater fatigue in 
older compared with young adults in response to high-velocity contractions remain 
poorly understood.   
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Use of motor point stimulation offers a non-invasive approach for identifying 
whether the cause of fatigue is proximal or distal to the stimulating electrodes (i.e., 
central or peripheral) (116).  Small reductions (~5%) in voluntary activation, defined as 
the neural drive to the contracting muscle, have been observed in both young and older 
men following contractions of the knee extensors at slow- and moderate-velocities (49).  
More recently, Sundberg et al. observed failure of voluntary activation in older, but not 
young, women following 80 maximal-velocity contractions at a load of 20% maximal 
isometric torque (222). However, the magnitude of the change in voluntary activation in 
the older women was small (<2%), and no association was observed between fatigue (% 
initial power) and changes in voluntary activation.  Thus, age-related differences in 
voluntary activation failure do not appear to contribute to age-related differences in 
fatigue in response to high-velocity contractions. 
The presence of low-frequency fatigue (LFF) can also be evaluated in vivo using 
motor point stimulation by comparing fatigue-induced changes in torque in response to 
low- vs. high-frequency stimuli (4,35,67,189).  With LFF, the decline and slowed 
recovery of torque produced by low-frequency stimuli are more pronounced than those 
elicited at higher frequencies (67).  Because LFF may stem, at least in part, from a failure 
in excitation contraction coupling (ECC) the low:high frequency torque ratio has been 
used as an indirect measure of ECC failure in vivo.  In single muscle fibers, a greater loss 
of force in response to low- vs. high-frequency stimuli is associated with impaired Ca2+ 
release (30,237).  Thus, age-related impairments in Ca2+ handling could contribute to the 
development of LFF (99).  In response to fatiguing isometric contractions in humans, 
there appear to be no age-related differences in LFF (4,35).  However, the potential role 
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of LFF in the greater fatigue and delayed recovery of power in older compared with 
younger adults in response to high-velocity contractions is not known. 
In unfatigued muscle, the half-time of torque relaxation (T1/2) is generally longer 
in older than young adults (24,48,49,114,222).  This difference could result from greater 
type 1 fiber composition (143) or differences in cross-bridge kinetics (164) in older 
muscle; the source of this slowing has not been definitively identified.  In fatigue, T1/2 
lengthens (114,131), presumably due to a slowing of Ca2+ release from troponin or its re-
uptake by the sarcoplasmic reticulum (1) in response to the accumulation of H+ (21).  
During fatiguing isometric contractions, some authors report a similar slowing of T1/2 in 
young and older muscle (48,114,131).  In contrast, during dynamic contractions of the 
knee extensor muscles, others reported a greater slowing of T1/2 in older compared with 
young men following contractions at moderate and fast, but not slow, velocities (49).  
More recently, intracellular pH was shown to be lower in older than young muscle in 
response to dynamic contractions of the knee extensors to fatigue (223), which could 
contribute to a greater slowing of T1/2 in older than young muscle.  
Given the existing questions about the causes of muscle fatigue in aging, the 
purpose of this study was to compare in young and older women several potential 
mechanisms that may contribute to age-related differences in fatigue following high-
velocity concentric contractions of the knee extensor muscles.  Baseline muscle 
architecture, as well as changes in voluntary activation and contractile properties, were 
evaluated during fatigue and for 30 minutes of recovery.  We hypothesized that fatigue 
(fall of peak power relative to baseline) would be greater, and recovery of power slower, 
in older compared with young muscle.  We further hypothesized that vastus lateralis 
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fascicle length and pennation angle would be shorter and smaller, respectively, in older 
compared with young women, and that fascicle length would be positively associated 
with peak power production at baseline, given the importance of the number of 
sarcomeres in series for power generation (228).  Based on the current literature, we did 
not expect to observe any age-related differences in voluntary activation at the end of the 
fatigue protocol (49,222).  However, we did anticipate greater low-frequency fatigue and 
slowing of T1/2 in older compared with young women. 
 
Methods 
Participants.  Sample size estimates were calculated a priori to detect significant 
differences in fatigue (% initial power) with 80% power, an alpha level of 0.05, and an 
equal number of participants in young and older groups (GPower v3.1; (70)).  For this 
calculation, values from a study that used a similar fatigue protocol were used to 
determine the effect size (24).  These calculations revealed 8 participants were required 
per group to detect significant age-related differences in muscle fatigue.  Thus, 8 young 
(21-36 years) and 8 older (66-76 years) women were studied.  Prior to enrollment, each 
participant gave their written, informed consent, as approved by the University of 
Massachusetts Amherst, and in accordance with the Declaration of Helsinki.  Physician’s 
approval to participate was obtained for all of the older volunteers between Visits 1 and 
2.  To avoid any potential age-by-sex interactions, we restricted this study to women.  
Participants reported being relatively sedentary in that they completed less than two 30-
min sessions of structured exercise per week.  They also reported being healthy, as 
evaluated by a health-history questionnaire, and were not taking any medications known 
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to affect physical function or muscle fatigue (e.g., beta-blockers, calcium channel 
blockers, etc.).  All participants answered ‘no’ to all questions on the Physical Activity 
Readiness Questionnaire (229).  To minimize the effect of fluctuating hormone levels on 
muscle function over the course of the menstrual cycle (207), all young women were 
studied during days 1-5 of the menses.  No participants had used any hormone 
replacement therapies in the 6 months prior to enrolling in the study. 
 
Procedures.  Participants reported to the Muscle Physiology Laboratory for 2 Visits.  At 
Visit 1, mobility function was measured and familiarization with the fatigue protocol was 
provided.  During Visit 2, muscle architecture of the vastus lateralis was measured, 
followed by the knee extensor fatigue protocol.  Visits were separated by at least 2 days. 
 
Mobility function and activity.  Measures of mobility and physical activity were obtained 
in order to characterize the study groups.  Mobility was measured using the timed up-
and-go (TUG) (188) and advanced short physical performance battery (SPPB-A) (210).  
The fastest time for the TUG was used for analysis.  At the end of Visit 1, participants 
were asked to wear a uniaxial accelerometer (GT3X, Actigraph, Pensacola, FL) at the hip 
for 7 days in order to characterize habitual physical activity levels.  Participants wore the 
accelerometer for a minimum of 10 hours per day, and at least 4 days (3 weekdays and 1 
weekend day).  These criteria have been shown to provide good reliability (>80%) for 
quantifying overall and moderate-to-vigorous physical activity (153,154).  Average daily 
activity counts and minutes spent in moderate-to-vigorous physical activity were 
192 
 
calculated using ActiLife v6.13 software (ActiGraph, Pensacola, FL) with established 
cutpoint thresholds (74). 
 
Muscle architecture.  Thigh, shank, and total leg length were measured using a tape 
measure.  The midpoint between the greater trochanter and lateral femoral condyle of the 
femur was marked with indelible ink and thigh circumference was measured at this 
position.  Subsequently, the participant was seated on a Biodex System 3 dynamometer 
(Biodex Medical Systems, Shirley, NY) with the same hip and knee angles used at Visit 
1.  After 10min of seated rest to account for fluid shifts in the thigh (171), ultrasound 
images of the participant’s vastus lateralis were collected via a linear array probe (Philips 
model L12-5, 12-5MHz), using a Philips HD11XE system (Philips Healthcare, Bothell, 
WA).  The probe was placed over the mark on the participant’s thigh, at approximately 
50% of the length of the femur.  Once the probe placement was optimized, determined as 
the position that yielded the best visualization of the deep and superficial aponeuroses 
and muscle fascicles, 5 images were collected.  All images were obtained at a hip and 
knee angle of 90° and 100°, respectively.  To check whether peripheral edema occurred 
during the imaging session, the widest circumference of the calf was measured before and 
after images were obtained. 
Ultrasound images were saved and transferred to a desktop computer for offline 
analysis using ImageJ software (v1.50i, National Institutes of Health, USA).  The 
pennation angle was identified as the angle between the fascicle and the deep 
aponeurosis.  Muscle thickness was measured as the distance between the internal 
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borders of the superficial and deep aponeuroses.  Because visualization of entire fascicles 
was not possible, fascicle length was estimated as follows: 
 Estimated fascicle length  
Muscle thickness
Sin θ
 [Eq. 1] 
where ϴ represents the measured pennation angle.  This approach, illustrated in Figure 
F.1, is commonly used in studies of muscle architecture (195).  To account for anatomical 
differences between participants, we report estimated fascicle length in addition to 
normalizing this measure to thigh length.  Analysis of some images was not possible 
because the superficial and deep aponeuroses were not parallel with each other.  As a 
result, muscle architecture was analyzed for 3 out of the 5 ultrasound images obtained 
from each participant. 
 
Muscle torque and power.  Prior to the measurement of isometric torque and dynamic 
power, participants completed 5 min of unloaded cycling at ~60-rpm to warm-up.  The 
dynamometer was used to test knee extensor torque and power during maximal voluntary 
isometric (MVIC) and dynamic (MVDC) contractions of the dominant leg (preferred 
kicking leg), respectively.  Participants were seated upright with their hips at 90° and a 
knee angle of 100° extension (180° = full extension).  The dynamometer was adjusted to 
ensure that the axis of rotation of the dynamometer’s lever arm was aligned with the axis 
of rotation of the participant’s knee joint.  The length of the lever arm was adjusted and 
secured with inelastic straps proximal to the malleoli.  Additional straps were fastened 
across the participant’s torso and hips to prevent unwanted movement.  Participants were 
instructed not to hold onto any part of the dynamometer during the testing to ensure that 
torque and velocity measurements were generated by the knee extensor muscles. 
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Peak knee extensor torque was measured with the dynamometer in isometric and 
isokinetic modes to determine MVIC and MVDC at 240°.s-1, respectively.  To determine 
the target torque for electrically-stimulated contractions (see Myoelectric stimulation 
below), participants completed 2 brief MVICs at a knee angle of 100° with 1 min rest 
between contractions.  If those 2 MVICs differed by more than 10%, additional MVICs 
were completed until the 2 strongest contractions were within 10% of each other.  To 
ensure participants were still familiar with the dynamic contractions performed at visit 1, 
participants completed two sets of 2 MVDCs at a concentric velocity of 240°.s-1, with 1 
min rest between sets to prevent muscle fatigue.  Participant’s limbs were allowed to 
return to the start position at a velocity of 500°.s-1 (i.e., against no load), and all MVDCs 
were completed over a 70° range of motion.  For all contractions, the participant sat with 
her arms folded across her chest and were instructed to “kick your leg out as hard and fast 
as possible.”  Visual torque-feedback, scaled to each participant’s maximum torque, was 
provided during each contraction.  
Analog signals corresponding to torque, velocity, and position were acquired from 
the dynamometer at a sampling rate of 2,500 Hz.  Data were analyzed as reported 
previously (23,24,131,132).  Briefly, peak torque was taken during the target isovelocity 
period.  Power was calculated as the product of peak torque and the corresponding 
velocity observed at that time. 
 
Myoelectric stimulation.  Motor point electrical stimulation was used to measure muscle 
contractile properties during isometric contractions at baseline, immediately after the 
fatigue protocol, and at 5, 10, 20, and 30 min of recovery.  Two 7.6 × 12.7 cm self-
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adhesive stimulating electrodes were placed transversely across the thigh.  One electrode 
was positioned 3-5 cm distal to the inguinal crease and the other was placed 2-3 cm 
proximal to the superior border of the patella.  High- (80-Hz) and low-frequency (10-Hz) 
stimulations were delivered (200-μs pulse duration, 500 ms) with a constant-current 
stimulator (DS7AH; Digitimer, Hertfordshire, UK).  The current that elicited an 80-Hz 
contraction resulting in 50% of the participant’s MVIC was used for all subsequent 
stimulations, as described previously (23,24).  Immediately prior to the fatigue protocol, 
participants completed a series of voluntary and electrically-stimulated contractions 
consisting of 2 MVDCs (240°.s-1), 1 MVIC, one 80-Hz and one 10-Hz contraction. A 
representative torque trace from the baseline series of contractions for 1 young woman is 
shown in Figure F.2.  This series of contractions was repeated at the end of the fatigue 
protocol and throughout recovery. 
 Muscle contractile properties were quantified as peak torque during the 10 and 
80-Hz contractions, as well as the maximal rate of torque development (RTD)), and T1/2 
from the 80-Hz tetanus.  The RTD was expressed as the percent of peak torque per 
millisecond (%pk.ms-1), to account for the effects of peak torque achieved on this 
measure.  The T1/2 was measured as the time for torque to decline to 50% of that achieved 
at the time of the last stimulus during the 80-Hz contraction.  Changes in the ratio of peak 
torques elicited during the 10-Hz and 80-Hz stimulations was used to determine the 
presence of LFF (67).  Additionally, the ratio of MVIC:80-Hz torque was calculated at 
each time point.  A decrease in this ratio reflects a greater fall in voluntary than 
stimulated torque production, suggesting the presence of central fatigue (18).   
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Fatigue protocol.  Following the baseline test series of contractions, the participant 
completed a unilateral knee extension fatigue protocol consisting of 1 MVDC at 240°.s-1 
every 2 s for 4 min.  Each contraction was cued by an auditory signal and strong verbal 
encouragement was provided by the investigators throughout the protocol.  Visual torque 
feedback, scaled to each participant’s MVIC, was provided throughout the fatigue 
protocol and recovery.  Fatigue was calculated as (24): 
 
average peak power of the final 5 contractions
average of peak power at baseline and during the fatigue trial
 100 [Eq. 2] 
To evaluate potential sites of fatigue and the recovery of power following fatigue, 
the test series was repeated immediately after the final contraction of the fatigue trial, and 
at 5, 10, 20, and 30 min of recovery.  Because deficits in torque and central fatigue can 
recover quickly, the final 2 contractions of the fatigue protocol were used as the first 2 
contractions of the test series at the end of the fatigue protocol.   
 
Statistical analyses.  All data were checked for normality and homogeneity of variance 
prior to any statistical comparisons, using the Kolmogorov-Smirnov test and Levene’s 
statistic, respectively.  If the assumptions of normality or homogeneity of variance were 
violated, non-parametric statistical comparisons were performed.  Differences in group 
descriptive characteristics, muscle architecture, and fatigue were analyzed using 
independent t-tests or Mann-Whitney U tests.  Changes in peak power, MVIC:80-Hz 
torque, 10:80-Hz torque, and contractile properties (RTD and T1/2) between baseline and 
fatigue, and throughout recovery, were analyzed using repeated measures 2-way MIXED 
procedure ANOVAs (group × time).  Linear regression analyses were performed to 
evaluate the relationships between muscle architecture and baseline isometric torque and 
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power, as well as fatigue and measures of physical activity and function, muscle 
architecture, and contractile properties.  For regression analyses in which estimated 
fascicle length was used, only the non-normalized values were included.  All statistical 
analyses were performed using the SPSS statistical software package (v25.0, IBM, 
Chicago, IL) with an alpha level of 0.05.  Data are reported as mean±SE, with exact p-
values, 95% confidence intervals for differences between group means, and effect sizes 
also provided.  Effect sizes were calculated as Cohen’s d (40). 
 
Results 
Baseline characteristics.  Group characteristics are reported in Table F.1.  The young and 
older groups had similar height, body mass, and BMI.  The young group had greater 
habitual physical activity (daily counts and MVPA) compared with the older group.  The 
measures of mobility function indicated a difference only for the SPPB-A, which was 
lower in the older group. 
At baseline, older women were weaker and less powerful than young women 
(Table F.2).  There was no difference between groups in the maximum RTD, but T1/2 was 
slower in older compared with young (Table F.2). 
The within-subject coefficient of variation for the 3 images analyzed for 
pennation angle, muscle thickness, and estimated fascicle length were 5.7±1.2 and 
5.0±1.1, 3.9±1.3 and 3.8±0.9, and 5.7±1.5 and 5.2±1.3% for young and older women, 
respectively, indicating that these were robust measurements in both groups.  Calf 
circumference did not change from pre- to post-imaging in young (38.8±1.6 vs. 38.8±1.5, 
p=0.991) or older (36.4±1.4 vs. 36.5±1.4, p=0.950) women, suggesting that fluid shifts 
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did not impact the architecture measures.  There were no differences between groups in 
pennation angle, muscle thickness, or fascicle length (Table F.2), nor was peak power at 
baseline associated with fascicle length in young (r2=0.085, p=0.493) or older women 
(r2=0.326, p=0.139).  Neither baseline peak power nor maximal isometric torque were 
associated with pennation angle or muscle thickness in young women (r2≤0.127, 
p≥0.386).  Likewise, neither peak power nor maximal isometric torque were associated 
with pennation angle in older women (r2≤0.234, p≥0.225), although there was a trend 
towards an association between muscle thickness and peak power in the older group 
(r2=0.468, p=0.061).  Lastly, muscle thickness was positively associated with maximal 
isometric torque in older women (r2=0.613, p=0.022). 
 
Muscle fatigue.  Changes in peak power during the 4-min fatigue protocol are shown in 
Figure F.3.  With the exception of 1 older woman, who could not attain target velocity 
after the first 25 contractions, all participants were able to complete the 4-min fatigue 
protocol.  Therefore, the fatigue data reported here represent the average for 7 older 
women.  Fatigue was greater in older compared with young women (33.0±4.7 vs. 
56.1±4.4% initial power, respectively; p=0.005, 95% CI: 7.9-35.1, d=1.86).  Analysis of 
changes in the MVIC:80-Hz torque ratio (from 2.02±0.06 and 1.87±0.11 at baseline in 
young and older groups, respectively, to 1.94±0.10 and 1.77±0.09 in young and older at 
fatigue) revealed no age×time interaction (p=0.918) or main effects of group (p=0.097) or 
time (p=0.317), indicating no failure of voluntary activation in either group in response to 
fatiguing contractions.   
199 
 
There was no group×time interaction (p=0.982) or main effect of group (p=0.399) 
for changes in the 10:80-Hz ratio from pre- to post-fatigue, but we did observe a main 
effect of time (p<0.001) for this measure (Figure F.4A), indicating the presence of LFF in 
both groups.  There was no group×time interaction (p=0.536), but we did observe main 
effects of group (p=0.004) and time (p=0.001) on T1/2 such that relaxation slowed 
similarly with fatigue in both groups (p=0.001, Figure F.4B).  The RTD did not change 
with fatigue in young (p=0.783) or older groups (p=0.99, data not shown). 
 
Recovery from fatigue.  The recovery of peak power showed a group×time interaction 
(p=0.025) such that older women recovered more in the first 5 min following the protocol 
than young women (p=0.005), Figure F.3.  Peak power did not differ from baseline by 5 
min of recovery in either group. 
Maximal isometric torque recovered following the fatigue protocol (main effect of 
time, p=0.001), with no effect of group (p=0.95) and no group×time interaction 
(p=0.103); Table F.3.  Full recovery of MVIC was observed 5 min post-fatigue in young 
and older groups (p≤0.001).   
The 10:80-Hz torque ratio revealed no group×time interaction (p=0.326), but we 
did observe main effects of time (p<0.001) and group (p=0.037, Figure F.4A) during 
recovery.  The 10:80-Hz torque ratio increased to pre-fatigue levels within 5 min of 
recovery in both groups (p≤0.01).  There was no group×time interaction (p=0.359), but 
we did observe main effects of time (p<0.001) and group (p<0.001) for changes in T1/2 
during recovery such that torque relaxation recovered comparably in young and older 
women (Figure F.4B).  There was no group×time interaction (p=0.973) and no main 
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effects of group (p=0.085) or time (p=0.867) for the RTD during recovery (data not 
shown). 
 
Factors associated with fatigue.  Regression analyses revealed that fatigue was not 
associated with any parameter of muscle architecture in the young or older women (r2 ≤ 
0.11, p ≥ 0.467).  The ΔMVIC:80-Hz torque from baseline to post-fatigue was not 
associated with fatigue in young (r2 = 0.17, p=0.306) or older women (r2= 0.001, 
p=0.995), confirming that voluntary activation failure did not contribute to fatigue in this 
study.  The Δ10:80-Hz torque from baseline to post-fatigue was directly associated with 
fatigue in young (r2 = 0.709, p=0.008) but not older women (r2=0.014, p=0.804).  In 
contrast, baseline T1/2 was inversely associated with fatigue in older (r2=0.591, p=0.043) 
but not young women (r2=0.145, p=0.351), as illustrated in Figure F.5.  Neither physical 
activity counts nor MVPA were associated with fatigue in young (r2 ≤ 0.035, p ≥ 0.659) 
or older (r2 ≤ 0.056, p ≥ 0.61) women.  Fatigue was associated with SPPB-A score in 
older (r2 = 0.564, p = 0.052), but not younger (r2 = 0.03, p = 0.667) women. 
 
Discussion 
This study was designed to evaluate whether age-related differences in muscle 
architecture, voluntary activation, or contractile properties might be potential 
mechanisms for the greater muscle fatigue observed in older adults in response to high-
velocity muscle contractions.  Peak power fell significantly more in healthy older women 
than in healthy young women, demonstrating the expected age-related difference in knee 
extensor muscle fatigue at high contraction velocities.  The results indicate that baseline 
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differences in contractile properties, and not acute changes in these properties in response 
to fatigue, may contribute to high-velocity fatigue in aging: baseline T1/2 was slower in 
older than young, and predictive of fatigue only in the older group.  There were no age-
related differences in muscle architecture across our study groups, and we provide new 
information that architecture did not contribute to the greater fatigue observed in the 
older group.  Comparisons of the fall in voluntary vs. stimulated tetanic contractions 
during fatigue (i.e., MVIC:80Hz torque ratio) indicated no decrement in voluntary 
activation in either group in response to this high-velocity contraction protocol, ruling out 
activation failure as a source of the difference in muscle fatigue between age groups.  
Comparable LFF was observed in both groups, indicating significant peripheral fatigue in 
response to this protocol that was independent of age.  Overall, these results support 
previous reports of greater fatigue in older muscle during high-velocity work (24,49,222), 
and suggest that this difference may be due in part to chronic changes in muscle 
properties, but not architecture, in the aged. 
 
Baseline.  Notably, there were no age-related differences in baseline muscle architecture 
of the vastus lateralis in these groups of healthy women (Table F.2).  While some studies 
have reported remodelling of muscle architecture in old age (170,173,191,228) such that 
muscle thickness, pennation angle, and fascicle length are reduced with age, most of 
those studies were conducted in men.  In contrast to those results, our data are in 
agreement with those of Kubo et al. who likewise observed no age-related differences in 
vastus lateralis fascicle length, normalized to thigh length, in women (126).  However, 
our results differ from that study insofar as we observed no age-related differences in 
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pennation angle and muscle thickness.  The cause of this discrepancy is not clear at 
present, but does not appear to be due to differences in the age of the participants, nor the 
repeatability of the measurement given the low coefficient of variation found in our 
study.  Questions as to how factors such as habitual physical activity and sex may 
influence architectural changes in old age, as well as the potential functional impacts of 
these changes, remain to be answered. 
At baseline, peak voluntary power and torque were ~40 and ~30% lower, 
respectively, in older compared with young women (Table F.2), which is consistent with 
previous reports (3,23,24).  The maximal RTD during electrically-evoked contractions 
was not different between young and older groups, similar to some (23,24) but not all 
reports in the literature (222).  The T1/2 was slower at baseline in older compared with 
young muscle, a result that is in agreement with most studies (23,24,48,49), and 
potentially due to slowed Ca2+ dissociation from troponin, slower crossbridge kinetics 
(164), a greater relative proportion of type I fibers (141), or a decrease in muscle-tendon 
unit stiffness with age (125).  The slower relaxation in older muscle does not appear to be 
caused by slowed Ca2+ re-uptake by the sarcoplasmic reticulum with age (94). 
 
Fatigue.  Consistent with previous reports (24,48,49,222), we observed greater knee 
extensor muscle fatigue in older compared with young women during contractions at 
240°.s-1.  The question of whether older muscle fatigues more than young depends upon 
the contraction velocity used to fatigue the muscle, with greater fatigue reported at higher 
speeds, i.e., those to the right on the force-velocity curve (24).  The fatigue resistance of 
older muscle under isometric conditions is well reported (33), and the cause of this 
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difference appears to be due to a lower reliance on glycolytic ATP production in older 
compared with young muscle (25,128).  Fatigue induced by slow- and moderate-velocity 
dynamic contractions is similar between young and older adults (23,24,49), while fatigue 
is generally greater in older than young muscle in response to high-velocity contractions 
(24,48,49,222,223,234), as found here.  The goal of this study was to evaluate several 
candidate mechanisms for this difference in fatigue at high contraction velocities.   
Although the young women in our study were more physically active than the 
older women (Table F.1), the magnitude of fatigue in each group was nearly identical to 
that reported by Callahan and Kent-Braun (24), who matched age groups for physical 
activity and used a similar fatigue protocol to the one used here.  Recently, Englund et al. 
reported that 12 weeks of progressive resistance training in mobility-limited older men 
and women improved total torque output (i.e., strength) during a moderate-velocity 
fatigue protocol of the knee extensors, but had no effect on fatigue, expressed as the 
relative fall in peak torque (68).  The effects of an intervention designed specifically to 
increase muscular endurance (i.e., fatigue resistance) remain to be determined, but the 
results to date suggest that the greater fatigue in older compared with young adults during 
high-velocity contractions may be independent of physical activity status.  In further 
support of this notion, we observed no relationship between physical activity counts or 
MVPA and fatigue in either young or older women.  
To evaluate the potential role of changes in the completeness of voluntary 
activation on the age-related differences in muscle fatigue observed here, we compared 
the changes in the MVIC:80-Hz torque from baseline to fatigue (18).  There were no 
changes in this measure from baseline to fatigue in either group, indicating no decrease in 
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voluntary activation with fatigue due to high-velocity contractions, a result similar to that 
reported previously in men (49).  Recently, transcranial magnetic stimulation and femoral 
nerve stimulation were used to examine potential neural mechanisms for greater fatigue 
with age following high-velocity contractions of the knee extensors in men and women 
(222).  In that study, the authors observed a reduction in voluntary activation with fatigue 
in older, but not young women, but these changes in voluntary activation were small and 
not associated with fatigue.  Rather, the authors found a positive association between 
fatigue and the decrease in stimulated twitch torque, consistent with an age-related 
difference in peripheral fatigue due to impairment within the muscle, potentially 
including failure of ECC or crossbridge function.  Indeed, subsequent work by this group 
has shown a significant association between metabolic by-products (Pi, H+, H2PO4-) and 
fatigue during a similar protocol, supporting the notion that age-related differences in 
muscle fatigue occur to differences in the intracellular milieu (62). 
Based upon measures of the m-wave (EMG response to a single electrical 
stimulus), previous studies of knee extensor muscle fatigue indicate that impaired 
excitability of the neuromuscular junction or along the sarcolemma are not responsible 
for the age-related differences observed in fatigue during voluntary dynamic contractions 
such as used here, including those at high velocities (49,222).  Thus, these studies also 
suggest that fatigue under these conditions originates within the muscle.  To determine 
whether greater fatigue in older compared with young muscle was due to failure of ECC, 
i.e., from the t-tubules to the cross-bridges, we compared changes in the 10:80-Hz torque 
ratio from baseline to fatigue (67).  This ratio decreased similarly with fatigue in both 
groups, indicating a comparable failure of excitation-contraction coupling in both young 
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and older women.  Thus, it appears that excitation-contraction coupling failure does not 
explain the age-group difference in fatigue in this study. 
Torque relaxation (T1/2) in response to the 80-Hz tetanic stimulus slowed to a 
similar extent in young and older women during fatigue, which is consistent with some 
literature (35,131).  In contrast, a greater slowing of twitch T1/2 in older compared with 
young muscle following moderate- and high-velocity, but not slow-velocity contractions 
of the knee extensors has been reported (49), with no sex-based differences observed 
(222).  The slowing of T1/2 with fatigue is likely due to an accumulation of proton in the 
cytosol during contractions (21), which has been shown to inhibit Ca2+-ATPase ~2-fold 
with a change in pH from 7.1 to 6.6 (2).  Indeed, the recent work of Sundberg et al (223) 
indicated greater fatigue due to more accumulation of Pi and H+ in the knee extensor 
muscles of older adults. 
Notably, baseline T1/2 was predictive of fatigue in older, but not young women, 
such that ~60% of the variation in fatigue during high-velocity contractions in the older 
group was associated with the rate of torque relaxation in the unfatigued muscle.  
Whether this relationship may reflect an underlying alteration to contractile function that 
is protective against the greater fatigue in older muscles during high-velocity 
contractions, is not known at present.  The mechanisms for slowed T1/2 in old age are not 
entirely clear, but do not appear to include impaired calcium resequestration by the 
sarcoplasmic reticulum (94).  Theoretically, the age-related slowing of T1/2 could be 
caused by: 1) a relatively greater volume of type 1 muscle fibers, 2) slowed detachment 
of myosin from actin, and 3) a less stiff muscle-tendon unit.  These potential mechanisms 
require further evaluation in the context of muscle fatigue in aging. 
206 
 
Recovery from fatigue.  Although peak power and maximal isometric torque were lower 
in older compared with young women at fatigue, both groups returned to pre-fatigue 
values by the fifth minute of recovery (Figure F.3).  Because both groups returned to pre-
fatigue values by the fifth minute of recovery, we could not determine whether recovery 
was faster in young or older women.  In contrast to our observation of maximal isometric 
torque recovering within 5 min, Allman and Rice found incomplete recovery of maximal 
isometric force of the elbow flexor muscles in young and older men following 
intermittent, submaximal isometric contractions, which likewise was accompanied by 
low-frequency fatigue in both groups (4).  More recently, Kent-Braun et al. reported no 
age-related differences in the recovery of torque following 4-min of contractions of the 
knee extensors at 120°.s-1 (109).  Those authors also observed maximal torque was almost 
completely recovered within 5 min, consistent with our observations here.  Overall, the 
rapid and complete recovery of power and isometric torque following a high-velocity 
protocol that induced substantial muscular fatigue suggests a robust resilience of the 
neuromuscular system in this group of healthy but sedentary older women. 
 
Limitations.  We assessed age-related differences in voluntary activation in response to 
fatiguing contractions using changes in the MVIC:80Hz ratio.  Although our observations 
are consistent with recent work (222), the 80-Hz stimulated contractions were delivered 
at an intensity eliciting 50% MVIC torque at baseline.  This approach may underestimate 
voluntary activation because not all motor units are recruited at 50% MVIC, and different 
motor units may be recruited at baseline and fatigue due to changes in the threshold for 
activation.   
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Conclusions.  This study shows that the greater muscle fatigue observed in older 
compared with young muscle during high-velocity contractions was not related to 
differences in muscle architecture, deficits in voluntary activation, failure of excitation-
contraction coupling, or an exaggerated, fatigue-induced slowing of contractile 
properties.  We have shown that baseline T1/2 is inversely associated with greater muscle 
fatigue in older women, which might be explained by selective atrophy of fast-twitch 
muscle fibers, slowed crossbridge kinetics, or changes in muscle-tendon unit stiffness 
with age.  Overall, our results suggest that the cause of age-related differences in muscle 
fatigue reside within the myofibers in healthy older adults; recent work suggests that 
intracellular metabolism may be important in this process (223). 
 
Acknowledgements.  The authors thank the participants for their contributions to this 
study. We are also grateful to Dr. Graham E. Caldwell for his insight and discussion 
relating to the acquisition and analysis of the ultrasound images. Lastly, we thank Sydney 
L. Connor and Jamie M. Truax for their help with the data analysis. 
 
Funding:  This research did not receive any specific grant from funding agencies in the 









95% CI P 
Effect 
size 
Age (yr) 23.4 ± 1.8 69.6 ± 1.1 -50.8, -41.6   
Height (cm) 164.5 ± 1.9 164.3 ± 2.6 -6.6, 7.1 0.942 0.03 
Body mass (kg) 65.3 ± 5.9 66.4 ± 3.8 -16.2, 14.0 0.877 0.08 
BMI (kg.m-2) 24.1 ± 2.2 24.6 ± 1.3 -6.0, 5.0 0.851 0.10 
PA (counts.d-1000) 286.0 ± 29.2 162.6 ± 10.4 52.8, 193.8 0.005 1.99 
MVPA (min.d-1) 47.3 ± 6.5 11.2 ± 2.3 20.5, 51.8 0.001 2.62 
Gait speed (m.s-2) 1.20 ± 0.04 1.17 ± 0.07 -0.1, 0.2 0.740 0.18 
Chair rise time (s) 14.1 ± 1.1 19.5 ± 1.6 -9.5, -1.3 0.140 1.41 
TUG (s) 8.3 ± 0.2 9.0 ± 0.6 -2.1, 0.7 0.382 0.59 
SPPB-A 2.9 ± 0.1 2.5 ± 0.1 0.02, 0.6 0.037 1.57 
Values are mean±SE. 95% CI, 95 % confidence intervals for the difference between group 
means; BMI, body mass index; PA, physical activity; MVPA, moderate- to vigorous-intensity 












95% CI P 
Effect 
size 
Muscle architecture      
Pennation angle 
(°) 
13.5 ± 0.4  13.0 ± 0.6 -1.1, 2.1 0.524 0.33 
MT (mm) 26.1 ± 1.5 23.0 ± 1.8 -2.0, 8.1 0.209 0.66 
eFL (mm) 113.7 ± 8.8 102.7 ± 8.0 -14.5, 36.5 0.371 0.46 
eFL/thigh length 3.1 ± 0.3 2.7 ± 0.2 -0.4, 1.1 0.330 0.50 
Contractile properties 
MVDC (W) 349.8 ± 31.5 202.3 ± 24.9 61.5, 233.6 0.002 1.84 
MVIC (Nm) 134.7 ± 12.0 93.8 ± 6.5 11.7, 70.3 0.01 1.50 
RTD (%pk.ms-1) 1.33 ± 0.12 1.08 ± 0.10 -0.1, 0.6 0.119 0.83 
T1/2 (ms) 118.8 ± 4.4 151.9 ± 6.0 -49.0, -17.2 0.001 2.20 
Values are mean±SE. 95% CI, 95% confidence intervals for differences in group means; MT, 
muscle thickness; eFL, estimated fascicle length; MVDC, maximal voluntary dynamic 
contraction; MVIC, maximal voluntary isometric contraction; RTD, maximum rate of torque 
development; T1/2, torque half-relaxation time. 
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95% CI P 
Effect 
size 
MVIC (% baseline) 
0R 76.3 ± 4.0 68.5 ± 1.7 1.3, 14.3 0.019 0.89 
5R 95.6 ± 2.0 96.0 ± 1.7 -6.8, 6.2 0.921 0.08 
10R 94.6 ± 2.3 97.4 ± 1.2 -9.3, 3.8 0.403 0.53 
20R 91.7 ± 3.5 95.8 ± 1.9 -10.7, 2.4 0.210 0.51 
30R 94.7 ± 1.8 94.9 ± 1.0 -6.6, 6.4 0.976 0.05 
80Hz (% baseline) 
0R 79.6 ± 2.8 72.4 ± 3.1 -3.6, 17.9 0.191 0.86 
5R 83.4 ± 3.7 78.6 ± 4.0 -6.0, 15.5 0.381 0.44 
10R 77.6 ± 4.3 72.0 ± 3.6 -5.1, 16.4 0.301 0.50 
20R 77.7 ± 4.3 70.6 ± 3.5 -3.7, 17.8 0.196 0.64 
30R 80.3 ± 4.1 68.2 ± 4.4 1.3, 22.8 0.029 1.01 
10Hz (% baseline) 
0R 58.9 ± 6.4 51.6 ± 3.1 -4.1, 18.5 0.208 0.51 
5R 77.5 ± 3.0 81.7 ± 3.7 -15.6, 7.1 0.458 0.44 
10R 63.5 ± 4.3 65.3 ± 2.5 -13.1, 9.5 0.750 0.18 
20R 56.1 ± 4.9 62.8 ± 3.1 -18.0, 4.6 0.240 0.57 
30R 60.5 ± 4.6 61.3 ± 2.7 -12.1, 10.6 0.895 0.07 
Values are mean±SE. 95% CI, 95% confidence intervals for differences in group means; 







Figure F.1. Ultrasound image from a representative young woman showing estimated 
fascicle length (eFL), muscle thickness (MT), and pennation angle (ϴ). 
 
 





Figure F.3. Age-related differences in muscle fatigue and recovery.  Older women 
experienced greater fatigue (*p=0.005), but both groups fully recovered within 5 min 




Figure F.4. Fatigue and recovery of contractile properties in young and older women.  A) 
10:80-Hz torque at baseline, fatigue, and throughout recovery.  The 10:80-Hz torque 
ratio decreased with fatigue (#p=0.001) and increased over the first 5 minutes of 
recovery in both groups (#p≤0.01).  B) T1/2 at baseline, fatigue, and throughout recovery.  
Relaxation was slower in older compared with young women at baseline, fatigue, and 
following 5 minutes of recovery (*p≤0.04).  In both groups, T1/2 slowed with fatigue and 
recovered within 5 minutes of recovery in both groups (#p=0.001), with no groupxtime 
interactions.  Data are mean±SE. The dark and light grey shaded boxes represent the 





Figure F.5. Associations between half relaxation time and fatigue.  Fatigue (peak power, 
% initial) was plotted against half relaxation time (T1/2) at baseline. Linear regression 
analysis revealed an association between these variables for older (r2=0.591, p=0.043), 
but not young women (r2=0.145, p=0.351), suggesting the age-related slowing of T1/2 
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